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Abstract 
 
Heart disease is a serious problem for both the individual and society at large. It 
takes many lives. As an acute cardiac nurse I have spent the bulk of my clinical 
and research career striving to provide acute cardiac care outwith the historical 
boundaries of the doctor-led, specialty-based, inpatient setting. The barometer 
of this work however must be the additive knowledge and consequent impact 
on practice it has provided to the cardiovascular community through peer-
reviewed publications. This thesis presents an analysis of the evidence base for 
contemporary developments in acute cardiac care, including 6 core peer-
reviewed publications, and 11 supporting publications where I am either 
primary or secondary author. These publications demonstrate the feasibility, 
safety and efficacy of programmes of cardiac care which depend on complex 
clinical decision-making and teamwork by nurses, paramedics and doctors. 
Critical appraisal of the publications is conducted and the research 
methodologies and theoretical underpinnings analysed. Strengths and 
limitations are identified and the implications and impact on clinical practice 
debated. One of the primary aims of this work is to identify a logical and 
programmatic approach to the body of work, concordant with and focussing in 
detail on the patient journey. Potential areas, and plans, for future research are 
detailed.  
 
Key themes such as moving the site of thrombolytic treatment to the 
Emergency Department (ED), streamlining care for patients presenting to the 
ED with Acute Coronary Syndromes (ACS), establishing and evolving 
communication networks between Coronary Care Unit nurses and ambulance 
paramedics, moving the site of thrombolytic treatment to the ambulance, 
developing an optimal reperfusion programme including pre-hospital 
thrombolysis, primary percutaneous coronary intervention and in-hospital 
thrombolysis, analysis and synthesis of treatment timelines as they are 
distributed across treatment groups are presented.  
 
In totality this work supports the direction of travel towards pre-hospital 
treatment of ACS. Although this may sound somewhat straightforward it is, and 
has been, a significant paradigm shift for multidisciplinary clinicians in the 
United Kingdom. These works in their totality have contributed to defining the 
optimal contribution of multidisciplinary experts to ACS treatment in the United 
Kingdom, and in a Scottish context have contributed to national policy and 
service provision. 
 
Finally this thesis does not sit specifically within the confines of “nursing 
research.” Rather it is defined by healthcare research by a nurse with 
multidisciplinary colleagues. The practice and research described herein is not 
confined within artificial boundaries within one discipline. Rather the study is of 
patient outcomes, systems of care and the contribution of nurses and 
paramedics to the care of patients with ACS.  
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1. For reasons of ease of presentation, brevity, reflexivity and academic 
style, the writing throughout this thesis will be the first person. 
 
2. By nature of the specialty to which this relates there are a number of 
abbreviations throughout this thesis. A glossary of terms appears as 
Appendix 1 (p117). 
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Chapter One - Introduction 
 
1.1 Introduction 
“Heart disease is a serious malady. It takes many lives and cripples many 
more. An intelligent physician can make a diagnosis with 
sufficient accuracy of any heart disease, can give good treatment,  
good advice and can arrive at the cause of the trouble with a fair  
degree of accuracy – no-one else can. 
Any physician can do any and all of these things in his office, the patient’s 
home or elsewhere. He does not need any elaborate or special equipment. 
What he does need, what the patient needs, and what the patient cannot get 
in any other way, is the personal service of a physician.” 
 
Anon, California and Western Medicine (1926: 372) 
 
Although at first-sight this statement might challenge the contemporary 
cardiovascular nurse, there are significant messages within it which are still 
resonant some 84 years after its publication. Heart disease is a serious 
problem for both the individual and society at large. It does indeed take many 
lives. Care for patients experiencing cardiovascular disease, can take place in 
a multitude of settings including both health-care institutions or in the patient’s 
home. There are many aspects of clinical cardiology which require 
knowledge, experience, reasoned judgement and sound decision-making 
rather than elaborate or special equipment.  
 
The evidence presented in this thesis, which relates to work published over a 
ten year period, will provoke the reader to ask whether or not the patient with 
heart disease in 2011 needs the “personal services of a physician,” or 
perhaps more importantly whether or not “no-one else can.”  
 
As an acute cardiology nurse I have spent the bulk of my clinical and 
research career, striving, like a number of others to provide acute cardiac 
care outwith the historical boundaries of the doctor-led, specialty-based, 
inpatient setting.  
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I have striven, in a pragmatic and programmed way, to gradually move the 
acute care of the cardiovascular patient to the place or places where it 
confers the greatest benefits. The barometer of this work however must be 
the additive knowledge and consequent impact on practice it has provided to 
the cardiovascular community through peer-reviewed publications. Davies 
and Rolfe (2009) postulate that a doctoral student being assessed by 
published works must already have a successful track record of publications 
in an established field, before submitting their thesis and defending their work 
in an oral examination.  
 
This thesis presents an analysis of the evidence base for contemporary 
developments in acute cardiac care, including eighteen peer-reviewed 
publications where I am either primary or secondary author. Six of these 
publications will be explored as my “core” pieces of published work. The 
remaining twelve publications, which include abstracts and reports, will be 
used as supporting material, as described in section 1.5 (p6).  
 
Based on a track record of success in investigating the subject area, 
colleagues and I were commissioned by the Chief Scientist Office 
(CSO)/Scottish Government Health Department (SGHD) to investigate the  
feasibility of implementing a programme of care based around guidelines of 
the Scottish Intercollegiate Guidelines Network (SIGN). This work was seen 
as being key to informing national policy and strategic direction.  
 
As one might expect these pieces of work when viewed collectively are 
multifactorial and multifaceted. This body of evidence demonstrates the 
feasibility, safety and efficacy of novel programmes of cardiac care which 
depend on complex clinical decision-making and teamwork by nurses and 
paramedics facilitated by telemedicine. It also further confirms the benefits in 
bringing healthcare to the patient, rather than the patient to healthcare. 
 
 
 
 
 
1.2 Background 
Diseases of the heart and circulatory system (cardiovascular disease (CVD)) 
are the main cause of death in the United Kingdom (UK) and account for 
approximately 200,000 deaths per annum. More than one in three UK deaths 
are as a result of CVD and almost half (48%) of deaths from CVD are as a 
result of its most common manifestation – Coronary Heart Disease (CHD). 
CHD caused almost 94,000 deaths, of which 31,000 were premature deaths 
in the UK in 2006 (Allender et al., 2008). Since this body of work is 
contextualised in Scotland, the latest Scottish mortality data are presented in 
Figure 1: 
 
Figure 1: Coronary Heart Disease in ages <75. European Age 
Standardised Rate of Mortality per 100,000 population in 
Scotland. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
              Scottish Government (2009) 
 
Mortality rates from CHD have declined significantly in Scotland over the last 
twelve years. Ministers may attribute these improvements to policy guidance 
including the CHD and Stroke Strategy for Scotland (Scottish Executive, 
2002) and updated in 2004 (Scottish Executive, 2004).  
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These policy initiatives have helped shape cardiovascular practice over the 
last ten years, in addition to advances in medical and surgical management of 
CVD, improvements in primary and secondary screening, improvements in 
access to CVD services, reductions in major risk factors, and major public 
health initiatives such as smoke-free legislation (Pell et al., 2008).  
 
Nevertheless, despite recent improvements, the death rate from CHD in 
Scotland remains disproportionately high when compared to European 
neighbours, with only Ireland and Finland ranking above Scotland. 
 
1.3 Aims of this thesis 
This thesis will outline the aims, drivers, context and questions which resulted 
in the published works presented. Critical appraisal of the publications will be 
conducted and the research methodologies and theoretical underpinnings 
analysed. Strengths and limitations will be identified and the implications and 
impact on clinical practice debated.  
 
One of the primary aims of this work is to identify a logical and programmatic 
approach to the body of work, concordant with and focussing in detail on the 
patient journey. Potential areas (and plans) for future research will also be 
detailed. 
 
1.4 Research Questions 
The primary research question for this work is: 
1.4.1 - What constitutes the optimal treatment model for patients 
presenting with Acute Coronary Syndromes? 
 
Secondary questions are: 
1.4.2 - What is the optimal contribution of multidisciplinary experts to 
Acute Coronary Syndromes treatment? 
1.4.3 - Based on this work, what areas require a research focus in the 
future? 
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These research questions were addressed through the peer-reviewed 
publications making up this body of work. A summary of published works can 
be found in section 1.5 (p6).  
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1.5 Published works 
 
Core published works 
1 McLean, S., Wild, S., Connor, P. & Flapan, A.D. (2010b) Treating ST 
Elevation Myocardial Infarction by Primary Percutaneous Coronary 
Intervention, In-hospital thrombolysis and Pre-hospital thrombolysis. An 
observational study of timelines and outcomes in 625 patients. Emergency 
Medicine Journal doi:10.1136/emj.2009. 086066. 
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decision making between Paramedics and CCU nurses based on 12 lead 
ECG telemetry expedites the delivery of thrombolysis in ST Elevation 
Myocardial Infarction. Emergency Medicine Journal 25 370-374. 
4 McLean, S. & Timmins, F. (2007) An exploration of the information needs 
of spouse/partner following acute myocardial infarction using focus group 
methodology. Nursing in Critical Care 12 141-150. 
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door-to-drug time and ST segment resolution in AMI by moving 
thrombolysis administration to the emergency department.  Accident and 
Emergency Nursing 12 2-9. 
6 Robb, C. & McLean, S. (2000) Using pressure dressings after femoral 
artery sheath removal. Professional Nurse 15 371-374. 
 Supporting published works 
7 Fox, K.A.A. & McLean, S. (2010) NICE Guidance on Chest Pain. Heart 96 
903-906. (Editorial) 
8 Fitzpatrick, D. & McLean, S. (2010) Reperfusion of the old or the new: Left 
Bundle Branch Block? Journal of Paramedic Practice 2 50–55. (Original 
paper) 
9 McLean, S. (2009a) Clinical history versus the exercise ECG in 
assessment of stable coronary artery disease. British Journal of Cardiac 
Nursing 4 363-366. (Original paper) 
10 McLean, S., Preston, J. & Flapan, A.D. (2008b) Belching: An unusual 
clinical presentation of Coronary Ischaemia. Scottish Medical Journal 53 
10. (Case report) 
11 McLean, S., Mondoa, C. & Divers, F. (2007) The Cardiology Nurse 
Consultant in Scotland. British Journal of Cardiac Nursing 2 589-591. 
(Narrative/Opinion piece) 
12 McLean, S. (2006) Chest Pain: Providing an integrated service for 
patients. Emergency Nurse 13 12-14. (Narrative/Opinion piece) 
 Published abstracts 
13 Maccioca, P., Cruden, N., McLean, S., Flapan, A.D. & Newby, D.E. (2010) 
Effect of smoking status on angiographic outcomes and 12-month mortality 
following primary percutaneous coronary intervention for acute myocardial 
infarction. Heart 96 (Suppl 1):A27. 
14 McLean, S. & Flapan, A.D. (2009) Decision-making between nurses and 
paramedics in reperfusion of ST elevation myocardial infarction. Heart 95 
(Suppl 1):A35. 
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15 McLean, S. (2009b) Decision-making between nurses and paramedics in 
reperfusion of ST elevation myocardial infarction. European Journal of 
Cardiovascular Nursing 8 (Suppl 1):S23. 
 Commissioned reports 
16 McLean, S., Wild, S., Connor, P. & Flapan, A.D. (2009) Strategies for 
optimal reperfusion in ST segment elevation myocardial infarction. A 
feasibility study for provision of primary percutaneous coronary intervention 
and pre-hospital thrombolytic therapy in Scotland: A report of one-year 
follow-up.  A report to the Chief Scientist Office re. grant no. CZB/4/413. 
(Grade – Excellent). 
17 McLean. S., Wild, S., Connor, P. & Flapan, A.D. (2008c) Strategies for 
optimal reperfusion in ST segment elevation myocardial infarction. A 
feasibility study for provision of primary percutaneous coronary intervention 
and pre-hospital thrombolytic therapy in Scotland. A report to the Chief 
Scientist Office re. grant no. CZB/4/413. (Grade – Excellent). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter Two – Review of the literature 
 
2.1 Acute Coronary Syndrome (ACS) 
The term ACS is essentially an “umbrella” term which encompasses a range 
of definitive diagnoses of acute Coronary Artery Disease (CAD) along a 
spectrum of outcome-based severity. It is well established that ACS, in their 
different clinical presentations share a common pathophysiological substrate 
(Bassand et al., 2007). Detailed studies have demonstrated that 
atherosclerotic plaque rupture within the coronary artery results in 
superimposed thrombosis and embolisation. The resulting hypoperfusion of 
the myocardium represents the basic pathophysiological mechanism of ACS 
(Bassand et al., 2007). Careful assessment using clinical acumen, diagnostic 
tools and quantitative risk-stratification are key to the optimal management of 
ACS.  
 
Figure 2: The spectrum of acute coronary syndromes. 
  
 
 
 
Bassand et al. (2007) 
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While there are published data on many thousands of patients describing the 
optimal management of ACS in the cardiology inpatient setting, there are 
significantly fewer data describing the identification and management of these 
patients in settings where patients present with undifferentiated chest pain 
(Lyon et al., 2007). Differentiating patients with ACS from patients with chest 
pain not due to plaque rupture within a coronary artery is a major diagnostic 
challenge (Carruthers et al., 2005). This is important given Deakin et al.’s 
report (2006) that only one of every eighteen calls to 999 ambulance services 
with chest pain result in an in-hospital diagnosis of ACS. 
 
While cardiovascular clinicians are familiar with the risk stratification of 
patients presenting with ACS, there is a dearth of evidence describing the 
application of this skill in an undifferentiated population (de Araújo Gonçalves 
et al., 2005), and no evidence reporting risk stratification by cardiovascular 
nurses in undifferentiated populations (McLean et al., 2010a).  
 
Pottle (2005) reported the non-inferiority of services provided by 
cardiovascular nurses in 454 patients attending her Rapid Access Chest Pain 
Clinic between 2001 and 2003. There are also reports of staff perceptions of 
“front-door” chest pain nurses (Dunkley et al., 2006; McLean, 2006; 
MacIntosh, 2010), and advantages and disadvantages of chest pain nurses in 
expediting patient flow through the care system (Mullan et al., 2007; O’Neill 
and Currie, 2007; MacIntosh, 2010). There are however few, if any, reports of 
the quantifying benefits of cardiovascular risk-stratification performed by 
cardiovascular nurses in the acute setting. 
 
Previous investigators have commented that one of the disadvantages of 
quantitative risk-stratification tools is that they are constructed from data 
pertaining to patients with confirmed ACS, rather than patients with 
undifferentiated chest pain (Lyon et al., 2007). The risk-scoring matrixes tend 
to be validated amongst patients admitted to specialist cardiology services, a 
group who are likely to be at higher risk of significant cardiac events than 
those presenting to an ED (Conway-Morris et al., 2006).  
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The Global Registry of Acute Coronary Events (GRACE) risk prediction tool 
provides a method of calculating the risk of in-hospital death, 6-month death 
and MI (Fox et al., 2006). The tool is designed to reflect a broad population of 
patients with ACS and has enrolled 102,341 patients in 247 hospitals over 30 
countries (GRACE, 2009). Portuguese investigators have reported that the 
GRACE score was superior to other available scores in predicting the risk of 
death or MI at one-year following hospital admission (de Araújo Gonçalves et 
al., 2005). Siebens et al. (2007) highlighted that risk scores such as GRACE, 
and others, are available to help nurses as they triage patients with chest pain 
in designated chest pain units. They cite evidence of patients with chest pain 
being safely triaged by nurses (Smith, 2000), while Quinn et al. (2000) 
concluded that CCU nurses were more likely to identify suitability for transfer 
to a general ward as compared with a physician-devised algorithm, in patients 
with chest pain.  
 
In spite of this however  there are few reports in the nursing literature detailing 
the training in, quality of, or assessment of clinical history taking (and risk-
stratification) by nurses (McLean, 2009a). This is a worrying phenomenon, 
given Ramani’s assertion (2004) that quality patient history taking leads to the 
final diagnosis in approximately 75% of cases.  
 
 
2.2 ST segment elevation myocardial infarction 
 
2.2.1 Evolution of treatment strategies in ST segment elevation 
myocardial infarction 
 
Along a spectrum of chronic and acute CAD, the condition resulting in the 
highest early mortality is ST Segment Elevation Myocardial Infarction 
(STEMI). The treatment of STEMI has developed significantly over the last 
40-years (Hanson and Williamson, 2006). One of the earliest developments 
was to establish specialist Coronary Care Units (CCU’s) to monitor cardiac 
rhythm and allow prompt treatment of ventricular arrhythmia by cardioversion 
using defibrillators (Quinn and Thompson, 1999). Professor Desmond Julian 
established one of the world’s first CCU’s in the Royal Infirmary of Edinburgh 
in the early 1960’s (Julian, 1961).  
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While the focus of community-based resuscitation by lay responders remains 
on the application of basic life support techniques, the use of defibrillation has 
moved over time from the CCU (Julian, 1961), to the ambulance (Pantridge 
and Geddes, 1967) and finally into the community by trained lay-responders 
(Hallstrom et al., 2004) and to ‘public access’ schemes (Davies et al., 2002). 
This demonstrates the journey of a treatment originally conceived in and for 
the CCU, out to its application in people’s homes, shops, airports and other 
community settings. 
 
In 1980 de Wood and colleagues demonstrated the role of occlusive coronary 
artery thrombus in acute myocardial infarction (de Wood et al., 1980). The 
use of thrombolytic drugs to restore coronary artery patency in myocardial 
infarction (MI) was then widely adopted following the major clinical trials of the 
1980’s (GISSI, 1986; ISIS-2, 1988). Like defibrillation, the use of thrombolytic 
therapy has moved from the CCU (Quinn and Thompson, 1999), to the 
Emergency Department (ED) (Pell et al., 1992; Quinn et al., 2005), then 
finally to the community (Schofer et al., 1990; Barbash et al., 1990; Weaver et 
al., 1993; Rawles, 1994). 
 
This very brief synopsis describes the evolution of two key advances in the 
treatment of cardiac arrest and myocardial infarction. There are in addition 
important historical milestones to acknowledge in the nursing contribution to 
the care of these patients. Quinn and Thompson (1999) cite 1964 as the year 
in which Dr. Meltzer (1964) published the first report of nurses formally being 
taught rhythm recognition and the application of defibrillation to patients in 
cardiac arrest. Killip and Kimball (1967) then made the very important 
statement in The American Journal of Cardiology that: “In our opinion, optimal 
treatment ... cannot be attained unless certain prerogatives hitherto reserve 
for the physician are delegated to the nurse.” (1967:463). These were crucial 
formative years for the pioneers of coronary care units and coronary care 
nursing. Quinn and Thompson (1999:135) pay tribute to Dr. Meltzer and his 
nursing colleague Rose Pinneo for what is widely regarded as one of the first 
and most widely used books on coronary care nursing (Meltzer et al., 1965), 
stating that they deserve credit as the “true pioneers of coronary care 
nursing.” 
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While the chronology may seem almost intuitive, significant debate remains in 
some parts of the clinical community regarding the scientific justification, 
evidence base and safety of developing what have become ‘modern’ 
programmes of STEMI care. While evolving evidence reported the benefits 
(or otherwise) of new generation drugs or interventional technologies, there 
was little evidence reporting how these technologies could be applied in a 
contemporary healthcare model, with its historical professional boundaries 
and intricate inter-professional relationships and governance arrangements.  
 
2.2.2 The critical importance of time-to-treatment 
The now ubiquitous phrase imparted upon every new recruit to cardiovascular 
units across the world of “minutes mean muscle,” has probably been in 
existence since the beginning of treatment of STEMI with thrombolytic (“clot-
busting”) drugs.  
 
Following de Wood et al.’s discovery (1980), cardiovascular scientists and 
clinical trialists embarked on a series of now seminal trials describing the 
treatment of myocardial infarction. There were pre-dated by a number of key 
exploratory trials attempting to assess the benefits of coronary artery 
recanalisation (reopening of the occluded coronary artery) by means of 
intravenous and intracoronary thrombolytic treatment. In an early meta-
analysis Yusuf et al. (1985) concluded that an overview of some 6,000 
patients in 25 randomised trials indicated that intravenous treatment with 
streptokinase produced a significant reduction (p<0.001) in the odds of death, 
and an even larger reduction in the odds of reinfarction (both at index 
admission and up to 6-months following hospital discharge), with an absolute 
frequency of serious adverse effects to set against this that was much smaller 
than the absolute mortality reduction (Yusuf et al., 1985). They stated that 
“because of the irreducibly large effects of the play of chance on individual 
trial results, the disadvantages of doing meta-analyses pale into insignificance 
compared with the disadvantages of not doing them, and of basing inference 
instead on whichever few trial results one happens to find the most attractive” 
(1985: 582), and concluded that future trials should obviously be much larger 
than previous trials. 
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ISIS-2 (1988) tested streptokinase, aspirin, both or neither in 17,187 patients 
with MI. There were significant mortality reductions when treating MI patients 
with aspirin versus placebo (p<0.0001) and streptokinase versus placebo 
(p<0.00001). Furthermore there was an additive effect, with patients receiving 
both agents having a superior outcome versus patients receiving neither 
agent or either agent alone (both p<0.00001).  This came at a cost of 
increased cerebral haemorrhage (p<0.05), and an excess of non-fatal 
reinfarction was reported when streptokinase was used alone, but this 
appeared to be avoided by the addition of aspirin. 
 
ISIS-3 (1992) then compared two treatment modalities. MI patients receiving 
unfractionated Heparin in addition to oral aspirin, over aspirin alone 
experienced slightly less reinfarction and mortality, though neither of these 
findings were statistically significant, and came with a cost of significant 
increases in cerebral and non-cerebral bleeding in the Heparin group (p<0.01 
and p<0.05 respectively). Perhaps more importantly this study found that (i) 
treatment with anistreplase was not superior to streptokinase, with no 
significant difference in mortality or reinfarction and at a cost of increased 
cerebral haemorrhage (p<0.0001), and (ii) treatment with tissue-plasminogen-
activator was superior to streptokinase in terms of significantly reducing 
renifarction (p<0.02), but again at a cost of increased cerebral haemorrhage 
(p<0.00001) and with no significant mortality benefit. 
 
In these trials patients were eligible if they were thought to be within 24-hours 
of the onset of the symptoms of suspected or definite MI (with or without ECG 
changes), with randomisation occurring at a median of 4-hours after the 
symptom onset (ISIS-2, 1988), and 9.6-hours in Yusuf et al.’s meta analysis 
(1985). The site of randomisation or treatment in both ISIS-2 (1988) and 
Yusuf et al. (1995) is not clear, although it is clear that no patients received 
treatment in the pre-hospital setting. 
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Lau et al. (1992) then published a cumulative meta-analysis of 36,974 
patients enrolled in 33 STEMI trials between 1959 and 1988. They suggested 
that the technique of cumulative meta-analysis allows practitioners and policy-
makers to study trends in ‘good’ and ‘bad’ effects and “pinpoint the first time a 
difference in outcome between treatment and control groups becomes 
statistically significant” (Lau et al., 1992:248). They purported that a 
consistent, statistically significant reduction in total mortality was achieved in 
trials published by 1973, after only eight trials including 2,432 patients had 
been completed. The results of the 25 subsequent trials, which enrolled an 
additional 34,542 patients had little or no effect on the odds ratio establishing 
efficacy, but did narrow the 95% confidence interval. While the authors did not 
suggest it explicitly, there may be an argument to be made from Lau et al. 
that the benefits of thrombolytic therapy in clinical practice could have been 
realised earlier. 
 
In 1994 the Fibrinolytic Trialists Collaboration (FTT, 1994) published an 
important meta-analysis of 58,600 patients in nine randomised trials 
conducted between 1982 and 1992. They concluded that in the 45,000 
patients presenting with ST segment elevation or Bundle Branch Block the 
relation between benefit and delay from symptom onset indicated highly 
significant absolute 35-day mortality reductions of about 30 per 1,000 for 
those presenting within 0-6 hours of symptom onset, around 20 per 1,000 for 
those presenting from 7-12 hours, and a statistically uncertain benefit of about 
10 per 1,000 for those presenting between 13-18 hours (with more 
randomised evidence needed in this latter group to assess reliably the net 
effects of treatment). This overview concluded that thrombolytic therapy was 
beneficial in a much wider range of patients than was given routinely in 
clinical practice, using Figure 3 to present the linear time-based reductions in 
treatment benefit. 
 
 
 
 
 
Figure 3: Absolute reduction in 35-day mortality versus delay from 
symptom onset to randomisation among 45,000 patients with 
ST segment elevation or Bundle Branch Block (BBB). 
 
 
FTT (1994) 
 
In 1996 Boersma and colleagues in Rotterdam published what became a 
seminal meta-analysis of 22 trials including 50,246 patients, of whom 16,197 
(21%) were randomised to thrombolytic therapy within 3-hours of symptom 
onset. Boersma and colleagues accepted that the ‘first golden hour’ of 
maximal benefit of thrombolytic therapy was supported by both experimental 
studies and randomised trials, however sought to explore whether or not a 
substantial additional reduction of mortality could be achieved with treatment 
within 2–3 hours of symptom onset. As demonstrated in Figure 4 (overleaf) 
they cited the first randomised studies of pre-hospital thrombolytic therapy in 
the meta-analysis, for example EMIP (1993). 
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Figure 4: Mortality at 35-days in randomised studies comparing pre-
hospital (circles) with in-hospital (squares) thrombolytic 
treatment. 
 
 
Boersma et al. (1996) 
 
Boersma et al. (1996) postulated that the FTT investigators (1994) concluded 
from these data a gradually increasing benefit with earlier treatment, without 
significant additional treatment effect at 0–1 hours, and that according to this 
analysis little would be gained by extra efforts to achieve very early, pre-
hospital thrombolytic therapy. Boersma et al. (1996) criticised the FTT 
decision to exclude small trials (which FTT arbitrarily defined as less than 
1,000 patients), particularly as a significant proportion of these trials included 
patients treated in the pre-hospital setting, and therefore treated very early. 
Boersma et al. also commented that the FTT statistical analysis was based 
on subdivision of patients according to delay from symptom onset with only 
two benefit estimations in the first 3-hours. Boersma et al. suggested that in 
this way, part of a potential large effect in the first 2-hours may be obscured 
by a relatively small effect in the third hour. The findings of Boersma et al. 
(1996) challenged the findings of FTT (1994) that there was linear benefit 
when reducing time-to-treatment in STEMI. 
 
Boersma et al. (1996) suggest that the absolute benefits of thrombolytic 
therapy in mortality reduction were greatest within 1-hour of symptom onset 
with 65 lives saved per 1,000 patients treated (Figure 5).  
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Lives saved per 1,000 patients treated were 37 from 1-2 hours of symptom 
onset and 26 per 1,000 patients from 2-3 hours. These estimations were 
significantly higher than those published by the FTT investigators (1994). 
 
Figure 5: Proportional effect of thrombolytic therapy on 35-day mortality 
according to treatment delay (Odds ratios, plotted with 95% CI 
on a log scale, are significantly different over the six groups 
(Breslow-Day test, p=0·001)). 
 
 
Boersma et al. (1996) 
 
The investigators stated that while they agreed with the concept of the ‘first 
golden hour,’ their alternative analysis supported a non-linear relation which 
was in-line with the experimental and pre-hospital trial data. As shown in 
Figure 6, they graphically presented their data to show the non-linear 
relationship, versus the linear findings of the FTT investigators (1994) (Figure 
3). 
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Figure 6: Absolute 35-day mortality reduction versus treatment delay. 
 
 
Boersma et al. (1996) 
 
Boersma et al. (1996) concluded that: “from a clinical standpoint, the 
challenge is to initiate thrombolytic treatment within the first 2 to 3 hours after 
symptom onset. A first important step will be to increase public awareness of 
the need to reduce delay in seeking medical help for cardiac symptoms. 
Second, as an aid to rapid diagnosis when there is chest pain suggestive of 
infarction, the general practitioner or ambulance team should obtain, 
preferably on-site, a computer-interpreted standard 12-lead ECG” (1996: 
774). 
Stating that many North American EMS systems had implemented PHT 
programmes despite the fact that most were situated in urban areas with 
rapid transit times and short door-to-needle times, Morrison et al. (2000) 
performed a meta-analysis of 6 RCTs including 6,434 patients. The primary 
objective of this meta-analysis was to critically appraise all RCTs of PHT 
versus IHT. The primary outcome measure was all-cause hospital mortality; 
secondary outcome measures were EMS scene times, time to thrombolytic 
treatment, infarction size, and adverse events, including ventricular fibrillation, 
cardiogenic shock, hypotension, bradycardia, bleeding, and stroke.  
 
   18
   19
The results of the 6 RCTs were pooled and indicated significantly decreased 
all-cause hospital mortality among patients treated with PHT compared with 
IHT (odds ratio, 0.83; 95% confidence interval, 0.70-0.98). Median time to 
thrombolysis was 104-minutes for the PHT group and 162-minutes for the IHT 
group (p=0.007). Results were similar regardless of trial quality or training and 
experience of the provider, which in the trials studied included general 
practitioners, intensivists, hospital physicians and EMS paramedics (Morrison 
et al., 2000).  
At around the same time as Boersma et al.’s meta-analysis, key trials began 
to emerge reporting the outcomes of performing Primary Percutaneous 
Coronary Intervention (PPCI) in STEMI. One of the first was published by 
Zijlstra et al. (1993). 152 patients were randomised to PPCI and 149 patients 
to streptokinase thrombolysis with median times to treatment of 62-minutes 
for PPCI and 30-minutes for thrombolytic therapy. There were no adjunctive 
therapies common to modern practice such as intracoronary stents or 
intravenous glyocoprotein inhibitors used in the PPCI group. The study found 
that there were statistically significant reductions in death (1% vs 7%), non-
fatal reinfarction (1% vs 12%) and stroke (0.7% vs 2%) in patients receiving 
PPCI. 
As with many new technologies, initial trials were small and single-centred. 14 
of the 23 trials cited in Keeley et al.’s meta-analysis (2003) for example had 
less than 100 patients in each treatment arm.   
 
Keeley et al. (2003) included 7,739 patients from 23 trials conducted between 
1993 and 2002 in their meta-analysis. Crucially they distinguished between 
patients receiving fibrin-specific (standard tPA, accelerated tPA and 
duteplase), versus non-fibrin specific (streptokinase 1.2mU and 1.5mU) 
thrombolytic therapy and demonstrated the superiority of PPCI over both 
fibrin specific and non-specific thrombolytic agents. Figure 7 displays the 
benefits in short and long term outcome: 
 
 
 
 
Figure 7: Short and long-term clinical outcomes in patients treated with 
PPCI or thrombolytic therapy. 
 
 
Keeley et al. (2003) 
 
Keeley et al. (2003) acknowledged that a number of the trials included in their 
meta-analysis did not reflect current and evolving practice at the time of 
publication (use of streptokinase, low or no use of intracoronary 
stents/intravenous glycoprotein inhibitors). Conversely the analysis is 
strengthened by the authors efforts to separate fibrin specific/non-fibrin 
specific agents, inclusion of multi-centre (and therefore multi-operator and 
multi-volume) PPCI programmes, and inclusion of long-term follow-up data. 
Like Boersma et al. (1996), and unlike FTT (1994), Keeley et al. (2003) do 
mention pre-hospital treatment. While focussing primarily on PPCI  Keeley et 
al. (2003) cite and discuss Bonnefoy et al. (2002), and stated that Bonnefoy 
et al. (2002) concluded that PPCI was no better than pre-hospital thrombolytic 
therapy in patients who presented within six hours of STEMI. 
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In the following year Bogaty and Brophy (2004) published criticism of Keeley 
et al. (2003), concluding “that reasonable health care professionals may still 
find considerable uncertainty about the superiority of primary angioplasty for 
all situations. The magnitude of benefit for primary angioplasty over 
thrombolysis is probably less than 1 to 2 lives saved/100 patients treated and 
largely depends on the choice of thrombolytic agent, time to treatment, place 
of treatment, and adjunctive therapy” (Bogaty and Brophy, 2004:292). They 
stated that there was scarce evidence that systematically transferring patients 
for primary angioplasty in routine practice would provide benefits over 
thrombolysis, and that consequently it may be most useful to view these 
treatments as complementary rather than competitive. Thrombolysis, they 
stated, remains a clinically and economically attractive option for the 
treatment of acute myocardial infarction that does not require the radical 
restructuring of health care systems (Bogaty and Brophy, 2004). 
 
Bonnefoy et al. (2002) cited the findings of the 1993 EMIP analysis, a 17% 
lower relative mortality in patients receiving prehospital thrombolysis (PHT) 
versus in-hospital thrombolysis (IHT), stating that thrombolysis had since 
evolved from a stand-alone strategy to a strategy where it had become 
combined with PCI. Their French study of 840 patients in 27 tertiary hospitals 
aimed to compare PHT followed by transfer to a centre with interventional 
facilities, versus PPCI.  The methodology of and recruitment to Bonnefoy et 
al.’s CAPTIM trial (2002) was criticised subsequently by Boersma et al. 
(2006) and Terkelsen et al. (2009). Firstly although 1,200 patients were 
needed to demonstrate a foreseen 44% relative reduction in the composite 
endpoint of death, non-fatal reinfarction and non-fatal stroke, only 67% of the 
target sample size was achieved (n=840) due to cessation of research 
funding. Thereafter coronary angiography and subsequent revascularisation 
were allowed in the thrombolysis group at the discretion of the responsible 
physician. This resulted in the significant majority of thrombolysis patients 
(358/419, 85%) having angiography within 30-days of treatment, and 70% 
(n=295/419) having angioplasty. Conversely only 86% (n=364/421) of 
patients assigned to PPCI underwent the procedure.  
Commentators (Boersma et al., 2006; Terkelsen et al., 2009) have since 
criticised this and claim that this was the reason for the similarities in death 
and in the composite endpoint (Figure 8).  
 
Figure 8: Kaplan-Meier curves for death (upper panel) and composite 
endpoint (lower panel) within 30-days after randomisation 
according to treatment group. 
 
 
Bonnefoy et al. (2002) 
 
CAPTIM therefore showed that PHT followed by PCI within 30-days of 
admission in 70% of cases, yielded a statistically similar outcome to PPCI. 
The authors do however comment that, although not a pre-specified outcome, 
an exponential mortality reduction was noted when thrombolytic therapy was 
initiated within 3-hours of symptom onset, and that mortality reduction was 
highest in patients treated within 2-hours of symptom onset than those treated 
later (44% vs 20%, p=0.001). 
 
Boersma and colleagues then revisited the issue of time-to-treatment in a 
second analysis in 2006.  
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The aim of their pooled analysis of 6,763 patients in 22 trials reported since 
1990 was to assess whether the clinical benefit of PPCI compared with IHT 
was modulated by time-to-treatment in a pooled analysis of Randomised 
Controlled Trials (RCTs) reported since 1990.  
 
Despite the study analysing time-to-treatment rather than logistics of 
treatment, the authors elected to exclude the CAPTIM trail (2002) from their 
analysis on the basis that it was a pre-hospital study. The median time to 
thrombolysis in the pooled analysis was significantly shorter than that of the 
beginning of PPCI (19-minutes vs 76-minutes respectively, giving an overall 
PPCI-related delay of 55-minutes (p<0.001)). In patients randomised to IHT 
30-day mortality increased two-fold as the presentation delay increased from 
less than 1-hour to over 6-hours (p<0.001), yet the trend to similar in PPCI 
patients was not significant (p=0.06). The combined endpoint of 30-day death 
and reinfarction occurred in 13.5% of IHT and 7.3% of PPCI patients 
(p<0.001), although it should be noted that a significant number of patients 
received streptokinase thrombolysis. According to presentation delay the 
treatment effect consistently favoured PPCI in all subgroups. The absolute 
mortality reduction by PPCI increased from 1.3% in patients randomised in 
the first hour after symptom onset to 4.2% in those randomised after 6-hours. 
Consequently with increasing delay, the number needed to treat to prevent a 
death decreased from 77 to 24 patients. Finally, Boersma and colleagues 
(2006) stated that the logistical and economic challenges which make ‘PPCI-
for-all’ unlikely, do not negate the importance of developing comprehensive 
and unified approaches to the delivery of acute cardiac care. They concluded 
that while PPCI-related-delays remain as high as 93-minutes (as they were in 
some population-based studies), thrombolysis would remain a viable 
treatment strategy when timely PPCI is not available: “one treatment does not 
fit all: time matters” (2006: 775). 
 
The real-world setting of STEMI reperfusion was described by the Swedish 
RIKS-HIA registry (Stenestrand et al., 2006). While acknowledging that RCTs 
are “rightly at the top of the evidence hierarchy” (2010:908), McNamara 
highlights that registry research has gained increasing visibility within 
cardiovascular medicine.  
He purports that while RCTs “may be able to provide the basis for the most 
‘beautiful’ management strategies, determining how these strategies work in 
the ‘real-world’ is critical” (McNamara, 2010:908). Stenestrand et al. (2006) 
compared the outcomes of PPCI with PHT and IHT in 26,205 STEMI patients 
admitted between 1999 and 2004. Figures 9, 10 and 11 summarise these 
data.  
 
Figure 9 describes temporal trends in PPCI and IHT and the continually 
widening gap between IHT and PPCI mortality favouring PPCI, perhaps due 
to an increase in the use of PPCI in 8.3% of STEMI patients in 1999 to 37.2% 
in 2004. Median delay was 47-minutes shorter for  PHT and 43-minutes 
longer for PPCI against a reference point of patients receiving IHT. PPCI was 
associated with lower mortality than IHT at 7-days, 30-days, and 1-year. Also 
PHT predicted a lower adjusted mortality than IHT at 30-days and 1-year. 
Finally, PPCI predicted lower mortality than PHT at 30-days (4.9% vs 7.6%) 
and at 1-year (7.6% vs 10.3%) (Figure 10). 
 
Figure 9: Temporal trends in 1-year mortality in IHT and PPCI patients 
in RIKS-HIA. 
 
 
Stenestrand et al. (2006) 
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Figure 10: Unadjusted cumulative mortality during the first year after 
the STEMI admission in RIKS-HIA. 
 
 
Stenestrand et al. (2006) 
 
Arguably the most powerful data to emerge from Stenestrand et al. (2006) 
related to differences in mortality when treatment was received early. During 
the first 2-hours of infarction, there was an approximate 2% absolute 
difference in mortality favouring PPCI, which rose to about 6% to 7% after 6 
to 7 hours. Not until after 7-hours’ delay did the age-adjusted 1-year mortality 
for PPCI reach the same mortality as thrombolysis given within 2-hours 
(Figure 11). While acknowledging the advantages and deficiencies of registry 
data, the authors concluded that the relative mortality benefits with PPCI 
might amount to approximately 20% during the first hours but increase to 35% 
after 4 to 7 hours. They stated that this was concordant with Boersma’s meta-
analysis (2006) and contradicts Bonnefoy et al.’s CAPTIM trial (2002) which 
claimed that PPCI was not superior (and indeed may be inferior) to PHT 
within 2-hours of symptom onset.  
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Figure 11: Estimate cumulative mortality for patients receiving 
reperfusion treatment within 2-hours or after 2-hours after 
symptom onset. 
 
 
Stenestrand et al. (2006) 
 
2004 saw the publication of updated STEMI guidelines of the American 
College of Cardiology (ACC)/American Heart Association (AHA). The 
publication (Antman et al., 2007) and the position statement of the European 
Society of Cardiology (Bassand et al., 2005) was, according to Terkelsen et 
al. (2009), based around findings in the meta-analysis of Nallamothu & Bates 
(2003). Terkelsen et al. (2009) are scathing in their criticism of Nallamothu & 
Bates’ work. They claim that Nallamothu & Bates inaccurately extracted 
tabulated data and used incorrect PPCI-related-delay times, thus 
underestimating the maximal accepted PPCI-related-delay.  
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Nallamothu and Bates (2003) used data from the 3 primary sources of Keeley 
et al. (2003) and extracted (i) 4-6 week incidence of death, reinfarction and 
stroke in patients who received PPCI or thrombolytic therapy, and (ii) the 
PPCI-related time delay. After excluding 2 of the 23 studies they performed 
variance-weighted linear regression analysis to assess the impact of PPCI-
related time delay on treatment differences for death in 21 studies, and the 
combined end point of death, reinfarction, or stroke in 13 studies reporting 
this end point. As PPCI-related time delay increased, the absolute mortality 
reduction favouring PPCI decreased significantly (0.94% decrease for every 
additional 10-minute delay; p=0.006). Overall, the two reperfusion strategies 
appeared to become equivalent with regard to mortality after a PPCI-related 
time delay of 62-minutes.  
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The impact of PPCI-related time delay on the composite end point of death, 
reinfarction, or stroke was also significant (absolute 1.17% decrease for every 
10-minute delay; p=0.016). The time to equivalence for the composite end 
point, however, was longer at 93 minutes. 
 
Terkelsen et al. (2009) repeated the regression analysis performed by 
Nallamothu and Bates (2003). They found that the acceptable PPCI-related-
delay was in fact 119-minutes (as opposed to Nallamothu and Bates’ 62-
minutes) when compared to all-comer thrombolysis, and 86-minutes when 
compared to fibrin-specific thrombolysis. The authors acknowledge however 
that their findings are based on summary statistics at trial level rather than 
individual patient data and thus should be interpreted with caution. 
Nevertheless they concluded that while the maximal PPCI-related-delay may 
be an issue unsettled, it is likely to be around 80-120 minutes.  
 
They state that the importance of reducing treatment delay in STEMI is 
logical, but can only be demonstrated properly in studies deliberately delaying 
treatment in one patient cohort – which they state would be unethical in the 
context of STEMI reperfusion. 
 
In the UK context at this time, work was underway to synthesise the findings 
of these data, and recommendations of international guidelines, into national 
policy. SIGN 93 for Acute Coronary Syndromes (2007) clearly stated that 
where PPCI could not be provided within 90-minutes of diagnosis in Scotland, 
patients with STEMI should receive immediate thrombolytic therapy. Scotland 
at this time had a well established PHT programme with 89% of patients 
receiving PHT within 60-minutes of EMS call in one study (McLean et al., 
2008). In England an observational study was funded by the Department of 
Health in collaboration with the British Cardiovascular Society (BCS) and 
British Cardiovascular Intervention Society (BCIS) to test the feasibility of 
developing PPCI services as the initial treatment for STEMI across England 
(Department of Health, 2008). Data from seven pilots (ten centres) were 
collected between April 2005 to March 2006. Patients recruited to the study in 
that year were then followed up for a further year to March 2007.  
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This study, which has led to little in the way of peer-reviewed evidence, 
reported that the development of PPCI services was feasible in a variety of 
geographical settings. The data to support this argument was that in the pilot 
centres studied the median EMS call-to-balloon times ranged from 86-
minutes to 159-minutes. In the 2,245 patients audited there was a mortality 
benefit in those receiving PPCI at both 30-days (5.6% PPCI vs. 7.9% 
thrombolysis), and at 12-months (9.9% PPCI vs. 14.8% thrombolysis) 
although the authors are clear that pre-specified analysis of mortality was not 
the objective of the study. While data are presented describing the increase in 
mortality resulting from increasing EMS call-to-balloon times, there are no 
data describing comparison with thrombolysis. Nor are data presented 
describing incremental benefits of PPCI and thrombolysis (which is not 
separated as IHT and PHT) over 1-2 hour gradations.  
 
A subsequent economic analysis of the report (Goodacre et al., 2008) 
concluded that an English PPCI service was more expensive than 
thrombolysis care but was likely (about a 90% probability) to be a cost-
effective use of NHS resources by NICE criteria. It also suggested that 
systems based on direct access to the catheter laboratory were almost 
certain (95% probability) to be cost-effective, whereas systems based on 
access via emergency departments, coronary care units or other wards were 
less certain (about a 75% probability) to be cost-effective. Finally it warned 
that transfer of patients from a non-PPCI hospital to a PPCI hospital with the 
time delays seen in the NIAP was unlikely to be cost-effective (about a 38% 
probability). Although (in my opinion) there are many and significant flaws in 
the NIAP report, the drive in England to establish ‘Heart Attack Networks’ was 
further enhanced by its publication. The position paper of the English National 
Director for Heart Disease and Stroke (Department of Health, 2006) and the 
wide-ranging NHS England review (Darzi, 2008) set out the arguments for 
creating specialist centres for STEMI to deliver improved service.  
 
The theme of heart attack networks is expanded in the narrative review of  
Fox and Huber (2008). They state that the delivery of STEMI care has lagged 
behind establishing the evidence for effectiveness.  
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Citing the GRACE registry (Fox, 2004) they state that approximately a quarter 
of all patients with STEMI still fail to receive reperfusion therapy. Additionally, 
for most patients delays substantially exceed guideline recommendations and 
secondary prevention is incomplete. They suggest that Cardiologists need to 
take the lead in improving systems of care, with the integration of pre-hospital 
care within “heart attack networks” involving intervention centres, non-
intervention hospitals, primary care, and paramedic ambulance care. The 
authors provided several examples to show that such systems were feasible, 
namely the Vienna network (Kalla et al., 2008) where 1,053 patients admitted 
to one of five major interventional centres across Vienna were studied before 
and after formation of a heart attack network.  
 
Although acknowledging the potential bias of a single centre study based on 
comparison with retrospective data, the authors state that the implementation 
of guidelines for the treatment of STEMI in a metropolitan area by means of a 
‘heart attack network’ led to a significant reduction in in-hospital mortality from 
16% prior to the network to 9.5% after its creation. While it must be 
highlighted that this paper is a report of their local clinical experience, the 
authors attribute the mortality reductions to a system whereby patients 
received the most appropriate reperfusion treatment (PHT, PPCI or IHT) 
based on time from symptom onset and geographical location. When patients 
were treated in the early phase of STEMI (defined as within 2 to 3 hours), in-
hospital mortality did not differ between PPCI and thrombolysis. However, if 
reperfusion therapy was initiated later than 3-hours after onset of symptoms, 
PPCI appeared to be the treatment of choice. Besides offering the fastest 
available reperfusion method to patients with STEMI of short duration, the 
reduction in the number of patients not receiving reperfusion at all might have 
had the strongest influence on the results. The authors concluded that these 
results serve as a reinforcement of the guidelines themselves and as a 
benchmark for the benefits of their implementation.  
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Given the continuing challenge in delivering timely and effective PPCI for 
STEMI, and their view that compelling evidence that delay to PPCI is 
associated with lesser myocardial salvage and worse outcomes, Armstrong et 
al. (2010) have designed a trial to evaluate “whether a strategy of prompt 
thrombolysis coupled with contemporary antiplatelet and antithrombotic 
therapy at the time of first medical contact, followed by timely catheterization 
or rescue coronary intervention in STEMI patients presenting within 3 hours of 
symptom onset, represents an appropriate alternative strategy to PPCI” 
(Armstrong et al., 2010:31). Recruitment to this international multi-centre trial 
is currently underway with patients being randomised to thrombolysis 
combined with modern adjunctive pharmacological treatments, and cardiac 
catheterisation within 6-24 hours or rescue PCI if reperfusion fails within 90- 
minutes of fibrinolysis, versus PPCI performed according to local guidelines. 
Composite efficacy end points at 30-days include death, shock, heart failure, 
and reinfarction. Safety end points include ischaemic stroke, intracranial 
hemorrhage, and major non-intracranial bleeding. Follow-up is extended to 1- 
year and includes all-cause mortality. The Strategic Reperfusion Early After 
Myocardial Infarction (STREAM) study (Armstrong et al., 2010) may fill a gap 
in the evidence by providing information on whether prompt thrombolysis at 
first medical contact, followed by timely catheterisation or rescue PCI in 
STEMI patients presenting within 3 hours of symptom onset, represents an 
appropriate alternative strategy to PPCI. 
 
Guidelines of the European Resuscitation Council (Nolan et al., 2010), 
although not explicitly, do suggest a system of care akin to the heart attack 
network described by Kalla et al. (2008). They state that PPCI is the preferred 
reperfusion strategy provided it is performed in a timely manner by an 
experienced team with an ‘acceptable’ delay between start of thrombolysis 
and first balloon inflation of between about 45 and 180-minutes depending on 
infarct localisation, age of the patient, and duration of symptoms. The 
guidelines state that a nearby hospital may be bypassed by the EMS provided 
PPCI can be achieved without too much delay, and that patients with 
successful thrombolysis but not in a PCI-capable hospital should be 
transferred for angiography and eventual PCI, performed optimally 6–24 
hours after thrombolysis (the ‘pharmaco-invasive’ approach).  
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The guidelines also raised the spectre of “cardiac arrest centres.” They state 
that there is wide variability in patient survival among hospitals caring for 
patients after resuscitation from cardiac arrest. There is what the authors 
describe as some ‘low-level’ evidence cited that Intensive Care Units 
admitting more than 50 post-cardiac arrest patients per year produce better 
survival rates than those admitting less than 20 cases per year. They also cite 
‘indirect evidence’ that regional cardiac resuscitation systems of care improve 
outcome in STEMI. The implication from these data is that specialist cardiac 
arrest centres and systems of care may be effective but, as yet, there is no 
direct evidence to support this hypothesis (Nolan et al., 2010). 
 
Huynh and colleagues (2009) undertook complex hierarchical Bayesian 
random-effect meta-analyses of 23 RCTs (n=8,140 patients) and 32 
observational studies (n=185,900 patients). Their motivation to include 
patients treated in observational studies stemmed from their belief that RCTs 
do not reflect the practice of STEMI care in the ‘real-world,’ giving examples 
where patients enrolled in STEMI RCTs are generally younger, have fewer 
co-morbidities, less renal disease and less cardiogenic shock than in real-
world practice (Huynh et al., 2009). They found that PPCI was associated 
with a 34% reduction in short-term mortality in RCTs and 23% lower mortality 
in observational studies when compared with thrombolysis. Interestingly they 
report that there was no conclusive difference in mortality in the meta-analysis 
of observational studies that used PHT, and that an estimate of difference in 
mortality between PPCI and PHT could not be done with confidence in RCTs 
as only two RCTs studied used PHT. Reductions in short-term reinfarction of 
65% and 53% were realized by the use of PPCI in RCTs and observational 
studies respectively. As one would expect in a meta-analysis the authors 
provide an extensive list of study limitations. They acknowledge that the 
greater use of thienopyridines in PPCI versus thrombolysis may have 
confounded results. They also acknowledge that the efficacy and safety of 
PHT compared with PPCI may be better evaluated in future large studies 
(Huynh et al., 2009). 
 
 
 
It is evident from the literature presented thus far there is a significant 
heterogeneity of views and conflicting evidence from meta-analyses/pooled-
analyses, RCTs, observational studies, cohort studies, expert opinion and 
clinical guidelines regarding the optimal mode of treatment in STEMI. In an 
effort to describe the application of these data and guidelines in a 
contemporary European context Widimsky et al. (2010) published data from 
the national MI registries of 30 countries. The annual incidence of hospital 
admission for STEMI ranged from between 44 to 142 per 100,000 inhabitants 
per year. PPCI was the dominant reperfusion strategy in twenty-two 
countries, thrombolysis in eight countries. The use of PPCI varied from 5% to 
92% of all STEMI patients (Figure 12), and thrombolysis from 0% to 55%. 
 
Figure 12: Hospitalised STEMI treatment in Europe. 
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Widimsky et al. (2010) 
 
The authors highlight the significant disparities in data quality and timing 
across the 30 countries studied.  
 
 
 
They make reference to the NIAP study (Department of Health, 2008) stating 
that patients treated with PPCI were younger than those treated with 
thrombolysis, suggesting a tendency to use PPCI in fitter patients who have a 
lower predicted mortality regardless of treatment strategy (Widimsky et al., 
2010). PPCI provision varied greatly across Europe, and did not correlate with 
either population size or economic status (as measured by Gross Domestic 
Product (GDP)). England and Wales for example had a catchment population 
of 2,642,445 per 24-hour PPCI centre. This compares with 354,559 in Italy, 
312,245 in France and 265,000 in Germany – a ten-fold greater service 
provision (Figures 13 and 14). 
 
Figure 13: Correlation between the annual number of PPCIs per million 
population and GDP per capita. 
 
 
Widimsky et al. (2010) 
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Figure 14: Primary PCIs per year per million inhabitants in European 
countries. (Grey colour, no data available; blue colour, 
countries participating in this study). 
 
 
Widimsky et al. (2010) 
 
Finally, Widimsky et al.’s study gave a valuable insight into the logistics of 
care and use of EMS. As shown in Figure 15, despite ranking 27th of 30 
countries for PPCI provision per population, the UK ranks 2nd of 30 in having 
the shortest time delays in patients treated by PPCI. 
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Figure 15: Time delays in patients treated by PPCI (FMC = First Medical 
Contact).  
 
 
Widimsky et al. (2010) 
 
In proposing how countries may overcome system delays the authors state 
that some of the problems may be overcome by organising ‘cooperating 
networks’ of PPCI hospitals in close vicinity and organized by the local EMS, 
citing the Vienna STEMI network (Kalla et al., 2006) as one such model. 
While the authors do not allude to it explicitly, it may be the case that the data 
presented in Figure 16 (overleaf) is key to this, and that minimising treatment 
delay in STEMI is less about organising “cooperating networks of PPCI 
hospitals in close vicinity,” but rather is about having an EMS care system 
where as many patients as possible arrive at the first hospital by EMS. 
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Figure 16: Percentage of STEMI patients arriving to the first hospital via                   
         EMS.  
 
 
Widimsky et al. (2010) 
 
 
2.2.3 Care delivery systems 
Evolving evidence and a gradual paradigm shift in cardiovascular, emergency 
and pre-hospital care, has seen an increasing emphasis on both pre-hospital 
diagnosis (Terkelsen et al., 2005) and pre-hospital treatment (Bonnefoy et al., 
2002) of STEMI. These reports however came from health-care systems in 
continental Europe where services, particularly ambulance services, are 
differently configured when compared to services in the UK. Some French 
emergency medical services for example are characterised by the presence 
of a physician on the ambulance. There are arguably few limits to the 
practices and procedures performed in the pre-hospital arena and Ranner 
(2009) states that the patient will receive the same standard of medical care 
as they would in the hospital ED.   
 
Bøtker et al. (2010) however in a systematic review found no compelling 
evidence to support this, other than perhaps in trauma.  
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The paucity of evidence supporting ambulance-based physicians in the 
treatment of ACS therefore decreases the UK applicability of Terkelsen et al. 
(2005) and Bonnefoy et al. (2002) in the sense that UK ambulances do not, 
nor are likely to have in the immediate future, the widespread and routine 
presence of a physician on-board. This gap in the evidence base relative to 
the UK health system is important to acknowledge.   
 
In a UK context Quinn et al.’s publication in 1998 was key in the evolution of 
thrombolytic treatment being administered by nurses/paramedics. Following a 
1995 publication assessing the safety of nurses assessing suitability of 
patients for thrombolytic therapy (Quinn, 1995),  Quinn and colleagues (Quinn 
et al., 1998) reported that 95% of CCU nurse respondents (n=37) were found 
to reach a standard of STEMI ECG interpretation deemed as “gold standard” 
by a panel of cardiologists. Wilmhurst et al.’s interrupted time-series (2000) 
and Qasim et al. (2002) then reported the safety, efficacy and benefits of 
nurse-initiated thrombolytic treatment. There was a significant increase in the 
number of UK centres adopting nurse administered thrombolysis following 
publication of this work 8-12 years ago. In contrast there are few reports in 
the contemporary cardiovascular literature of nurses/paramedics in other 
European countries either administering, or being engaged in autonomous 
decision-making regarding the administration, of these drugs. There are some 
reports from Australasia (Kucia et al., 2001; Kremser and Lyneham, 2007) 
which support the role of nurses in this domain, however McDermott et al. 
(2008) concluded from their review of 42 papers that although the array of 
quality improvement processes they studied were associated with significant 
improvements in door to reperfusion time, suboptimal study designs and 
inadequate information about implementation limit the usefulness of this 
literature (McDermott et al., 2008). 
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Chapter Three – Research Process 
 
3.1 Introduction 
It has been stated the ultimate goal of nursing is to provide evidence-based 
care that promotes quality outcomes for patients, families, health care 
providers and the health care system (LoBiondo-Wood and Haber, 2010). It 
seems reasonable therefore to define nursing research as a scientific process 
that validates and refines existing knowledge and generates new knowledge 
that directly and indirectly influences nursing practice (Burns and Grove, 
2009).  
 
Many volumes of work have been written debating realms of nursing 
knowledge, definitions of nursing, nursing’s position in the broader health-
care environment, and the theoretical constructs underpinning nursing 
practice, education and research (Risjord, 2010). While a proportion of the 
academic research community encourage continuation and expansion of this 
debate (Erickson, 2009) others have encouraged a cessation. Tillman (2009: 
458) suggests that this debate “never seems to go anywhere…seeming never 
to amount to much more than “interesting conversation.”” Howe (2009: 466) 
suggests that the debate is “tiresome” and urges “getting over this 
conversation and resisting the formation of “paradigm cliques.”” 
 
3.2   Evidence-based practice 
Evidence-based practice aims to apply the best available evidence gained 
from the scientific method to clinical decision making (Timmermans and 
Mauck, 2005). It seeks to assess the strength of evidence of the risks and 
benefits of interventions (including lack of intervention). Evidence quality can 
range from meta-analyses and systematic reviews of double-blind, placebo-
controlled clinical trials at the top of the evidence pyramid (Figure 18), down 
to personal opinion at the bottom. As an example the Centre for Evidence-
Based Medicine (2010) suggests levels of evidence according to the study 
designs and critical appraisal of prevention, diagnosis, prognosis, therapy, 
and harm studies (http://www.cebm.net/index.aspx?o=1025). 
 
These principles are used commonly by guideline groups. Figure 17 displays 
the hierarchy of evidence as described by SIGN (2008). Figure 18 displays a  
synthesis of the hierarchy of evidence as I understand and utilise it. 
 
Figure 17: Levels of evidence, SIGN 50. 
 
SIGN (2008) 
 
Figure 18: Hierarchy of evidence. 
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The Evidence-Based Practice and certainly the Evidence-Based Medicine 
hierarchies are of course positively skewed towards empirical research, 
namely within medicine. It is unlikely that qualitative researchers would wish 
their work to be situated within this hierarchy. Perhaps more usefully the NHS 
Health Development Agency produced in 2004 a document describing 
“Integrative approaches to qualitative and quantitative evidence.” This 
document was commissioned to assist those looking to synthesise qualitative 
and quantitative evidence. It suggests specific approaches to assessing and 
synthesising the quality of qualitative evidence, but perhaps most importantly 
states as follows: 
 
“Are there hierarchies of evidence within the different types of qualitative 
investigation?: The short answer is ‘probably not – or at least, not any that 
everyone would agree on’. Mays et al. (2001) argue that the epistemological 
diversity of the field renders any single hierarchy of evidence inappropriate for 
qualitative research. Barbour (1998) also cautions against the development of 
hierarchies of evidence, referring for example to the dangers of using 
interview data as the yardstick against which to measure the validity of focus 
group data. Few other commentators have even approached the question of 
a hierarchy of evidence within qualitative inquiry.” 
 
Health Development Agency (2004: 10) 
 
A contributory factor to this statement may lie in the philosophical bases of 
the research paradigms. 
 
3.3 Philosophical bases of qualitative and quantitative research, and 
moves to post-positivism 
 
Although some distinction between methods is well placed, it is increasingly 
acknowledged that the qualitative and quantitative paradigms are not as 
philosophically diverse or mutually incompatible as is often conveyed (Watson 
et al., 2008). Staunch identification of methods within particular paradigms 
may not be as accurate, or even as useful an endeavour as past trends would 
indicate.  
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This tendency may lead to over-simplification of methods in relation to 
paradigms, or worse, confusion over the philosophies and assumptions that 
underpin particular methods (Polit and Beck, 2008). Qualitative research 
offers a reliable, credible, and useful approach to research, particularly in the 
world of nursing. It evolved from behavioural and social sciences as a method 
of understanding the unique, dynamic nature of human beings (Burns and 
Grove, 2009). Qualitative researchers believe that truth is both complex and 
dynamic and can be found only by studying people as they interact (Hardy et 
al., 2009). 
 
The quantitative approach to scientific enquiry emerged from the logical 
positivism branch of philosophy, which revolves around rules of logic, truth 
and predictions (Polit and Beck, 2010). Quantitative researchers believe that 
truth is absolute and that human behaviour is objective, purposeful and 
measurable (Bryman, 2008). While logical positivism forms the foundation for 
a significant proportion of research papers, the philosophy is inappropriately 
deemed synonymous with empirical method, with some commentators 
suggesting that labeling quantitative researchers as ‘positivists’ is in effect 
limiting rather than opening thoughtful discussion (Howe, 2009).   
 
Johnson (2009) suggests that researchers have increasingly grounded their 
quantitative work in more of a post-positivist philosophy. Post-positivism 
includes a much broader range of views, including explicitly anti-positivist 
views such as pragmatism (Phillips, 2006), where pragmatic researchers link 
the choice of approach directly to the purpose of and the nature of the 
research questions posed (Creswell, 2003). Bredo (2009) postulates a ‘fault-
line’ along which post-positivist thoughts about reductionism and holism in 
research exist, and suggests that dogmatic subscription to either of these 
approaches is deleterious. Many nursing researchers continue to base their 
arguments on a positivistic view of science, and although some 
acknowledgement of post-positivism has occurred in the nursing literature, 
this has yet to permeate into mainstream nursing research (Burns and Grove, 
2009).  
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From the mid-1980’s the philosophy of post-positivism has increasingly been 
noted as that which underpins contemporary empirical research activity 
(Burns and Grove, 2009). Key influences in promoting post-positivist 
philosophies include the works of Karl Popper (1959) and Thomas Kuhn 
(1970). Essentially an alternative conceptualisation of truth was proposed by 
the post-positivists. Like positivism, metaphysical considerations were still 
deemed to be outwith the sphere of science. However, in contrast, a realist 
perspective of science was advocated, with unobservables deemed to have 
existence and the capability of explaining the functioning of observable 
phenomena (Phillips, 2006). Like the positivists, science was still deemed to 
require precision, logical reasoning and attention to evidence (the approach 
still focusses on rendering complex aspects of human beings researchable, 
seeking causation, prediction and explanation in the patterns and regularities 
of life), but was not confined to that which could be directly perceived. Phillips 
(2006) concluded that achievement of a better understanding of post-
positivism and greater focus on the philosophical assumptions underpinning 
research methods, may help ameliorate the distinctions perceived to exist 
between qualitative and quantitative methodologies, with the unhelpful debate 
being confined to the past.  
 
Groat and Wang (2002) assert that the philosophy of post-positivism is that 
truth can be discovered only in a probabilistic sense. This is in contrast to the 
positivistic ideal of establishing cause-and-effect explanations of immutable 
facts. They suggest that research methods should be selected, and their 
philosophical underpinnings discussed, solely on the phenomenon to be 
researched and nature of the research questions. 
 
3.4 Research paradigms and this body of work 
3.4.1 Qualitative research 
Quantitative research approaches used in specific cohorts of patients 
following MI have been criticised by some in favour of qualitative 
methodologies (Scott and Thompson, 2003).  
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This was particularly relevant in the research exploring the information needs 
of spouses/partners of patients suffering acute MI (McLean and Timmins, 
2007). It was clear that (i) the research objective (to explore the 
spouse/partner experiences of information received and required following 
acute MI), and (ii) philosophical criticisms of quantitative methodologies 
previously employed during published work conducted with this group, would 
be best addressed by a framework and design lending itself to maximal 
exploration of the spouse/partner experience. To this end a focus group 
methodology was employed. 
 
The work describing focus group methodology was primarily conducted and 
published in the mid-late 1990’s. There is little in the contemporary nursing 
research literature describing or defending focus groups as a methodology 
(as opposed to a data collection tool).  Morgan and Bottorff (2010) make the 
point that of 50 articles reviewed in an American journal, only six advanced 
focus groups as a method. They do however reinforce the value of the focus 
group “method” in qualitative research. Kitzinger (1995: 105) defined the 
focus group approach as “group discussions organised to explore a specific 
set of issues.” Such discussion takes place in a social setting, moderated by a 
group leader, so as to generate descriptive or explanatory information (Lane 
et al., 1999). Focus group methodology has been used in health service 
research to examine people’s experiences of the health service, health 
education and the attitudes and needs of communities (Sloan, 1998). Twinn 
(1998) however, submitted that the time consuming nature of the process, 
supports the view of Kreuger (1995) that focus groups do not provide a quick 
and cheap method of undertaking qualitative research. 
 
Rudolph and Hill (1994) reported the application of the methodology in 
assessing the effectiveness of educational programmes on health behaviours. 
Both of these points were particularly relevant in the context of McLean and 
Timmins (2007), where the research aim was to explore perceived need and 
support. There are favourable reports of focus group methodology being used 
in studying perceived needs.  
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Robinson (2001) reported that as a result of using focus group methodology, 
researchers felt the incongruence between perceived and actual needs as 
stated by clients was clarified. Lane et al. (1999) support this and suggested 
that the focus group approach is an effective means of ascertaining perceived 
needs. The philosophical underpinnings of the methodology are 
commensurate with the principal advantage of focus groups, namely the 
ability to use participant interaction to gain in-depth understanding and rich 
data that would not be obtained through other techniques (Webb and Kevern, 
2001). Sim and Wright (2000) suggested that focus groups are unique, in that 
they combine elements of group process theory with qualitative research 
methods, highlighting the importance of the interaction of the group in 
determining the quality of the data. The researcher serves as an instrument in 
validating, enriching and explaining the data. The analysis process relies 
heavily upon the conceptual and creative perceptions of the researcher in 
assigning interrelatedness and determining meaning across data sets (Sim 
and Wright, 2000). Kvale (2007: 5) situates the focus group alongside the 
seminal ‘qualitative interview’ works of Freud (1963), Piaget (1960), and Jung 
(1964) but suggests that it is more aligned to the “depth interview” work of 
Dichter (1964) or “non-directive interview” work of Rogers (1967). Webb and 
Kevern (2001) make a broad criticism of the literature describing focus group 
research in its superficial discussion of the methodology without specific 
analysis or critique. They further criticise a tendency towards an 
unsophisticated application of the method and non-rigorous method mixing. 
Pivotally they conclude that researchers must pay greater attention to 
marrying the underlying methodological assumptions, with the methods used 
to analyse and report the data generated. They fail however to acknowledge 
the positive benefits of focus groups in hypothesis generation for future 
studies. 
 
3.4.2 Quantitative research 
As postulated earlier, research methods should be selected, and their 
philosophical underpinnings discussed, solely on the nature of research 
questions.  
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Although related to similar cohorts of patients (those with STEMI who have 
received reperfusion treatment), the key publications which comprise this 
body of work and ongoing work in the same subject area, addressed different 
research problems, had different research questions, made different 
assumptions and required different research designs (with their different 
philosophical underpinnings).  
 
This resulted in selection of a qualitative research method for the single paper 
specifically exploring perceived needs of spouses (McLean and Timmins, 
2007), and quantitative method for the papers assessing optimal models of 
care in ACS (McLean et al., 2004; McLean et al., 2008a; McLean et al., 
2008c; McLean et al., 2009; McLean et al., 2009b; McLean and Flapan, 2009; 
McLean et al., 2010b). Bryman (2008) states that a quantitative research 
strategy has a deductive orientation towards the role of theory in relation to 
research, a positivistic epistemological orientation, and an ontological 
orientation towards objectivism. He also however states that the connection 
between research strategy on the one-hand, and epistemological and 
ontological commitments on the other is not deterministic, and that positivism 
by definition entails elements of both a deductive approach and an inductive 
strategy.  
 
3.4.3 Rigour 
The rigorous quantitative researcher striving for excellence will be disciplined, 
scrupulously adhere to detail, be strictly accurate, and strive for ever more 
precise measurement methods, representative samples and study designs 
(Burns and Grove, 2009). This is the focus of the seminal work of the 
Chalmers Research Group (http://www.chalmersresearch.com/home.html) 
who strive for fair and free-from-bias conduct and assessment of research. 
 
The specific steps which comprise the research process will be critically 
examined and re-examined for errors and weaknesses. Reducing these 
errors and weaknesses is key to ensuring that the research findings 
postulated are an accurate reflection of reality (Gerrish and Lacey, 2010).  
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To come to a conclusion about whether or not the research findings are 
representative of “real world truth,” each aspect of the study must be 
subjected to critical scrutiny (Polit and Beck, 2010).  
 
3.5       Randomised Controlled Trials  
The methodology for a RCT uses strategies from medical and 
pharmacological research, with Phase I to Phase IV trial categories 
developed specifically for testing experimental drug therapy (Watson et al., 
2008). RCTs are frequently referred to, either implicitly or explicitly, as the 
“gold standard” of quantitative research design. LoBiondo-Wood and Haber 
(2010) state importantly however that the RCT does not necessarily fit the 
“knowledge-building” needs of nursing and that criteria for defining a study as 
a clinical trial as opposed to defining it as an experimental study have not 
been teased out in the nursing literature.  
 
Strengths 
Conceptually the term clinical trial as it is used in the literature seems to be 
closely aligned to the design of a Phase III pharmaceutical trial (Burns and 
Grove, 2009). Clearly defined interventions constructed from evidence from 
previous studies are definitively tested against hypotheses and effects 
measured (Bryman, 2008). The study is conducted in a clinical (rather than a 
laboratory) setting and has high internal validity (Polit and Beck, 2010).  The 
random allocation of patients with equivalent distribution of known and 
unknown prognostic factors is such that differences in outcome at the end of 
the study should only be explained by differences in treatment effect (Isley, 
2006). When researchers organise large RCTs the number of subjects 
enrolled mostly allows for more precise findings with broader applicability and 
are generally better at dealing with confounding variables and bias (Isley, 
2006). Clinical trials have played a crucial role in the development of 
treatment strategies for cardiovascular disease since the earliest trials were 
conducted in the 1950s, but it was not until the 1970-80s that the results of 
clinical trials had a major impact on the choice of cardiovascular treatments 
(Yusuf, 1999). 
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Weaknesses 
As the RCT moves from the explanatory to the pragmatic, it becomes more 
difficult to isolate the effect of the treatment from the other aspects of 
delivering the intervention (Isley, 2006). Thus mechanistic inferences become 
weaker while the applicability of the findings becomes more secure (Isley, 
2006), resulting in a reduced ability to generalise and infer with confidence. 
The modern “mega” RCTs are especially criticised for issues around 
faulty/incorrect comparators, post-hoc analyses, exclusion criteria, subgroup 
analyses, small treatment effects and formation of composite endpoints 
(Montori, 2006). Isley (2006: 161) is especially critical of composite endpoints 
which he refers to as “a smorgasbord of events that may be possibly affected 
by the treatment in question.”  
 
The answers in the RCT environment are much less clear because of the 
potential sources of influence on trial results, as well as the possibility that the 
prevailing hypothesis is incorrect (Bryman, 2008). Reviews of RCTs 
performed in general surgery have reported that more than 90% of trials 
reviewed had inadequate sample sizing, powering, exclusion criteria, 
standard of interventions in apposite arms of the trial and justification of 
conclusions (Burns and Grove, 2009). The Cochrane Collaboration (2002) 
also caution against ‘publication bias,’ citing that many researchers have 
shown that those studies with significant, positive, results are easier to find 
than those with non-significant or 'negative' results. The subsequent over-
representation of positive studies in systematic reviews may mean that they 
are biased toward a positive result. Further, Ioannidis (2005) showed that of 
forty-nine RCTs published in three major journals and cited over one-
thousand times, the effectiveness claims of around one-third appeared to be 
exaggerated or contradicted by subsequent research. 
Linde et al. (2001) heavily criticised the reporting of drop-outs and 
withdrawals in sufficient detail in RCTs, which have less generalisability, are 
slower to conduct, are more expensive, and cannot answer as broad a range 
of questions as observational studies (Katz, 2006). In addition, many 
commentators express concern regarding inherent ethical issues in RCTs.  
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There are perhaps the obvious issues of intervention versus placebo arms of 
studies where either has a patently harmful or positive effect. For example 
randomising patients to smoking or non-smoking in order to assess the 
impact on the dependent variable would not be ethical due to the known 
deleterious effects of smoking on health, and therefore on patients 
randomised to the smoking arm of the study (Levin, 2007). Indeed this would 
be contrary to the principles of the Nuremberg code (1986) and this research 
question may perhaps be better, or more ethically, answered by the use of a 
comparative descriptive design (as per my work in Maccioca et al, 2010). 
Hutton et al. (2008) on the other hand suggest that rarely, if ever, are the 
principles of informed consent applied in their entirety in RCTs, and that as a 
result it could be argued that the majority of RCTs do not comply with the 
ethical standards expected at the time of ethics committee approval.  
In an attempt to define contemporary standards the European Union, Japan, 
United States, Australia, Canada, the Nordic countries and the World Health 
Organisation subscribe to the International Conference on Harmonisation 
(ICH) / WHO Good Clinical Practice (GCP) standards 
(http://www.ich.org/LOB/media/MEDIA482.pdf). This provides a unified 
standard for the conduct of clinical studies. thus any country that adopts this 
guideline should follow the same robust standard. 
The “true experiment” 
Fawcett et al. (1994) stated some fifteen years ago that the previous 
technique of testing interventions, the “true experiment,” was being seriously 
questioned by a growing number of scholars due to modifications to the 
original experimental design having decreased the validity. They reported that 
a revolutionary new approach was evolving which held great promise for 
testing interventions. Watson et al. (2008) also highlighted that the “true 
experiment” is based on the atheoretical logical-positivist approach to 
research, which is not consistent with the theory-based approach through 
which nursing constructs their body of knowledge.  
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Bryman (2008), when quoting the rigid rules of the true experiment as initially 
defined by Fisher (1935) states that the method is much easier to apply when 
studying corn (as Fisher did), than when studying human-beings (as nurses 
do). Studying human-beings requires modifications in the true experiment 
which weaken the power of the design and threaten the validity. 
Commentators have suggested that subjects in clinical trials are increasingly 
unlike the target population (Burns and Grove, 2009).  
 
3.5.1 Randomised Controlled Trials and this body of work 
These criticisms were especially relevant when considering the RCT (the 
“true experiment”) as a methodology for this body of work. Cardiology, and in-
particular ACS is often heralded as an area famous for its “mega” RCTs, with 
many hundreds of thousands of patients having being randomised since the 
seminal thrombolysis trials of the 1980’s. There are few areas of cardiology 
practice which have not been studied by means of an RCT. This is the case in 
the areas relevant to this work (STEMI, thrombolytic therapy and risk 
assessment in ACS).  
 
When planning the research presented in this body of work, one may argue 
that it would have been reasonable to replicate major RCTs of investigators 
like Bonnefoy et al. (2002), and Terkelsen et al. (2005). This may have been 
all the more appropriate, and additive to the body of knowledge, given the 
significant differences in the provision of pre-hospital (EMS) care in both 
France (Bonnefoy et al., 2002) and Denmark (Terkelsen et al., 2005) where 
these studies were conducted. Other researchers have designed studies 
aiming to do precisely this and conduct studies which are necessary to both 
(i) contribute to a gap in the evidence, and (ii) provide evidence relevant to 
the particular healthcare context. An example of this is the STREAM study 
(Armstrong et al., 2010), where providing adequate numbers of patients 
recruited are within a UK context, the study interventions are equally as 
deliverable in the UK health context as in the North American and Continental 
European contexts.  
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The findings from STREAM (Armstrong et al., 2010) will therefore have a 
significantly greater weight of applicability in the UK as opposed to, for 
example, the findings of the ON-TIME II study (van’t Hof et al., 2008), which 
due to the fact that the study intervention required an ambulance-based 
physician, are not immediately applicable in a UK model. 
 
3.6 Intervention studies 
The term applied research has been defined as a scientific investigation 
conducted to generate knowledge that will directly influence or improve 
clinical practice (Gerrish and Lacey, 2010). The purpose of applied research 
is to solve problems, to make decisions, or to predict or control outcomes in 
real-world practice situations (Hardy et al., 2009).  
 
An increasing number of intervention studies are being conducted by nurse 
researchers in an effort to further develop and refine an evidence-based 
practice (Bryman, 2008). Burns and Grove (2005) state that 87% of research 
ideas originate from clinical practice, with many fewer arising from the 
theoretical literature, interactions with colleagues or funding priorities. One 
may argue that methods used by nurses to answer their questions need to 
reflect this. Like the experimental/RCT design the quasi-experimental 
research design involves an intervention; however quasi-experimental 
designs lack randomisation, the signature of a true experiment. The definition 
of a quasi-experimental design therefore is an intervention in the absence of 
randomisation (Polit and Beck, 2010). LoBiondo-Wood and Haber (2010) 
highlight that the quasi-experiment is conducted to examine the effect of an 
intervention on an outcome. They propose three facets of a study intervention 
in such a research design, and state that a study intervention must be: 
1. Clearly and precisely developed 
2. Consistently implemented with protocol 
3. Examined for effectiveness through quality measurement of dependent 
variables or outcomes (Burns and Grove, 2009). 
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The strength of quasi-experiments is that they are practical and are aligned to 
nursing research which, by definition, occurs in natural settings where it can 
be difficult, impractical or indeed unethical to deliver interventions to some 
people and not to others (Polit and Beck, 2010). This would certainly have 
been the case with my research, particularly that studying reperfusion 
treatment in STEMI. Quasi-experimental designs are unlikely to either 
exclude as many patients, or suffer refusal to participate in the study as 
evidenced in experimental trials (Bryman, 2008).  
 
This creates somewhat of a paradox for the researcher where it results in a 
broader generalisability of the results, however at the risk of results which are 
both less conclusive and have less validity (Polit and Beck, 2008). The most 
commonly used quasi-experimental design, particularly by nurse researchers, 
is the non-equivalent control group before-after design (Bryman, 2008). This 
design involves two or more groups of subjects observed before and after 
implementation of an intervention. The design is similar to the before-after 
design in experimental research however subjects are not randomly assigned 
to groups, and hence the ‘inferiority’ of this design in the evidence hierarchy 
described in section 3.2 (p38). While without randomisation the researcher 
cannot assume that the experimental and control groups are equivalent at the 
outset of the study, this design remains strong because the collection of pre-
test/pre-intervention data allows the researcher to determine the level of 
dependent variable before the change/intervention was made (Polit and Beck, 
2010). Where the comparison and experimental groups are similar at 
baseline, the researcher can be relatively confident when inferring that any 
post-test differences are the result of the study intervention (Munro, 2005).  
 
3.6.1 Intervention studies and this body of work 
My body of work relates to the real-world, contemporary, pragmatic provision 
of acute cardiac care by multidisciplinary clinicians, with a particular emphasis 
on the reperfusion treatment of STEMI. It does not seek to demonstrate 
efficacy (or otherwise) of one specific intervention over another. If exploring 
the superiority of treatment A over treatment B had been the purpose of this 
work, then one may have argued that: 
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(i)  it was atheoretical, logical-positivist approach to research, which is 
not consistent with the theory-based approach through which 
nursing constructs its body of knowledge, and 
  
(ii)  it was direct (or indirect) replication of work already conducted and 
therefore not additive to the existing body of knowledge in this 
subject area. 
 
Rather, this body of work seeks to add to the existing body of knowledge by 
scientific investigation conducted to generate knowledge that will directly 
influence or improve clinical practice. When planning and conducting this 
applied research, with the aim of directly influencing clinical practice and 
affecting outcomes in real-world practice situations, it became clear that 
intervention studies using quasi-experimental research methodology were the 
natural evolution of the research purpose, framework, and assumptions, and 
would best answer the research questions. 
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Chapter Four – Critical analysis of published works 
 
4.1 Introduction 
The submission for a PhD by publication must demonstrate evidence of an 
original and significant contribution to knowledge within the discipline, in peer-
reviewed published works (Davies and Rolfe, 2009). The multiple project 
format of the PhD by publication allows for a closer relationship with practice 
than is often possible with the traditional monolithic thesis (Courtney et al., 
2005). What is key however to rigorous examination of PhD by publication is 
the candidate’s critical self-assessment, which is the most important and 
difficult skill for academics to master, and the best indication of doctoral level 
work (Davies and Rolfe, 2009). 
 
4.2 Framework for self-assessment 
There are in existence a plethora of tools, structures and models which serve 
to either evaluate, or strengthen the reporting, of research studies (Watson et 
al., 2008; LoBiondo-Wood and Haber, 2010; Risjord, 2010). The research 
design detailed in Chapter 3 and selected for the core pieces of work 
comprising this thesis (McLean et al., 2004; McLean et al., 2008a; McLean 
and Flapan, 2009; McLean, 2009b; McLean et al., 2010) was a quasi-
experimental design: the non-equivalent control group before-after design. 
Bryman (2008) suggested that where nurse researchers choose a quasi-
experimental research design,  the non-equivalent control group before-after 
design is the one most commonly used (Bryman, 2008), and involves two or 
more groups of subjects observed before and after implementation of an 
intervention (Polit and Beck, 2010).  
 
The Public Health Resource Unit (2009) provide researchers with a useful 
toolkit (http://www.phru.nhs.uk/Pages/PHD/resources.htm) designed to guide 
the researcher through the research project. Following some consideration I 
have elected to use these tools as a framework to evaluate my studies and 
the strength of the research reports.  
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It is important to recognise that other than a single patient case-study 
describing an unusual presentation of coronary ischaemia (McLean et al., 
2008b) and a paper translating previous work and evidence into 
contemporary practice by describing the a trio of services which comprise a 
“gold standard” chest pain service (McLean, 2006), each of the papers 
comprising this body of works has undergone peer-review, critical to 
establishing a reliable body of research and knowledge (Burns and Grove, 
2009). 
 
“Hindsight is an exact science” 
(Bellamy, 1996: 13) 
 
While Bellamy, an author of popular fiction may indeed have a point, it is 
important that this thesis provides recognition of deficiencies in single papers, 
the series of papers, or the programme detailed herein as a whole. Efforts will 
then be made to evidence how recognition of these deficiencies has aided 
learning, quality of work, addition to knowledge and the future direction of 
research. This section of the thesis will therefore dissect the body of works, 
using the Public Health Resource Unit checklists (2009) to aid the process.  
 
4.3 The “thread” 
Programmatic research is typically large-scale research conducted over the 
medium to long term, and is designed to impact on problems of priority 
interest (Watson et al., 2008). A research programme comprises planned, 
purposeful, and substantively and/or theoretically linked studies with 
demonstrable public benefit (LoBiondo-Wood and Haber, 2010) and involves 
a substantive line of enquiry in which researchers seek to advance and apply 
knowledge in line with local, national and international initiatives. A research 
programme is underpinned by a vigorous research culture. Programmatic 
research has been used effectively across a wide range of disciplines and 
research issues (Polit and Beck, 2008) and is the defining characteristic of 
scholarship (Boyer, 1997). 
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This thesis does not purport that the published works represent or stem from 
a programme of research. Rather one of the key aims of this thesis, submitted 
in support of published works, is to demonstrate a deliberate and 
programmed approach to the body of evidence. Table 1 (p56) presents a 
summary of the publications comprising this thesis, while Figure 19 (p58) 
presents research themes tabulated chronologically against the published 
works. Figure 20 (p59) then describes research foci, hypotheses, issues 
following analysis and conclusions as they evolved over this programme of 
work.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No. Aim Type of Work Sample 
size 
Outcome measures Main findings 
1 To describe the effects of 
implementing of a PPCI service 
and compare the distribution of 
reperfusion therapies 12-months 
pre and post introduction of PPCI 
Quasi-experimental 
study using a non-
equivalent control 
group before-after 
design 
625 pts Type of Rx, mode of 
presentation, length-of-stay, 
30-day readmission and 
death, time indicators and 
time distributions across Rx 
groups were reported 
Diagnosis-to-Rx and door-to-Rx times were 
impressive when compared with other 
international data. In patients receiving 
PPCI mortality appeared to be reduced and 
length of stay was significantly reduced 
2 To investigate whether 
application of the GRACE risk-
score by Cardiology Nurse 
Specialists in the Emergency 
Department, identifies patients at 
increased risk of death and 
prolonged hospitalisation  
Retrospective 
analysis of cardiac 
risk scores 
prospectively 
collected by chest 
pain nurses in the 
emergency 
department seeing 
patients with 
undifferentiated 
chest pain 
504 pts Death at follow-up Statistically significant differences (p<0.05) 
in the likelihood of death, prolonged length 
of hospital stay, acute coronary syndrome, 
and cardiac catheterisation over low, 
moderate and high-risk groups as assessed 
by the chest pain nurse 
3 To assess the benefits of moving 
heart attack treatment from the 
A&E department  to the 
ambulance  
Quasi-experimental 
study using a non-
equivalent control 
group before-after 
design 
812 pts Call-to-Drug time, Door-to-
Drug time and Pain-to-Drug 
time. Treatment failure and 
time to presentation were 
also recorded and in-
hospital adverse clinical 
events 
 
 
 
 
 
 
Statistically significant reductions (p<0.05) 
in on-scene time, travel time, Call-to-Drug 
time, Door-to-Drug time and Pain-to-Drug 
time when Rx given in the ambulance 
Table 1: Methods vs. aims of the published works 
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4 To explore the self-perceived 
information needs of 
spouses/partners following acute 
myocardial infarction  
Qualitative study 
using focus group 
methodology with 
spouses of STEMI 
patients 
15 spouses/ 
partners  
 
Two focus 
groups 
facilitated 
and 
transcribed 
by me, and 
enriched by 
personal 
notes   
Thematic analysis used. 
Detailed description of 
credibility, dependability, 
confirmability and 
transferability. 157 words 
and statements ‘reduced’ to 
4 key themes: emotional 
reactions, the need for 
information, pulling-apart 
and pulling-together, and 
feeling like a burden 
Recommends specific, tailored, menu-
based cardiac rehabilitation which directly 
involves spouses from the beginning of the 
patient journey 
5 To assess the benefits of moving 
heart attack treatment from the 
CCU to the A&E department 
Quasi-experimental 
study using a non-
equivalent control 
group before-after 
design 
74 pts Door-to-Treatment time, 
time to ECG resolution, use 
of IV beta-blockers and in-
hospital adverse clinical 
events 
Statistically significant reductions (p<0.05) 
in Door-to-Treatment time, Pain-to-
Treatment time, proportion of Rx given in 
A&E, proportion receiving beta-blocker, 
time to receiving beta-blocker, ECG 
resolution and combined adverse clinical 
endpoints in the year post-intervention 
6 To assess the superiority of 
application of pressure bandages 
(vs. no pressure bandage 
application) to puncture sites 
following femoral artery sheath 
removal 
Randomised control 
study with a non-
inferiority hypothesis 
654 pts Rebleed, pseudoaneurysm, 
surgical/radiology referral or 
a composite of all. Presence 
of and size of haematoma 
and bruising were recorded 
in both groups by staff and 
patient completed diagrams 
No statistically significant difference in 
individual or combined sequelae with an 
odds ratio confidence interval of 0.74 to 
3.89. Trend towards more complications in 
the pressure bandage group (4.7% vs 
2.8%) 
Figure 19: Research themes tabulated against published works 
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Figure 20: Research Foci, hypotheses, issues following analysis and conclusions 
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The purpose in presenting these figures is to demonstrate that the body of 
work comprises a logical and coherent set of interlinked publications that build 
up a body of evidence. The resulting overarching themes are: 
 
 Moving thrombolytic therapy to the ED 
 Refining care for patients presenting with ACS 
 Establishing and evolving communication networks between CCU 
nurses and EMS paramedics 
 Moving thrombolytic therapy to the ambulance 
 Developing an optimal reperfusion programme PHT, PPCI and IHT 
 Analysis and synthesis of treatment timelines as they are distributed 
across treatment groups 
 Using these data to postulate optimal models of reperfusion treatment 
 Seeking novel ways of improving the proportion of STEMI patients who 
arrive at the catheter lab with some degree of flow down the coronary 
artery by exploring how evidence from different EMS settings might be 
applied in the UK using paramedics and CCU nurses as the primary 
decision-makers. 
 
4.4 Research framework 
The research framework is the important, abstract, logical structure of 
meaning which guides the development of the study, or studies, and provides 
the researcher with the tool by which he/she can relate their findings to a 
body of knowledge (Bryman, 2008). In quantitative research the framework 
may either emerge deductively from a conceptual model, or inductively from 
the clinical observations of the researcher (Polit and Beck, 2010). Nursing 
research has been heavily criticised in the past for either unclear or entirely 
absent theoretical perspectives (Watson et al., 2008).  
 
4.4.1 Conceptual map 
One strategy for expressing a framework is a conceptual map, which 
diagrammatically illustrates the interrelationships of the concepts and 
statements in either a single study or a series of studies (Burns and Grove, 
2009). Figure 21 (p62) describes the interrelationships of concepts inherent to 
this body of work.  
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The final diagram on the map (labeled as ‘this evidence 2’) is the final 
distillation of the research programme and is intended to assist in grasping 
the gestalt of the phenomenon detailed in this thesis: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21: Concept map. 
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Bryman (2008) states that conceptual maps are useful beyond the study (or 
studies) for which they were developed, and that they may suggest 
hypotheses that can be tested in future studies. This is the intention of the 
conceptual map underpinning this work. The next logical inclusion in the map 
will be focussed around the future direction of the work and will report ways of 
improving the proportion of STEMI patients who arrive at the catheter lab with 
some degree of flow down the coronary artery. This is explained further in 
section 5.3 (p97). 
 
4.5 Ethical issues  
In any discipline that involves research with human beings, researchers must 
address ethical issues. Ethical considerations are especially prominent 
because the line of demarcation between what constitutes expected practice 
and the conduct of research can be blurred (Polit and Beck, 2010). While the 
phenomenon of ethically conducted research defies precise delineation 
(Burns and Grove, 2009), there are a plethora of historical events, codes of 
conduct, regulations, statutory mechanisms and guidelines pertaining to 
research involving human beings. From the atrocities of the Nazi medical 
experiments (Steinfels and Levine, 1976), through the Nuremberg code 
(1986) and Declaration of Helsinki (1986), attempts have been made to 
ensure a minimum of non-maleficence, with detailed guidance around self-
determination, autonomy, competence and consent, privacy, autonomy, 
confidentiality, fairness, discomfort, risks, benefits, conflict of interests and 
harm (LoBiondo-Wood and Haber, 2010; Watson et al., 2008; Polit and Beck, 
2010; Gerrish and Lacey, 2010). These principles are captured more 
contemporaneously in the ICH-GCP standards 
(http://www.ich.org/LOB/media/MEDIA482.pdf) and Caldicott regulations 
(Department of Health, 2010). 
 
While acknowledging the potential inadequacies, Hutton et al. (2008) provide 
an argument which resonates in relation to my research. My published works 
are not “implementation research” as defined by Eccles et al. (2009).  
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Nevertheless the core work undertaken around the multidisciplinary provision 
of STEMI reperfusion treatment, and moving the site of treatment from the 
CCU to the ED, and the ED to the ambulance, does contain elements that are 
pertinent to the science of implementation research.  Hutton et al. (2008) 
argue that the distinction between implementation research and service 
development is blurred, often small, and that the requirement for formal ethics 
approval may deleteriously affect the development of evidence-based 
clinically-effective interventions. They argue that the “natural experiment” 
conducted by the professional or group of professionals (who have a core 
ethical duty to “do the best” for their patient, including implementation of 
evidence-based clinically-effective interventions) should be catered for in the 
complex world of institutional ethics committees. They describe ethics 
committees as being “confused” about this, but also make clear that research 
involving developments of service provision should not be maverick, and that 
one might argue that “service developments” should also be subject to some 
form of ethical review, given that they potentially pose similar risks to 
research studies. 
 
This is an argument that has resonance, particularly in McLean et al. (2004), 
McLean et al. (2008a), McLean et al. (2008c), McLean and Flapan (2009), 
McLean et al. (2009), McLean (2009b), and McLean et al. (2010b). In each of 
these pieces of work, and as a “thread” throughout these works, there was a 
prospective decision to study the effects of moving the site of, and/or 
personnel delivering, STEMI reperfusion treatment. This concords with the 
definition of the quasi-experiment (LoBiondo-Wood and Haber, 2010) as one 
which is conducted to examine the effect of an intervention on an outcome.  
 
It also aligns with Burns and Grove’s (2009) definition of study interventions in 
quasi-experimental research design, where the study intervention must be: 
1. Clearly and precisely developed 
2. Consistently implemented with protocol 
3. Examined for effectiveness through quality measurement of dependent 
variables or outcomes. 
 
   65
One may argue however that the distinction between the work done in these 
studies, and what could be described as “service development” is small. 
Although not to downplay the design and process of my research, it could 
also be suggested that had this work not been designed in the way it was, 
then it may simply have been implemented as an evidence-based, clinically 
effective change in service provision. To this end the extraction of data from 
medical records following the intervention (or service development) need not 
always be governed by formal approval by the institutional ethics committee 
(MRC, 2003). Indeed some have advocated that not asking for formal consent 
to access medical records, in appropriate instances, minimises impact on 
patients in terms of time and unnecessary inconvenience (Tu et al., 2004). It 
might also be suggested that adherence to the Caldicott principles of: 
justifying the purpose of the proposed use of data, not using data unless 
necessary, using the minimum amount of data, ensuring that access to data 
is on a ‘need-to-know’ basis, ensuring that those with access to data are 
aware of their responsibilities and understand and comply with the law, 
(Department of Health, 2010) is acceptable practice in this type of research. 
  
Hutton et al. (2008) relate this argument to ethical theories. They argue that a 
consequentialist ethic would balance the implication of the informed consent 
requirement (that if the research cannot provide valid results then 
opportunities to improve people’s health will be lost), with the consequences 
of not requiring informed consent.  
 
The informed consent duty based around a Kantian philosophy (Kant, 1781) 
on the other hand would mean that the researcher’s duty to seek informed 
consent was absolute, and takes priority over any duty to act so that 
knowledge may be gained and health improved (Hutton et al., 2008).  
 
Eccles et al. (2009) explore the principle of non-maleficence, suggesting that 
while it is typically understood as the principle of doing no harm through direct 
or harmful actions, there may be an argument that the principle applies to 
omission, regardless of motivation.  
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The synthesis of their argument is that where the professional fails to engage, 
or is prohibited from engaging in, activities which will clearly afford benefit 
based on evidence-based and clinically effective interventions, then perhaps 
the principle of non-maleficence has been breached. They cite evidence that 
the public do appear to understand that formal informed consent raises 
significant problems, and that public concern about confidentiality and 
protection of patient rights might be addresses by other means (Robling et al., 
2004). Assurance may be sought from the Royal College of Nursing (2009) 
who state that in some instances it is not always practical or a requirement to 
secure a formal/signed consent, and this assurance is helpful in the context of 
the research underpinning my published works. Nevertheless Ethics 
Committee advice was gained for McLean et al. (2008c), and McLean and 
Timmins (2007). Ethics Committee advice was also sought for McLean et al. 
(2008a) and McLean et al. (2010b). 
 
4.6 Limitations  
An important part of any research process is to examine, weigh-up and set 
out weaknesses and limitations of the study (Hardy et al., 2009). This is the 
mark of the mature researcher and of mature research (Watson et al., 2008), 
and concords with Weber’s (1988) aspiration of ‘value-free research’ (Turner, 
2000). In acknowledging limitations, an opportunity is created to suggest 
areas for future research (LoBiondo-Wood and Haber, 2010). Theoretical 
limitations restrict the abstract generalisability of the study findings and are 
reflected in the study framework and conceptual and operational definitions 
(Polit and Beck, 2010).  
 
Methodological limitations restrict the credibility of the study findings and limit 
the population to which the findings can be generalised (Risjord, 2010). 
Limitations result from factors such as unrepresentative samples, weak study 
design, single setting, limited control over treatment, instruments with limited 
reliability, limited control over data collection, and improper use of statistical 
analyses (Burns and Grove, 2009). As stated previously the recognition of 
assumptions by the researcher is a strength rather than a weakness (Burns 
and Grove, 2009).  
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While specific limitations of individual studies will be discussed in section 4.7 
there are some generic assumptions worthy of presentation at this point. 
These are characterised in Table 2: 
 
Table 2: Assumptions of research framework, design and interpretation. 
 
Assumption 
of… 
 
Calculating increased risk of an event confers an absolute 
increase in likelihood of that event occurring   
Comparable (no statistically significant differences in) baseline 
characteristics suggest homogeneity across two or more groups 
Changes in the dependent variable are the direct result of the 
study intervention 
“Disease” and “Symptoms” are two distinct concepts  
The sample studied is representative of the population  
Research 
Framework 
Time is a continuous variable which is recorded in a standard 
way by the multiple individuals involved in care delivery 
EMS paramedics have a level of training which is sufficient for 
them to identify STEMI 
Consistent and homogenous decision-making in the care of 
patients with ACS is desirable  
Provision of information about an event results in increased 
knowledge about the event 
Study Design 
Spouses wish to help and aid the recovery of their partner 
following STEMI 
100% of patients experiencing ACS wish the most timely 
treatment possible 
Reducing time-to-treatment in STEMI is beneficial 
The risks of treatment in ACS are (i) explained to patients, (ii) are 
understood by patients, and (iii) are outweighed by the benefits   
Interpretation 
of Findings 
Findings are transferable across differing geographical contexts 
 
4.6.1 Limitations of research framework 
Limitations of the research framework generally pertain to the philosophical 
underpinnings of both the research paradigm and particular framework 
employed (Risjord, 2010), with complex, abstract phenomena involved. For 
example, while there will be proponents of statistical analysis who claim that 
the absence of difference in two or more groups (as calculated by statistical 
testing) makes a valid claim for homogeneity, there will be those from 
naturalistic paradigm who believe that statistical significance is too crude a 
measure upon which to make this claim, or indeed that attempting to make 
this claim at all is by definition anathema to nursing research (LoBiondo-
Wood and Haber, 2010).  
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Similar principles apply to the assumption that changes in the dependent 
variable are the direct result of the study intervention.  
 
There exists a growing body of literature critiquing the phenomena, semantics 
and implications of what are generally described as “diseases” and 
“symptoms.” Modern healthcare appears to find it increasingly difficult to 
disentangle these concepts, and is in my opinion (as per Fox and McLean, 
2010) primarily responsible for blurring these concepts. Studies failing to 
carefully identify the research purpose (for example is the aim to identify 
presence or absence of CAD, or presence or absence of angina pectoris) will 
be significantly limited. 
 
4.6.2 Limitations of study design 
Decisions taken at the study design stage have the potential to limit the 
reliability and generalisability of the study (Gerrish and Lacey, 2010).  
 
Apparently straightforward assumptions such as spouses’ wish to help and 
aid the recovery of their partner following STEMI, or provision of information 
about an event results in increased knowledge about the event (as studied in 
McLean and Timmins, 2007), must be deliberately and carefully considered. 
This makes the job of the researcher difficult and identifying these apparently 
straightforward issues is often overlooked, occasionally with a negative 
impact of the study findings (LoBiondo-Wood and Haber, 2010). For studies 
receiving funding, the associated peer-review process may help identify these 
issues at an early stage (LoBiondo-Wood and Haber, 2010). 
 
There are in addition operational and logistical issues in study design which if 
not carefully considered have the potential to limit the study results. As an 
example from this body of works there was an assumption that EMS 
paramedics have a level of training which is sufficient for them to identify 
STEMI.  
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This assumption was carefully considered and as a clinician experienced in 
this field I know while the mandatory training of this staff group is sufficient 
and consistent (due to the fact it is a national programme, co-ordinated from 
the national training school) there is an anecdotal geographical disparity 
across the UK in the retention, refreshing and implementation of these skills. 
One may argue that this heterogeneity is a limitation of the generalisability of 
my study findings. My belief however was that correcting the results for the 
skill and knowledge level of the individual paramedic would potentially render 
the work unfeasible, not to mention the difficulties in reliably measuring 
knowledge retention per se. Furthermore my work is applied research looking 
at the pragmatic and real-world provision of STEMI care. I would therefore 
contest that, even if it were possible, correcting my results for differing 
skills/knowledge levels of individual paramedics would have been in conflict 
with the aims of my research, which was to study this cohort of patients in a 
real-world service provision setting. The logical step however having 
acknowledged this limitation would have been to document it in my report and 
suggest that others may wish to consider it as an area for future research, 
which on reflection I did not do and should have done.  
 
4.6.3 Limitations of interpretation of findings 
Coming from a clinical practice perspective Hallberg (2006) claims that a 
significant proportion of nursing studies do not lend themselves to 
implementation in clinical practice because they are descriptive and do not 
attempt to test new strategies or determine the effects of interventions. In a 
later paper she states that this is also true for theoretical and interpretive 
research which needs to be tested for applicability (Hallberg, 2009). She 
concludes that nurse researchers must be aware of the kind of knowledge 
they produce, how findings are interpreted and generalised or applied, what 
further studies are needed, and the implications for clinical practice. 
 
There is an example of how one might advise caution in the interpretation of 
findings in this body of works. As stated previously the expression “minutes 
mean muscle” is one widely used across the cardiovascular multidisciplinary 
community.  
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The majority of clinicians working in cardiovascular care will have been 
schooled in this way and will strive to minimise treatment delays as much as 
possible in STEMI. There are even dedicated professional and lay internet 
resources promoting exactly this concept (http://minutesmeanmuscle.com), 
and it is a concept I subscribe to. There are however those who believe that 
this argument is not without caveats. Investigators have suggested that in fact 
this concept remains valid only within the first 2-3 hours of infarction and that 
at time points beyond this the concept does not stand and delays to treatment 
are much less relevant (Boersma et al., 2006). Some investigators suggest 
that clinicians could consider withholding thrombolytic treatment for some 
considerable time in patients presenting greater than 2-3 hours after 
symptoms onset (particularly in patients aged over 65 years with infarction of 
the inferior surface of the heart), in favour of PPCI (Pinto, 2006). As a concept 
this appears to be contrary to the ‘minutes mean muscle’ concept detailed 
above. What this example demonstrates is that interpreting findings in the 
context of what may appear a well established concept, may in fact require 
further consideration of alternative and evolving concepts.  
 
Concluding for example that clinical performance based on the results of 
study X (symptoms-to-PHT time of 115-minutes) was superior to clinical 
performance based on the results of study Y (symptoms-to-PHT time of 125-
minutes), is perhaps not quite so intuitive as one might expect and 
interpretation of the findings of these studies should be performed with 
caution. While EMS care systems in continental Europe are differently 
configured when compared to services in the UK, comparison of the pre-
hospital care of patients with ACS is difficult across the ESC countries. 
Moreso this makes the formulation of guidelines applicable to member 
countries of the ESC even more difficult.  
 
Researchers and readers of research papers must bear these complex 
geographical and logistical heterogeneities in mind when formulating and 
interpreting research findings. 
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4.7  Presentation of the core published works 
My first ever study was undertaken while I was a junior staff nurse on a 
Cardiology ward.  My cath-lab colleague and I perceived that the application 
of pressure dressings to the femoral artery puncture site following cardiac 
catheterisation was done with varying degrees of quality, based on weak 
evidence of efficacy and at the cost of significant distress to patients, 
particularly men. We therefore undertook a study (Robb and McLean, 2000) 
randomising 654 patients to an intervention (a pressure bandage or usual 
care) following femoral artery sheath removal. The results, showing no 
statistically significant difference in individual or combined sequelae, and a 
trend towards more complications in the pressure bandage group (4.7% vs 
2.8%), initiated a change in practice in our institution such that this practice 
was stopped. Following peer-review the resulting manuscript became my first 
publication. 
 
My second core publication resulted from work assessing the benefits of 
moving heart attack treatment from the CCU to the ED. This quasi-
experimental study (McLean et al., 2004) used a non-equivalent control group 
before-after design and showed statistically significant reductions in door-to-
treatment time, pain-to-treatment time, proportion of treatment given in the 
ED, proportion of patients receiving beta-blocker, time to receiving beta-
blocker, ST segment resolution and combined adverse clinical endpoints in 
the year following the study intervention. This was to become the first of my 
three quasi-experimental studies assessing the benefits of changing either 
the site or mode of reperfusion treatment in STEMI (McLean et al., 2004; 
McLean et al., 2008a; McLean et al., 2010b), and my first of six publications 
relating to delivery of cardiovascular care outwith the confines of the CCU 
(McLean et al., 2004; McLean, 2006; McLean et al., 2008a; Fitzpatrick and 
McLean, 2010; McLean et al., 2010a; McLean et al., 2010b).  
 
In 2007 I published my first and only qualitative study exploring the self-
perceived information needs of spouses/partners following AMI (McLean and 
Timmins, 2007).  
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Two focus groups involving spouses/ partners were facilitated and transcribed 
by me, and enriched by personal notes. 157 words and statements were 
‘reduced’ to 4 key themes: emotional reactions, the need for information, 
pulling-apart and pulling-together, and feeling like a burden. 
Recommendations of the study were that cardiac rehabilitation should be 
specific, tailored and menu-based, directly involving spouses from the 
beginning of the patient journey. 
 
Following this I embarked upon my largest study to date. Including 812 
patients in a quasi-experimental study using a non-equivalent control group 
before-after design, it assessed the benefits of moving thrombolysis treatment 
from the ED to the ambulance (McLean et al., 2008a). We reported 
statistically significant reductions in EMS on-scene time, travel time, EMS 
call-to-drug time, hospital door-to-drug time and symptom onset-to-drug time 
when thrombolytic treatment was given in the ambulance by EMS 
paramedics. This preparation of the manuscript resulting from this study took 
some time, with a particularly detailed presentation and analysis of data. 
Following an iterative process of peer-review, the manuscript became my first 
work to be published in a predominantly medical journal, the Emergency 
Medicine Journal, an international journal with an impact factor of 1.347.  
  
These successes then led to the commission by the Chief Scientist Office / 
Scottish Government Health Department (CSO/SGHD) to undertake a study 
assessing the feasibility of providing a hybrid reperfusion programme 
including PPCI and thrombolysis in Scotland, as recommended in national 
guidance (SIGN, 2007). The study was designed as a quasi-experimental 
study using a non-equivalent control group before-after design and included 
854 patients over a two year period. The conclusions of the study were that 
the SIGN recommended hybrid programme was safe and effective, and the 
report to CSO/SGHD included a series of recommendations described as 
prerequisites to a successful STEMI reperfusion service. The report (McLean 
et al., 2008c) and the one-year follow-up report (McLean et al., 2009) were 
graded as excellent by the CSO/SGHD Health Services Research Committee 
(Appendix 3: 121). 
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I returned to the familiar field of cardiovascular care outwith the confines of 
the CCU in my next publication (McLean et al., 2010a). This was a 
retrospective analysis of cardiovascular risk scores, prospectively applied by 
cardiovascular nurse specialists in the ED. This study included my first use of 
Kaplan-Meier survival analyses and showed, with a strong statistical 
significance, differences in the likelihood of death, prolonged length of 
hospital stay, ACS, and cardiac catheterisation over low, moderate and high-
risk groups as assessed by the chest pain nurse.  
 
Finally my most recent paper (McLean et al., 2010b) describes the effects of 
implementing of a PPCI service and compares the distribution of reperfusion 
therapies 12-months pre and post introduction of PPCI. Diagnosis-to-
treatment and door-to-treatment times were impressive when compared with 
other international data. In patients receiving PPCI mortality appeared to be 
reduced and length of stay was significantly reduced. Temporal trends in a 
real-world reperfusion programme were described and we reported, for the 
first time in any of my publications to date, data relating to the concept of 
total-ischaemic time. 
 
Confirmation of my unique contributions to these papers is provided in Table 
1 (p56) and in Appendices 4 (p122), 5 (p123) and 6 (p125). 
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4.8 Self-assessment of my publications 
4.8.1 Introduction sections 
The introduction section should describe why the study was done and what 
questions and hypotheses it addresses. It should allow others to understand 
the study’s context and judge its potential contribution to knowledge (NIHR, 
2009; Burns and Grove, 2009).   
 
On analysing the publications comprising this body of work the introductions 
do appear to set an appropriate context for the study which follows. There is 
also evidence of learning.  
 
The introduction to McLean et al. (2004) was perhaps somewhat overdetailed 
and elements may have been best placed in the discussion section of the 
paper and cross-referenced with the results. Watson et al. (2008) and Burns 
and Grove (2009) describe this process of ‘revisiting’ the literature following 
formation of the results as a key stage of the research process and one which 
enriches the validity and rigour. The work of McLean et al. (2008a), McLean 
et al. (2010a) and McLean et al. (2010b) however present a more focussed 
and concise introduction to the study, with a corresponding increase in the 
breadth and depth of literature cited in the discussion section of the papers. 
This change in practice came about as a direct result of the peer-review 
process and demonstrates the influence it has in improving the practice of the 
novice researcher and author. 
 
Nevertheless the body of work does suffer from not having clear, explicit and 
unambiguous statements of what questions and hypotheses the studies 
sought to address. There are general statements informing the reader that the 
paper will describe the intervention and comparison, but there is an absence 
of explicitly stated aims/objectives/questions/hypotheses which in retrospect 
are necessary to inform the reader and would have enhanced the body of 
work.  
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On reflection these points have been raised by peer-reviewers and as the 
complexity of my research increases are points which I must learn from and 
develop, particularly given Vandenbroucke et al.’s assertion (2007) that 
substandard statement of objectives hinder the reader from formulating their 
own conclusions regarding pre-specified versus post-hoc analyses, and 
assessing any deviations from the original study plan. 
 
4.8.2 Methods 
4.8.2.1 Study design 
Key elements of the study design should be presented early in the methods 
section so that the reader can understand the basics of the study (Watson et 
al., 2008). “Authors should refrain from calling a study ‘prospective’ or 
‘retrospective’ because these terms are ill-defined and papers rarely define 
what they mean” (Vandenbroucke et al., 2007: 809). As a result of critical 
reflection, there are now apparent deficiencies in some of the earlier works 
comprising this thesis.  
 
As shown in Table 3a there are papers where despite the study being quasi-
experimental with a non-equivalent control group before-after design, the 
statement describing the design is unclear and tends towards a descriptive 
nature. Further, in the early work of Robb and McLean (2000), there is no 
explicit statement presenting the reader with the study design, despite the fact 
that it is a randomised control trail. This prevents the reader from making a 
full and objective evaluation of the findings and their relevance.  
 
Table 3a: Unclear statements of study design. 
 
“This paper reports the introduction and application of a 
combination of measures in the ED aimed at: 
reducing…”  
McLean et al., 
(2004: 3) 
“We report our experience of working with the SAS in …”  McLean et al., 
(2008a: 370) 
 
As the work progressed developments in the more recent publications have 
taken place such that that the aim of the study is explicitly stated, prefixed by 
the words “The aim of this study…”  
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While the two examples listed in Table 3b (p76) are from quantitative papers, 
the paper of McLean and Timmins (2007: 142) also states “The study aimed 
to explore spouse/partner experiences of information received and required 
following AMI.” Although this statement is not quite as explicit as the 
statements presented in Table 3b, it should be borne in mind that McLean 
and Timmins (2007) was the sole qualitative work comprising this thesis and 
therefore had a broad and more open-ended research aim. 
 
Table 3b: Clear statements of study design. 
 
“The aim of this article is to determine whether 
systematic application of the GRACE risk-score by 
cardiology nurse specialists predicts long term outcome 
among unselected patients with chest pain.”  
 
McLean et al., 
(2010a: 91) 
“The aim of this study was to describe the effects of 
implementing of a PPCI service and compare the 
distribution of reperfusion therapies 12-months pre and 
post introduction of PPCI.”  
 
McLean et al., 
(2010b: 2) 
 
In terms of the recommendation that the words ‘prospective’ and 
‘retrospective’ should be avoided, I would suggest that my work has 
employed the terms usefully and with appropriate and transparent definition. 
The following excerpt from McLean et al. (2010a: 92) is evidence of this:  
 
“The GRACE score was systematically and prospectively applied to all 
patients with undifferentiated chest pain in the ED assessed by chest pain 
nurses between September 2005 and April 2008. A random sample of 504 of 
the first 7000 patients was analysed retrospectively to determine the 
relationship between risk score and outcomes”  
 
This statement makes very clear what the prospective and retrospective 
elements of the design are and allows the reader to come to their own 
conclusions on the appropriateness, or otherwise, of the study design. 
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4.8.2.2 Setting 
Readers of research papers require information on setting and locations of 
studies to allow them to assess the context and generalisability of a study’s 
results (Polit and Beck, 2010). From the early work of Robb and McLean 
(2000) to the more recent work of McLean et al. (2010b) there is a thread of 
clear and transparent descriptions of the study setting, locations, dates, 
periods of recruitment and follow-up.  
 
From recollection, issues have never been raised by peer reviewers regarding 
ill-defined study settings. Table 4 provides examples of this: 
 
Table 4: Descriptions of study setting. 
 
“Of the 739 patients undergoing diagnostic or interventional 
catheterisation at The Royal Infirmary of Edinburgh 
between October 1998 and February 1999, 654 (88.5%) 
were studied. Those included met the inclusion criteria of a 
procedure being performed through a 7-French gauge 
sheath (11cm) and complete data being available. The 
data set collected for each patient included…”   
 
Robb and 
McLean  
(2000: 372) 
“NHS Lothian is South-East Scotland’s largest health board 
area, has a population of 810,000 people of whom 79% 
live in urban areas, and includes 3 acute receiving 
hospitals, one of which, the Royal Infirmary of Edinburgh 
contains three cardiac catheterisation laboratories (cath-
labs). The establishment of the 12-lead 
electrocardiography (ECG) telemedicine and PHT 
programmes in this population has been described 
previously.”  
 
 
McLean et al., 
(2010b: 2) 
 
4.8.2.3 Participants 
Stating the eligibility criteria, sources and methods of selection of participants, 
and providing a rationale for the selection of the study group or groups is 
crucial, regardless of the study design (Polit and Beck, 2010). Detailed 
description of the study participants helps the reader understand the 
applicability of the results (Watson et al., 2008). As detailed in the previous 
section on study setting (4.8.2.2, p77) there is a thread throughout these 
works stating the sources, methods and rationale for selection of the study 
participants. On reflection however there are papers where description of 
what in essence is ‘sampling’ has not been adequately performed.   
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A good description of sampling is provided by McLean and Timmins (2007: 
142) who state that “Purposive sampling was used. The study population 
included spouses/partners of patients who had attended (with at least 50% 
completion) a cardiac rehabilitation programme over a 5-month period at the 
hospital.”  
 
McLean et al. (2004) on the other hand provides the reader with detail as to 
the attrition from the selection of the study sample (n=74 patients discharged 
with a diagnosis of STEMI, who received thrombolytic therapy and had a full 
data set available) from the study population (n=3,060). This paper does not 
however make an explicit statement that the non-probability convenience 
sampling method was used, or perhaps more importantly, why (ease, 
expense, ready access, representative of ‘real-world’ practice). This is an 
important issue as described by Gerrish and Lacey (2010) who state that 
sampling is central to quantitative research designs and decisions regarding 
sampling have a major impact on the meaning and generalisability of the 
research findings (Risjord, 2010). 
 
4.8.2.4 Variables, data sources and measurement 
A common deficiency in published research reports is an absent or 
insufficient definition of variables (Gerrish and Lacey, 2010). The way in 
which data items are measured affects the reliability and validity of a study 
and make it difficult to detect, analyse or claim relationships (LoBiondo-Wood 
and Haber, 2010).  
 
From a baseline of good quality work in defining variables, data sources and 
diagnostic criteria, the quality of my work has improved again as time, and the 
publications comprising this thesis, have evolved. Details of all variables 
explicitly defined in the manuscripts are presented in Table 5 (p79) and 
demonstrate this evolution: 
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Table 5: Explicit definition of variables. 
 
Robb and McLean 
(2000) 
McLean et al.  
(2008a) 
McLean et al.  
(2010) 
Data collection 
information sheets  
Application of the 
GRACE score 
Year 1 of the 
reperfusion programme 
Pressure dressing 
application technique 
GRACE score 
recording 
Year 2 of the 
reperfusion programme 
Post procedural 
mobilisation 
Data sources 12-lead ECG 
programme 
Post procedural 
observations 
Killip class PHT programme 
Haematoma Blood result availability Time of diagnosis 
Bruising Death Diagnostic 
electrocardiographic 
criteria 
Clinical sequelae Follow-up period Protocol for ECG 
acquisition 
Confounding variables Length of hospital stay Total number of STEMIs
Mechanical device use Cardiac catheterisation Self-presentation 
 GRACE score 
categories 
Exclusion criteria 
 Duration of follow-up Primary PCI 
 Time from admission 
to death 
Rescue PCI 
  ST segment resolution 
  Admission protocol 
  Measurement of infarct 
related artery flow 
  Readmission 
  Mortality 
  Time of EMS call 
  Time of EMS scene 
arrival 
  EMS scene time 
  EMS drive time 
  Time of reperfusion 
treatment 
  Time of reperfusion 
assessment 
  PPCI-related delay 
  Data sources 
 
Furthermore where it is not mentioned in Robb and McLean (2000) (and 
should have been), McLean et al. (2010a) clearly state that a potential 
limitation of the study is inter-observer reliability.  
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The paper states that “One possible limitation of this study would be if there 
were variations in scoring between the various CPNs. This was not analysed 
in the study, but could be an area for future research.” (McLean et al., 2010: 
95). This shows an evolution and maturity of research quality. Robb and 
McLean (2000) involved staff and patients sketching around areas of (self-
perceived) haematoma and bruising and in retrospect was clearly at risk of 
diverse inter-observer reliability, which should have been made clear in the 
research report.  
 
4.8.2.5 Bias 
Biased studies produce results that differ systematically from the truth and 
therefore readers must be aware of what measures, if any, were taken during 
the course of the study to reduce the potential of bias (Burns and Grove, 
2009).  
 
Dependability of data in most qualitative work is closely related to 
confirmability, and to the level of transparency created by the researcher. 
McLean and Timmins (2007) for example informs the reader: 
 The researcher (SMcL) acted as moderator 
 The length of the focus groups 
 The data collection media: tape recordings and researcher notes 
 Timelines 
 The researcher’s engagement (SMcL) with and immersion in the data 
(replaying tapes, making further notes, recording the researcher’s 
thoughts and feelings) 
 Data transcription 
 Data analysis techniques 
 The thematic framework 
 The data reduction technique and logistics (three phases) 
 The process of returning back to the literature 
 Rationale for claiming credibility, dependability, confirmability and 
transferability 
 A clear description of the study audit trail 
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In doing so there was an explicit effort to not only minimise any potential bias, 
but also an effort to present a sufficiently rich account to allow the reader to 
form their own judgements. In contrast there was no effort in that study to 
present the draft findings back to the participants and provide them with an 
opportunity to confirm or refute any of the content. On reflection this was a 
missed opportunity to (a) further enrich the paper, and (b) improve the 
confirmability and potential impact. 
 
4.8.2.6 Study size 
A quantitative research study should be large enough to obtain an estimate, 
with a sufficiently narrow confidence interval, to meaningfully answer a 
research question (Munro, 2005). Small studies which show ‘interesting’ or 
‘statistically significant’ associations are published more frequently than small 
studies that do not have ‘significant’ findings (Watson et al., 2008). 
 
On reviewing the papers comprising this thesis none of them have explicit 
statements regarding power calculations, or indeed information regarding how 
the study size was arrived at. It is however implicit in several of the papers 
(McLean et al., 2004; McLean et al., 2008a, McLean et al., 2010), and 
explicitly stated in McLean et al. (2010b) that the purpose of the study was 
not to prospectively test the effect of an independent variable on a dependent 
variable.  There may be an argument to suggest that sample size calculations 
as they are known in the world of the RCT are not strictly relevant in non-
equivalent control group before-after design.  
 
4.8.2.7 Statistical methods 
In general terms there is no one ‘correct’ statistical analysis, but rather 
several possibilities which may serve to address the same question, but make 
different assumptions (Munro, 2005). Nevertheless, even though the 
distinction between pre-specified and exploratory analyses may sometimes 
be blurred, authors should clarify reasons for particular analyses so as to 
enable the reader to objectively assess their applicability (Watson et al., 
2008). 
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While it is acknowledged in the previous section that explicit calculation of 
sample size was not performed in the works comprising this thesis, there is 
evidence of the appropriate use, one a case-by-case basis, of statistical tests. 
In Robb and McLean (2000), McLean et al. (2004), McLean et al. (2008a) and 
McLean et al. (2010a), statistical tests were used, all through the prospective 
involvement of a statistician. Table 6 presents the range of tests used: 
 
Table 6: Statistical methods. 
 
Robb and 
McLean (2000: 
373) 
McLean et al. 
(2004: 4) 
McLean et al. 
(2008a: 371) 
McLean et al. 
(2010a: 92) 
Chi-squared test 
for categorised 
variables 
Two sample t-
tests for 
differences 
between means 
from independent 
samples 
Two sample t-
tests in normally 
distributed groups 
Kaplan-Meier 
analysis of 
survival 
Mann-Whitney 
test for 
quantitative 
variables 
Two sample tests 
for differences 
between 
proportions 
Mann-Whitney 
test where the 
distribution did 
not appear 
normal and there 
were two  
groups 
Log rank tests 
 Mann-Whitney 
test for 
differences 
between medians 
Kruskal-Wallis 
test where the 
distribution did 
not appear 
normal and there 
were more than 
two groups 
Chi-squared tests 
   Kruskal-Wallis 
test 
 
 
On reflection there was no feedback from reviewers that any of the tests 
applied were unreasonable, or that unreasonable assumptions were made 
during their application.  
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This acceptance that the statistical tests used in the papers was reasonable is 
likely testament to my prospective use of a statistician which according to 
LoBiondo-Wood and Haber (2010) is a crucial decision for not only the de 
novo researcher, but also for the experienced researcher who may not be 
exposed to the range of statistical analyses options and limitations on a 
regular basis. 
 
4.8.3 Results 
4.8.3.1 Descriptive and outcome data 
Readers of research papers need information about variables which may 
potentially confound the study results including whether and how they were 
measured, in order to make judgments about study validity (LoBiondo-Wood 
and Haber, 2010). Authors should also report sufficiently rich descriptive data 
before addressing the possible association between variables and outcomes, 
(Polit and Beck, 2008). 
 
While there is some evidence of efforts to document potentially confounding 
factors throughout this body of work, there are unfortunate inconsistencies. 
Robb and McLean (2000), McLean et al. (2004) and McLean et al. (2008a) 
clearly document (as continuous, mean, median and range values): 
 Male versus Female gender 
 Age  
 Height 
 Weight 
 Body Mass Index 
 Systolic blood pressure 
 Diastolic blood pressure 
 Presence of aortic valve disease 
 Previous cardiac catheterisation 
 Consultant versus Registrar procedures 
 Use of mechanical devices 
 Use of anti-coagulant or anti-platelet drugs 
 Presence of diabetes mellitus 
 Cigarette smoking versus non-cigarette smoking 
 Location of myocardial infarction 
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 Territory of myocardial infarction 
 Previous cardiovascular history (myocardial infarction, coronary 
angiography, PCI, coronary artery bypass grafting) 
 Concomitant medications 
 Time from onset of symptoms to arrival at hospital 
 
McLean et al. (2010a) however makes no mention of any confounding 
variables, despite being a study describing long term outcome following 
attendance to the ED with chest pain. In addition McLean et al. (2010b), while 
describing gender, age and territory of infarction, may have benefited from a 
more comprehensive an detailed presentation of confounding factors, 
particularly as it describes outcome (logistical and clinical) between before 
and after groups. 
 
4.8.4 Discussion 
4.8.4.1 Key results 
The discussion section of the paper addresses the central issues of validity 
and the meaning of the study (Polit and Beck, 2010). Surveys however have 
found that the discussion section of papers are often dominated by 
incomplete or biased assessments of the study’s results and their 
implications, and rhetoric supporting the authors’ stance (Horton, 2002).  
 
There is evidence in this body of works of evolution in the quality of the 
discussion section. In McLean et al. (2004) the discussion section is to a large 
extent a more expansive results section, with use of repetition. Results are 
restated with a broader discussion suggesting possible reasons, and there 
are only 4 attempts to place the results in the context of other studies. 
McLean et al. (2008a) on the other hand situates the results in the context of 
previous literature on 13 occasions, and McLean et al. (2010b) on 11 
occasions.  
 
This improvement in presentation of results is more in keeping with the style 
of presentation of applied research in peer reviewed journals. 
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4.8.4.2 Limitations 
The identification and discussion of the limitations of a study are an essential 
part of scientific reporting (Burns and Grove, 2009). While many of the papers 
comprising this thesis have limitations acknowledged (McLean et al., 2004; 
McLean et al., 2008a; McLean et al., 2010a, McLean et al., 2010b), there are 
others which do not (Robb and McLean, 2000; McLean and Timmins, 2007). 
The studies where limitations are not explicitly acknowledged may be argued 
to be weaker as a result. In addition to the limitations of singular pieces of 
work, it is important to discuss limitations in the body of work per se. Each of 
the studies has been performed in either a single hospital (Robb and McLean, 
2000; McLean et al., 2004; McLean and Timmins, 2007; McLean et al., 
2010a) or single health board area with three receiving hospitals (McLean et 
al., 2008a; McLean and Flapan, 2009; McLean, 2009b; McLean et al., 
2010b).There are some concerns that single centre studies have a 
generalisability which is inferior to studies performed in a multi-centre 
environment (Burns and Grove, 2009), and as discussed in Chapter 5 this is 
an area for future development of my research.   
 
LoBiondo-Wood and Haber (2010) do point out however that the ‘tension’ 
between acknowledging limitations of study, versus the fear of the 
implications of a very negative critique on professional reputation and 
responsibility, is a tension which as yet is unresolved. 
 
4.8.4.3 Interpretation 
The heart of the discussion section is the interpretation of a study’s results 
(Watson et al., 2008). Over-interpretation is common and human: even when 
the researcher tries hard to provide an objective assessment, reviewers often 
rightly point out that he/she went too far in some respects (LoBiondo-Wood 
and Haber, 2010). In fact no study is generalisable per se (Risjord, 2010), the 
term being meaningful only with regard to clearly specified conditions.  
 
The question of the degree to which the results of a study are generalisable is 
often a matter of judgment that depends on the study setting, characteristics 
of participants, variables examined and outcomes and relationships assessed 
(Polit and Beck, 2010).   
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Robb and McLean (2000) shows the immaturity of the de novo researcher, 
when there is a move directly from the results section to the conclusion 
section of the study without any intervening discussion or attempt to interpret 
the results in the context of the study objectives, limitations or results from 
previous studies.  
 
McLean et al. (2004) does in retrospect present statements which require a 
‘leap of faith’ and are perhaps driven by the opinion and local context of the 
authors rather than an objective and rigorous examination of the study 
results. An example is “The higher incidence of a second dose of thrombolytic 
agent for failure-to-reperfuse in Year 2, is probably due to combination of 
increased awareness of the phenomenon in CCU…” (McLean et al., 2004: 7). 
While memory serves this to be a reasonable statement for practice at that 
time in that hospital, it does not stand up to robust external scrutiny and has 
almost certainly gone “too far” as suggested by LoBiondo-Wood and Haber 
(2010), where the hypothetical obverse of the statement may in fact be that 
the higher incidence of failure-to-reperfuse was a negative outcome of the 
study intervention.  
 
McLean et al. (2010a) and McLean et al. (2010b) are examples of perhaps a 
more restrained and mature approach where statements made in the 
interpretative phase of the paper are more objective and are based on the 
results presented in the study. As an example of this, Table 7 presents the 
statements made in the discussion of McLean et al., (2010a), and how they 
relate to the results of the study: 
 
 
 
 
 
 
 
 
 
 
   87
Table 7: Interpretation versus supporting data; McLean et al. (2010a). 
 
Interpretation Supporting data 
This study demonstrates the 
feasibility of determining the 
GRACE score during the 
assessment of patients 
presenting to the ED 
GRACE score data was collected on over 
7000 patients over a 32-month period by 
chest pain nurses in the ED seeing this 
patient group, and thus by definition its 
determination must be feasible 
The GRACE score as predicted 
by the chest pain nurse in the ED 
powerfully predicts outcome  
There were statistically significant 
differences  (p=<0.0001) in (i) survival to 
follow-up, (ii) length of hospital stay, (iii) 
cardiac catheterization on index admission, 
and (iv) confirmed ACS, over the 3 GRACE 
strata as assessed by the chest pain nurse 
Nurses assessing patients with 
chest pain can play an important 
role in the diagnostic process 
As above 
 
 
4.8.5 Target journals 
Although there are no definitive regulations (nor evidence base) to stipulate, it 
is generally recommended that the “beginning researcher” submits work to 
journals which focusses on their core domain of practice (LoBiondo-Wood 
and Haber, 2010). Concentrating on their specific area of expertise will 
facilitate a simpler and more rewarding process for the novice writer (Burns 
and Grove, 2009). Once writing experience is achieved however, a seasoned 
writer will be more proficient and confident with researching and presenting 
new and challenging topics, and will likely have developed the confidence, 
ability and expertise to submit to journals of higher standing (larger audience, 
multidisciplinary, impact factor, increasingly robust peer-review, widely known 
reputation) (Polit and Beck, 2010).  
 
Because journals vary in content and style, it is crucial that researchers 
familiarise themselves with the targeted publication. It is most important to 
recognise the goal of the publication and who makes up their readership - 
their audience (Burns and Grove, 2009). This is critical in ensuring that the 
findings and the implications reach the intended audience. 
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The work comprising this thesis has been published in range of nursing, 
medical and paramedical journals. Publications have been deliberately 
targeted at journals with the readership to whom the paper would be most 
relevant. Robb and McLean (2000) was published in the Professional Nurse 
at a time when that journal had a wide readership and a policy of publishing 
both generalist and specialist papers. McLean et al. (2008a) was published in 
the Emergency Medicine Journal, a respected journal aimed at clinicians 
(doctors, paramedics and nurses) working in pre-hospital care and ED’s. 
McLean (2006) on the other hand was a paper describing my views on an 
optimal model for delivering emergency cardiovascular care. This paper 
translated my clinical experience and the empirical data of McLean et al. 
(2004) and what would become McLean et al. (2008a), to present a 
recommendation of what could be a contemporary practice model.  
 
There is also a demonstrable evolution of quality in the status of the journals 
over time. The last two publications comprising this body of works are in 
renowned peer-review journals with registered impact factors. One of the 
publications is an invited joint-editorial in Heart, the UK’s and one of Europe’s 
leading cardiovascular journals with an impact factor (May 2010) of 4.964, 
demonstrating my progression as an author.  
 
4.8.5.1 Citations 
From January 2011 searches of the citation engines of the ISI Web of 
Knowledge (http://wok.mimas.ac.uk)  and Publish or Perish, 
(http://www.harzing.com/pop.htm) the papers comprising this thesis have 
been cited in 64 other publications, of which only 6 were self-citations. This 
figure however may be misleading for two reasons. The first is that McLean et 
al. (2009a), McLean et al. (2010a), Fitzpatrick and McLean (2010), Fox and 
McLean (2010), Maccioca et al. (2010) and McLean et al. (2010b) have all 
been published within the last 6-months and therefore the likelihood of them 
being cited in papers which have gone to press is limited. The second reason 
is that some of the journals in which the papers were published do not belong 
to publishing groups whose products feature on the seminal searching 
databases (PubMed, Medline, Cinahl). This makes citation of these works, or 
recording of citation of these works very difficult.  
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There may also be an argument that journal citations are not a surrogate for 
impact on clinical practice, and that clinical practice can be influenced in ways 
other than citation. It is noteworthy that McLean et al. (2004) was cited in the 
SIGN 93 guidance for ACS (2007). Publication in national guidelines is high 
accolade and one that is difficult to capture simply by citation searching. 
Journal of publication, peer-review status, impact factor and citations of the 
core papers comprising this body of works are tabulated in Table 8. It is 
difficult to postulate why these papers were cited in the proportions they were, 
and at the time they were. As an example nurse researchers in Singapore in 
2011 submitted a manuscript to a national nursing journal in which they 
reference the work of Robb and McLean (2000) some eleven years ago. 
 
Table 8: Journal, peer-review status and impact factor (January 2011). 
 
 
No Cited Journal     Peer       
  review 
Impact 
factor 
1 7 Emergency Medicine Journal Yes 1.347 
2 7 British Journal of Cardiac Nursing Yes  
3 11 Emergency Medicine Journal Yes 1.347 
4 15 Nursing in Critical Care Yes  
5 18 Accident and Emergency Nursing Yes  
6 6 Professional Nurse Yes  
 
 
4.8.6 The “thread” and contribution to knowledge 
Figures 19 (p58) and 20 (p59) present the body of works comprising this 
thesis as a complete and coherent programme of interlinked publications, 
culminating in the conceptual map presented in Figure 21 (p62). Figure 19 
clearly demonstrates progression through themes of moving thrombolytic 
therapy to the ED, refining care for patients presenting with ACS, establishing 
and evolving communication networks between CCU nurses and EMS 
paramedics, moving thrombolytic therapy to the ambulance, developing an 
optimal reperfusion program including PHT, PPCI and IHT, analysis and 
synthesis of treatment timelines as they are distributed across treatment 
groups, and using these data to postulate optimal models of reperfusion 
treatment. 
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Davies and Rolfe (2009) argue that the sequential and developmental nature 
of the individual projects within the PhD by Published Works encourages both 
integration and flexibility. They say that the PhD by this route can, and should, 
grow and change as it develops. I believe that the progression of themes 
described in the previous paragraph are evidence of an integrated flow of 
ideas, and an intuitively sequential ordering of research topics.  
 
In taking a ‘wide-angled’ view of this body of works, its independent 
contribution to knowledge, and significance, is graphically presented in the 
conceptual map (Figure 21, p62).  The “established evidence” (1 and 2) as 
presented in the map is indeed established evidence. The role of occlusive 
thrombus in STEMI, the time dependent risks of mortality and morbidity, and, 
the benefits of reopening the occluded coronary artery (either by chemical or 
mechanical means) have been well established since the 1980’s (De Wood et 
al., 1980; ISIS-2, 1988). The contribution of this body of work, in its totality, is 
summarised in “this evidence” (1 and 2) of Figure 21, and in Figure 22 (p91): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22: The contribution of this body of works to knowledge. 
 
 
 
In totality the work of McLean et al. (2004), McLean et al. (2008a), McLean et 
al., (2008c), McLean et al., (2009), McLean and Flapan (2009), McLean 
(2009b), Fitzpatrick and McLean (2010) and McLean et al., (2010b) 
recommends travelling in the leftwards direction along the horizontal axis of 
Figure 22, as represented by the red arrow. Although this may sound 
somewhat straightforward it is, and has been, a significant paradigm shift for 
multidisciplinary clinicians in the United Kingdom. While this thesis by no 
means seeks to claim sole or primary responsibility for this shift, the works 
have contributed to the body of knowledge informing it, and I would postulate 
have answered the primary research in terms of what constitutes the optimal 
treatment model for patients presenting with Acute Coronary Syndromes. 
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In terms of the second research question the work of McLean (2006), McLean 
et al. (2008a), McLean et al., (2008c), McLean and Flapan (2009), McLean 
(2009b), Fitzpatrick and McLean (2010), Mclean et al., (2010a), and McLean 
et al., (2010b) have in my view defined the optimal contribution of 
multidisciplinary experts to what is bespoke and robust ACS treatment in the 
United Kingdom, and in a Scottish context have contributed to national policy 
and service provision. 
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Chapter Five – Reflexivity 
 
5.1 Introduction 
Reflexivity is defined as a critical approach to professional practice that 
questions how knowledge is generated (D’Cruz et al., 2007). The reflexive 
practitioner understands the cognitive processes by which knowledge is 
created and that knowledge is not simply a resource to ‘deploy’ in practice 
(Taylor and White, 2000).  
 
Researcher reflexivity requires an awareness of the researcher's contribution 
to the construction of meanings throughout the research process, and an 
acknowledgment of the impossibility of remaining 'outside of' one's subject 
matter while conducting research (Risjord, 2010). Reflexivity then, urges 
researchers to explore the ways in which their involvement with a particular 
study influences, acts upon and informs the research (Nightingale and 
Cromby, 1999). There are two types of reflexivity: personal reflexivity and 
epistemological reflexivity. ‘Personal reflexivity’ involves reflecting upon the 
ways in which values, experiences, interests, beliefs, political commitments, 
wider aims in life and social identities have shaped the research (Willig, 
2001). It also involves thinking about how the research may have affected 
and possibly changed the researcher. ‘Epistemological reflexivity’ requires 
engagement  with questions such as: How has the research question defined 
and limited what can be 'found?,' How has the design of the study and the 
method of analysis 'constructed' the data and the findings?, How could the 
research question have been investigated differently?, To what extent would 
this have given rise to a different understanding of the phenomenon under 
investigation? (Willig, 2001). Thus, epistemological reflexivity encourages 
researchers to reflect upon the assumptions that have been made in the 
course of the research, and encourages researchers to think about the 
implications of such assumptions for the research and its findings (Willig, 
2001).  
 
In simple terms, the starting point for my research was based on observations 
from practice and a curiosity as to why interventions are done in a certain 
way.  
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This then developed into generating evidence and moving it on to influence 
practice. People who deliver care are the audience at whom the papers are 
aimed, and an impact on the delivery of, decision-making in, and settings for 
cardiovascular care is the desired goal. Challenges for the future and 
opportunities to develop evidence remain foremost.  
 
The reason for describing my journey in these terms relates to Risjord’s 
(2010), Nightingale and Cromby’s (1999) and Willig’s (2001) assertions 
around personal reflexivity and the fallacy of claiming to remain 'outside of' 
one's subject matter while conducting research. From attempting to deliver an 
RCT as a very junior staff nurse, through to being cited in national guidelines, 
my journey has been informed and influenced by key relationships, clinical 
practice, the peer-review process, and the impact of and response to my last 
paper. While by its very nature the process may not have been quite as 
forensically sequenced as described in this thesis, the sequential and logical 
flow of my works has been as a result of not being ‘outside of one’s subject 
matter’ (Risjord, 2010), and rather have been as a result of enjoying the bulk 
of my career deeply immersed in the evolving evidence and practice of caring 
for patients with ACS.   
 
5.2 Personal reflections 
The process of constructing this thesis has been an enjoyable and truly 
rewarding experience. The chronology and progress of my career from new 
staff nurse, to charge nurse, to nurse specialist and then to nurse consultant 
has played a significant part in shaping my published works. Paradoxically the 
published works have undoubtedly shaped my career, where the gravitas, 
professional respect and currency which publishing in national and 
international peer-review journals brings, has afforded me opportunities which 
would not have arisen were it not for the reputation I have garnered through 
these works.  
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I recognise that the opportunities I have had in being awarded Nurse 
Fellowship of the ESC, membership of the ESC Working Group on Acute 
Cardiac Care, and a commissioned editorial in one of Europe’s leading heart 
journals (Fox and McLean, 2010), would not have arisen were it not for my 
body of published work. Although a personal and perhaps subjective view, 
and therefore not included in the body of this thesis, it has been 
overwhelmingly gratifying to see, feel and hear of the improvements in the 
standard of care for patients with ACS in the centres where this work has 
been conducted. That the work was conducted in a major hospital 
environment has meant that there have been, relatively minor, disputes and 
disagreements along the way. These have required time, effort and resolve to 
address, yet act as an opportunity and have been part of my developmental  
process and research learning.  
 
Particularly pleasing is the response to the programmes described by these 
works, not by colleagues who have believed in them since their inception, but 
by those colleagues who have not. I have had positive interactions with 
colleagues who initially were sceptical of a programme where nurses and 
paramedics are the primary decision-makers in the treatment of STEMI, or in 
nurses being responsible for the primary risk-stratification of patients 
presenting to the ED with undifferentiated chest pain.  Perhaps most 
gratifying of all is the fact that these colleagues have been convinced through 
carefully constructed, coherent and programmed quasi-experimental and 
observational research, with the data used to inform publications on the issue. 
 
Similarly it has been a privilege and a pleasure to watch, and to be a key part 
in, the evolution of nurses and paramedics in this domain. For no additional 
financial reward, and therefore for no other reason than a sense of 
professional duty and desire to improve patient outcome, these practitioners 
have revolutionised the care of patients with ACS. I believe that the care of 
these patients will never recede to where it was even as recently as 10 years 
ago (to the right of the horizontal axis of Figure 22, p91). These groups have 
changed the face of ACS care forever.  
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While it makes me proud to have worked alongside them, I do not believe that 
many of them understand just how seismic either the shift in practice, or their 
contribution to it has been. Figure 22 does not do justice to this and I again 
would emphasise the enormity of what has been achieved across the United 
Kingdom. 
 
Of course at the beginning of this journey with my first paper (Robb and 
McLean, 2000) I had no thoughts of composing a body of work which would 
be submitted for doctoral examination. While the PhD by a traditional route 
has some clear advantages in terms of research training that focusses on a 
single issue, it has been criticised for producing a low yield of publications, 
with some successful candidates failing to publish their work at all (Davies 
and Rolfe, 2009). The PhD by Published Works has clear advantages in 
terms of adding to the body of literature.  
 
The challenge in composing a thesis to support the body of published works 
has been in identifying and feeling comfortable with frameworks which furnish 
the evaluation of the body of work in totality. Through describing the 
background, context, aims, philosophical basis of post-positivism, principles 
of causality and rigour, underpinning principles of interventional studies, 
ethical issues, limitations, use of the NIHR toolkit (2009) and the conceptual 
map I am personally assured that I have constructed a framework by which 
my work can be assessed in objectivity. This has significantly increased my 
understanding of my own work and perhaps more importantly has informed 
my learning. I am convinced that I have and will become a “better” researcher 
as a result. 
 
Contrary to my preconceptions I did not find this process a lonely or isolated 
experience. In fact I found it both comforting and rewarding. I found that it 
helped me, through deep and honest introspection, to self-define my place 
within my specialty world, within the research world, and within the nursing 
world. It has, beyond doubt, energised me and given me focus, enthusiasm 
and new skills to take forward into my post-doctoral research.  
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In terms of the nursing world, this work has further compounded my 
determination to move nursing away from the ‘naval-gazing’ which I believe it 
to be guilty of. Professor John Paley from the University of Stirling has 
published several times criticising the “destructive naval-gazing of nursing,” 
and in-particular in nursing academia (Paley, 1996). I do not subscribe to the 
term “nursing research.” Rather I subscribe to healthcare research by nurses. 
As a clinician and a researcher working in a health-care environment I do not 
confine my practice or research within artificial boundaries within one 
discipline. I believe this to be a positive feature of my work. I justify this by 
stating that I study patient outcomes, systems of care and the contribution of 
multidisciplinary clinicians to the care of patients with ACS. Collectively these 
outputs contribute to healthcare research. 
 
Post-procedural complications, effectiveness of interventions, reducing time-
to-treatment in heart attack, “extended” nursing and paramedical roles 
involving telemedicine, synergies of “nurse-led” services when combined, 
exploration of information and support needs, analysis of contemporary 
patient journeys, and exploration of specialist nurse assessment of 
cardiovascular-risk are to my opinion at the heart of healthcare research by 
nurses. For those who believe these to be “medical” rather than “nursing” 
issues I would cite the following who state that ‘nursing’ relates to: developing 
person-centred systems (Risjord, 2010), improving health and health 
outcomes of clients (Polit et al., 2010), evaluating practice (Watson et al., 
2008), study and assessment of patient outcomes (Schmidt and Brown, 2009) 
and generation of an evidence-base (LoBiondo-Wood and Haber, 2010). 
 
I believe these statements to define the gestalt of my research. 
 
5.3 Future research 
As a body of work I believe that it must now evolve further, perhaps bi-
directionally. This of course will not be possible without the collaboration of 
others. I think the first direction will be similar to the one described in this 
thesis.  
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As empirical research testing the efficacy of novel pharmacological agents for 
use in ACS evolves, so does the opportunity to conduct applied research 
testing their utility in real-world clinical practice (as opposed to the RCT 
environment). van’t Hof et al. (2008) reported the benefits of administering the 
glycoprotein inhibitor Tirofiban in the pre-hospital setting. They undertook a 
double-blind, randomised, placebo-controlled trial including 984 patients 
where 491 were assigned to receiving the drug in the ambulance. They 
concluded that there were benefits in clinical outcome as a result. 
 
The van’t Hof et al. (2008) study was performed in ambulances in Belgium, 
Holland and Germany. As highlighted in the first chapter of this thesis, health-
care systems across continental Europe, particularly ambulance services, are 
configured differently when compared to services in the UK, with some 
emergency medical services being characterised by the systematic presence 
on-board the ambulance of a physician. This was a characteristic of van’t Hof 
et al.’s (2008) study where all ambulances had an on-board physician. There 
is therefore an opportunity to study the clinical utility of this regime in a UK 
context. While the UK cardiology community is engaged in debate regarding 
optimal models of STEMI reperfusion treatment, understanding the pre-
hospital utility of a drug which is arguably the most useful adjunctive 
treatment in patients undergoing PPCI would be a useful addition to 
knowledge. The framework for such a piece of work would be similar to the 
work comprising this thesis with a few notable exceptions.   As acknowledged 
in the limitation section of this thesis, the generalisability of this body of work 
is less strong than it might be due to the single-centre nature of the 
publications. Whether as part of the study proposed above, or another study, I 
will endeavour to undertake multi-centre research in the future, with gaining 
clinical trial experience and expanding my collaborative links being key 
objectives. I believe that this will be key to my development as a clinical 
researcher. 
 
A further area for research might be in understanding more about the 
treatment of patients with ACS from the perspective of the paramedics and 
nurses engaged in it.  
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Quinn et al. (2009) performed a survey of paramedics perceptions of their role 
when considering thrombolytic therapy for patients with STEMI. They found 
that paramedics hold a range of views and perceptions of their role in 
administering the treatment, some of which appear to be related to age and 
length of service.  
 
While many paramedics view thrombolytic therapy as a positive step in 
patient care, the authors concluded that further work is required to elicit 
paramedics views on alternative reperfusion strategies such as PPCI. As yet 
there are no UK publications reporting this, nor the views of CCU nurses and 
a carefully designed study would undoubtedly add to knowledge. 
 
Finally I have over the course of my research and clinical career formed the 
view that the pre-hospital 12-lead ECG is the pivotal component of the 
assessment of patients presenting to EMS with suspected ACS, particularly 
STEMI. Use of pre-hospital ECG is however suboptimal in some countries 
with only around 10% of STEMI patients receiving one in the analysis of the 
United States National Registry of Myocardial Infarction (Curtis et al., 2004). I 
am currently involved in discussions with colleagues in England planning a 
study which will assess the clinical benefits of the pre-hospital ECG, and the 
predictors for patients having/not having one performed, which will hopefully 
contribute to the evidence-base in this domain.    
 
5.4 Conclusion 
On page one of this thesis, referencing the California and Western Medicine 
Editorial (1926) I set a challenge that the evidence presented in this thesis 
would provoke the reader to ask whether or not the patient with heart disease 
in 2011 needs the “personal services of a physician,” or perhaps more 
importantly whether or not “no-one else can.”  It is my contention that this has 
been achieved and that the great work of the men and women who deliver 
world-class care to these patients has been made clear. It is gratifying that we 
have come far; and fascinating that we have even further to go. 
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Appendix 1 
 
 
Glossary of terms 
 
ACS  Acute Coronary Syndrome  
AMI  Acute Myocardial Infarction  
ASR  Age Standardised Rate  
CAD  Coronary Artery Disease 
Cath Lab Cardiac Catheterisation Laboratory  
CCNAP Council on Cardiovascular Nursing and Allied Professions 
CCU  Coronary Care Unit  
CHD  Coronary Heart Disease  
CNS  Clinical Nurse Specialist  
CPNs  Chest Pain Nurses 
CSO  Chief Scientist Office  
CVD  Cardiovascular Disease  
ECG  Electrocardiogram  
ED  Emergency Department  
EMS  Emergency Medical (Ambulance) Services  
ESC  European Society of Cardiology 
GRACE Global Registry of Acute Coronary Events  
IHT  In-Hospital Thrombolysis  
MI  Myocardial Infarction 
n  number (sample size) 
NFESC Nurse Fellow of the European Society of Cardiology 
NHS  National Health Service 
NIHR  National Institute for Health Research 
PCI  Percutaneous Coronary Intervention  
PhD  Doctor of Philosophy 
PHT  Pre-Hospital Thrombolysis  
PHRU  Public Health Research Unit 
PPCI  Primary Percutaneous Coronary Intervention  
RCT  Randomised Controlled Trial  
RN  Registered Nurse  
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Rx  Treatment  
SAS  Scottish Ambulance Service 
SGHD  Scottish Government Health Department  
SIGN  Scottish Intercollegiate Guidelines Network  
STEMI  ST segment elevation myocardial infarction 
UK  United Kingdom 
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Current post 
 
 Divisional Nurse, Circulatory, Respiratory & Metabolic Sciences Division, Barts 
and The London NHS Trust 
 
 
Awards/Memberships 
 
 Awarded British Heart Foundation Excellence Award for Cardiac Nursing in 2006 
 Awarded Nurse Fellowship of The European Society of Cardiology in 2008 
 Voted President Elect of The British Association for Nursing in Cardiovascular 
Care in 2009 
 Professional memberships: 
 British Association for Nursing in Cardiovascular Care 
 European Society of Cardiology Working Group on Acute Cardiac Care 
 European Society of Cardiology Working Group on Acute Cardiac Care Pre-
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 European Society of Cardiology Council on Cardiovascular Nursing and Allied 
Professions  
 European Society of Cardiology Expert Consensus Group on the Pre-Hospital 
Care of ST Elevation Myocardial Infarction 
 
 
Research/Educational 
 
 Currently undertaking PhD by Published Works, Edinburgh Napier University 
 First-class Masters degree in Nursing 
 Peer reviewer for: 
 The Emergency Medicine Journal 
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Chief Medical Officer Directorate             
Chief Scientist Office  
T: 0131-244 2248  F: 0131-244 2285 
roma.armstrong@scotland.gsi.gov.uk 
 
Dr Andrew D Flapan 
Department of Cardiology 
Royal Infirmary of Edinburgh 
Little France Crescent 
EDINBURGH 
                  EH16 4SA  
 
Our ref: CZB/4/413 
2 March 2010 
 
Dear Dr Flapan 
 
FINAL REPORT 
STRATEGIES FOR OPTIMAL REPERFUSION IN ST SEGMENT ELEVATION 
MYOCARDIAL INFARCTION. A FEASIBILITY STUDY FOR PROVISION OF 
PRIMARY PERCUTANEOUS CORONARY INTERVENTION AND PRE-
HOSPITAL THROMBOLYTIC THERAPY IN SCOTLAND 
 
The Biomedical and Therapeutic Research Committee considered the Final Report on this 
project. 
 
The Committee graded the report as Excellent.   
 
Please share this information with your co-applicants: S McLean, P Connor and S Wild. 
 
Yours sincerely 
 
 
 
DR ROMA ARMSTRONG 
Biomedical and Therapeutic Research Committee 
 
CSO has moved to electronic working so unless requested otherwise, please respond by 
e-mail. 
 
St Andrew’s House, Regent Road, Edinburgh  EH1 3DG 
www.scotland.gov.uk  
CSO 22 Rev 
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SCHOOL OF CLINICAL SCIENCES AND 
COMMUNITY HEALTH 
UNIVERSITY/BHF CENTRE FOR 
CARDIOVASCULAR SCIENCE 
 
The University of Edinburgh 
Chancellor’s Building 
49 Little France crescent 
Edinburgh EH16 4SB 
 
Telephone:  0131 242 6378 
International Telephone:  +44 131 242 6378 
Fax: 0131 242 6379 
 
Email:  k.a.a.fox@ed.ac.uk  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
11 October 2010  
 
 
Dear Sir/Madam 
 
PhD Thesis: Scott McLean 
 
I am pleased to provide this letter to define the contributions of Scott Mclean in relation to 
the following two publications: 
 
Fox, K.A.A. & McLean, S. (2010) NICE Guidance on Chest Pain. 
Heart 96 903-906. 
Scott McLean made an equal contribution to the design, drafting and revisions of this 
manuscript and he was entirely responsible for the data analysis (exploring the application of 
the NICE Guidance in relation to the Edinburgh dataset). 
 
McLean, S., Phillips, A., Carruthers, K. & Fox, K.A.A. (2010a) Use of the GRACE score 
by cardiology nurse specialists in the emergency department. British Journal of Cardiac 
Nursing 5 91-95. 
Scott McLean was responsible for the development of a highly innovative programme of 
chest pain evaluation by cardiology nurse specialists. He was the lead on the analysis of the 
data, the interpretations and the drafting and revisions of the manuscript. 
 
Yours faithfully 
 
Keith A A Fox 
Professor of Cardiology 
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Dr. Andrew D Flapan 
Clinical Director ‐ CTR Directorate 
The Royal Infirmary of Edinburgh 
Little France Crescent 
Edinburgh 
EH16 4SA 
 
20th November 2010 
 
Dear Sir/Madam 
 
PhD Thesis: Scott McLean 
 
I am pleased to provide this letter to define the contributions of Scott Mclean in relation to 
the following publications: 
 
McLean,  S.,  Wild,  S.,  Connor,  P.  &  Flapan,  A.D.  (2010)  Treating  ST  Elevation  Myocardial 
Infarction by Primary Percutaneous Coronary Intervention, In‐hospital thrombolysis and Pre‐
hospital  thrombolysis. An observational  study of  timelines and outcomes  in 625 patients. 
Emergency Medicine Journal doi:10.1136/emj.2009. 086066. 
Scott McLean and I were jointly responsible for formation of the idea that we could perform 
this study. He was responsible for designing the data collection and data analysis strategies, 
leading the study, and, with added input from Sarah Wild and I, primarily authoring the final 
submission. 
 
Maccioca, P., Cruden, N., McLean, S., Flapan, A.D. & Newby, D.E.  (2010) Effect of smoking 
status on angiographic outcomes and 12‐month mortality  following primary percutaneous 
coronary intervention for acute myocardial infarction. Heart 96 (Suppl 1):A27. 
Nicholas  Cruden  and  I  were  responsible  for  the  idea  for  this  study.  Paul  Maccioca  was 
responsible for the data collection and authoring of the final submission. Scott McLean and 
Paul Maccioca were responsible for analysis the pre/post intervention data.   
 
McLean,  S.  &  Flapan,  A.D.  (2009)  Decision‐making  between  nurses  and  paramedics  in 
reperfusion of ST elevation myocardial infarction. Heart 95 (Suppl 1):A35. 
Scott McLean and I were jointly responsible for formation of the idea that we could perform 
this study. He was responsible for designing the data collection and data analysis strategies, 
leading the study, and authoring the final submission. 
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McLean, S., Wild, S., Connor, P. & Flapan, A.D. (2009) Strategies for optimal reperfusion  in 
ST  segment  elevation  myocardial  infarction.  A  feasibility  study  for  provision  of  primary 
percutaneous  coronary  intervention  and pre‐hospital  thrombolytic  therapy  in  Scotland: A 
report of one‐year follow‐up.  A report to the Chief Scientist Office re. grant no. CZB/4/413. 
Scott McLean and I were jointly responsible for formation of the idea that we could perform 
this  study.  He  was  primarily  responsible,  with  added  input  from  Sarah  Wild  and  I,  for 
authoring the final report to the Chief Scientist Office. 
 
McLean,  S.,  Egan,  G.,  Connor,  P.  &  Flapan,  A.D.  (2008)  Collaborative  decision  making 
between Paramedics and CCU nurses based on 12 lead ECG telemetry expedites the delivery 
of thrombolysis  in ST Elevation Myocardial Infarction. Emergency Medicine Journal 25 370‐
374. 
Scott McLean and I were jointly responsible for formation of the idea that we could perform 
this study. He was responsible for designing the data collection and data analysis strategies, 
leading the study, authoring the final manuscript and steering it through the iterative peer‐
review process to publication. 
 
McLean. S., Wild, S., Connor, P. & Flapan, A.D. (2008) Strategies for optimal reperfusion  in 
ST  segment  elevation  myocardial  infarction.  A  feasibility  study  for  provision  of  primary 
percutaneous  coronary  intervention  and pre‐hospital  thrombolytic  therapy  in  Scotland. A 
report to the Chief Scientist Office re. grant no. CZB/4/413. 
Scott McLean and I were jointly responsible for formation of the idea that we could perform 
this study. He was responsible for writing the grant application to the Chief Scientist Office 
and leading the study. He, with some input from co‐applicants was responsible for framing 
the  research questions, designing  the data collection and data analysis  strategies,  leading 
the  study  and  research  nurse,  and,  with  added  input  from  Sarah  Wild  and  I,  primarily 
authoring the final report to the Chief Scientist Office.   
 
McLean, S., Preston,  J. & Flapan, A.D.  (2008) Belching: An unusual clinical presentation of 
Coronary Ischaemia. Scottish Medical Journal  53 10. 
Scott McLean was  responsible  for  the diagnosis  and  initial  treatment plan of  the patient 
described in the case study. He initiated drafting, writing and submission of the manuscript. 
 
Yours sincerely 
  
Dr. Andrew D Flapan 
Clinical Director – CTR Directorate 
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Gaining ethical  / management approval 100% 
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Data collection 10% 
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Gaining ethical  / management approval 100% 
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Data collection 30% 
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Writing up report 75% 
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& Fox, K.A.A. (2010a) Use of the 
GRACE score by cardiology nurse 
specialists in the emergency 
department. British Journal of Cardiac 
Nursing 5 91-95. 
Preparing manuscript for publication 75% 
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Myocardial Infarction. Emergency 
Medicine Journal 25 370-374. 
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Preparing research proposal / grant application [includes research 
design] 
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Gaining ethical  / management approval 100% 
Developing and testing data collection instruments 100% 
Data collection 100% 
Data analysis 100% 
Writing up report 100% 
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spouse/partner following acute 
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group methodology. Nursing in Critical 
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Preparing manuscript for publication 50% 
None 
Preparing research proposal / grant application [includes research 
design]  
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Gaining ethical  / management approval 85% 
Developing and testing data collection instruments  90% 
Data collection 80% 
Data analysis 80% 
Writing up report  80% 
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Treating ST elevation myocardial infarction by
primary percutaneous coronary intervention,
in-hospital thrombolysis and prehospital
thrombolysis. An observational study of timelines
and outcomes in 625 patients
S McLean,1 S Wild,2,3 P Connor,4 A D Flapan5
ABSTRACT
Objective To describe the effects of implementing of
a percutaneous coronary intervention (PPCI) service and
compare the distribution of reperfusion therapies
12 months pre and post introduction of PPCI.
Design Observational study with data collected
12 months pre and post-availability of Primary PCI as
routine treatment.
Setting Lothian region in South-East Scotland.
Patients 625 Patients who received reperfusion
treatment between December 2005 and November
2007.
Results PHT was given to 96/328 patients (29%) prior
to availability of PPCI as routine treatment. Following
routine availability, PPCI was delivered to 248/297
patients who received reperfusion treatment (84%).
Median diagnosis-to-PCI balloon inflation time and
hospital door-to-balloon time were 84 and 54 min,
respectively. Patients received PPCI balloon inflation
within 90 min of diagnosis in 60% of cases. PPCI-related
delay was 74 min compared with prehospital
thrombolysis (PHT). PHT (152 min) and PPCI (166 min)
had shorter symptom onset-to-assessment of
reperfusion times than in-hospital thrombolysis (IHT)
(226 min).
Conclusions More than two-thirds of the total-
ischaemic-time in (ST-segment elevation myocardial
infarction) STEMI occurs before the patient reaches
hospital, with less than one-third being accounted for by
door-to-needle (IHT) or door-to-balloon (PPCI) time. The
magnitude of difference in the time between symptom
onset-and-assessment of reperfusion treatment efficacy
is short and should be considered, particularly in patients
treated with thrombolysis in hospitals without cath-lab
facilities. Optimal reperfusion treatment including
a combination of PHT, IHT and PPCI, as recommended in
international guidelines, is feasible in the UK although the
balance between the use of different treatments will
differ between urban and rural areas.
Individual randomised trials and pooled analyses1e3
have reported the importance of minimising delays
in the treatment of ST-segment elevation myocar-
dial infarction (STEMI), however few systems of
care presented in the literature have successfully
demonstrated shortening of prehospital and
in-hospital time delays. Optimal treatment for
STEMI has been deﬁned as a reperfusion strategy
which includes both primary percutaneous coronary
intervention (PPCI) and thrombolytic therapy.4
This strategy will dramatically improve clinical
outcome compared with conservative treatment
strategies, if the most appropriate treatment is
offered within the shortest possible time delay
from symptom onset.4 Unfortunately, 25e30% of
patients across Europe with STEMI do not receive
reperfusion treatment1 and there are unacceptably
long-time delays to treatment reported in real-
world registries,2 so that only a minority of
patients receive all guideline-indicated therapies
within desirable timescales.5
This situation may be improved by building
systems of care in which Emergency Medical
Systems (EMS), hospitals with PCI facilities and
non-PCI-capable hospitals work together to reduce
the time from symptom onset-to-administration of
reperfusion treatment, or ‘total-ischaemic-time
(TIT).’6 These ‘STEMI networks’ may not only
reduce TIT but should also increase the proportion
of patients receiving reperfusion therapy, with
resultant decreases in short and long-term
mortality.7
While the majority of treatment delay in STEMI
occurs prior to arrival at the interventional hospital,
with door-to-PPCI balloon time accounting for
around only one-third of the delay between
symptom onset and reperfusion treatment,6 many
of the reported initiatives have focused only on care
in the ﬁnal interventional hospital.8 9 Deﬁning the
optimal time interval between a patient presenting
to emergency healthcare services and receiving
reperfusion therapy in STEMI has generated
signiﬁcant debate. Guidelines from the American
Heart Association/American College of Cardi-
ology10 use conﬂicting terminology by suggesting
that both hospital door-to-PPCI balloon inﬂation,
and ﬁrst medical contact-to-balloon inﬂation
intervals should be less than 90 min. European
Society of Cardiology guidelines4 recommend that
the time between ﬁrst medical contact and PPCI
balloon inﬂation should be less than 90 min in
patients within 2 h of symptom onset, and less
than 120 min in patients presenting more than 2 h
after symptom onset.
A recent report describing PPCI in England11
suggests that a desirable call-to-balloon time should
be within 120e150 min, however guidelines in
Scotland12 state that patients with STEMI should
be treated with PPCI where the diagnosis-to-balloon
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time does not exceed 90 min. These guidelines also state that
where PPCI cannot be provided within 90 min of diagnosis,
patients should receive immediate ﬁbrin-speciﬁc thrombolytic
therapy.12
The interchangeable use of these four terms (call, ﬁrst medical
contact, door and diagnosis) as the starting point for desirable
treatment intervals further complicate the logistical challenges
presented by delivering PPCI.
This paper describes the introduction of a programme of
optimal reperfusion based around a 90 min diagnosis-to-PPCI
balloon time, involving prehospital decision-making by ambu-
lance paramedics and coronary care unit (CCU) nurses.
Following the release of Scottish Intercollegiate Guidelines
Network (SIGN) guidelines on management of acute coronary
syndromes, the Chief Scientist Ofﬁce provided funding to assess
the feasibility of an optimal reperfusion programme (ORP),
based around these guidelines12:
1. Patients with an ST elevation acute coronary syndrome
should be treated immediately with primary percutaneous
coronary intervention.
2. Where primary percutaneous coronary intervention cannot
be provided within 90 min of diagnosis, patients with ST
elevation acute coronary syndromes should receive imme-
diate thrombolytic therapy.
Data were collected on patients receiving reperfusion therapy
over 24 months from December 2005 to November 2007. The
reperfusion programme during the ﬁrst 12 months of this period
(year 1) consisted of prehospital thrombolysis (PHT) and
in-hospital thrombolysis (IHT), with PPCI reserved for patients
who had contraindications to thrombolytic therapy. The second
12 months of data collection were on commencement of the
ORP (year 2), when treatment options were PPCI, PHTand IHT
(for patients self-presenting to a hospital without cath-lab
facilities).
METHODS
NHS Lothian is South-East Scotland’s largest health board area,
has a population of 810 000 people of whom 79% live in urban
areas, and includes three acute receiving hospitals, one of which,
the Royal Inﬁrmary of Edinburgh contains three cardiac
catheterisation laboratories (cath-labs). The establishment of the
12 lead electrocardiography (ECG) telemedicine and PHT
programmes in this population has been described previously.13
The aim of this study was to describe the effects of imple-
menting of a PPCI service and compare the distribution of
reperfusion therapies 12 months preintroduction and post-
introduction of PPCI.
Data items were deﬁned/collected as follows.
General
Time of diagnosis was taken from the time of the ﬁrst diagnostic
ECG whether this was performed in the prehospital or in-
hospital setting. This is supported by the position statement of
the European Society of Cardiology which emphasises the
importance of the exact time of STEMI diagnosis being estab-
lished by the ECG, whether it is in the prehospital setting,
Emergency Department (ED) or CCU.14 Prehospital ECG
recordings taken by EMS paramedics were transmitted to the
ECG receiving station based in the CCU. Criteria for the electro-
cardiographic diagnosis of STEMI were identical to those in
many of the reperfusion studies15 16: >0.1 mV of ST segment
elevation in >2 limb leads, or >0.2 mV in >2 precordial leads.
Legislation in the United Kingdom (UK) allows EMS paramedics
to autonomously administer treatment to patients suffering
acute coronary syndromes including oxygen, aspirin, glyceryl
trinitrate, morphine, clopidogrel and tenecteplase within
nationally agreed inclusion/exclusion criteria.17 Where the ﬁrst
EMS ECG did not meet electrocardiographic criteria for STEMI,
the acquisition of further ECG recordings were symptom-driven
(worsening or return of chest discomfort). Where the ﬁrst in-
hospital ECG did not meet criteria for STEMI, local policy was
to repeat the ECG within 60 min. Total number of STEMIs was
deﬁned as the number of patients with a discharge summary
coded for STEMI, regardless of disposal (discharge, transfer or
in-hospital death). Self-presentation was deﬁned as patients who
arrived at hospital by means other than an ambulance. Variables
of interest from ambulance report forms, medical records, the
cath-lab database and discharge summaries were entered in to
a Microsoft Access database by a research nurse.
Exclusion criteria
Exclusion criteria for year 2 were: initial 12 lead ECG not diag-
nostic of STEMI, out-of-hospital cardiac arrest and patients to
whom no reperfusion treatment was administered. The same
exclusion criteria applied in year 1, with the addition of patients
who received PPCI due to contra-indications to thrombolysis.
PPCI definitions and service
PPCIwas deﬁned as PCI performed on a patientwith no exclusion
criteria, who presented with an initial ECG showing diagnostic
ST-segment elevation. Rescue PCI was deﬁned as PCI performed
due to inadequate resolution of ST-segment elevation following
the administration of thrombolytic therapy, as assessed by 12 lead
ECG recording 60 min following the administration of PHT/IHT.
During ofﬁce hours (MondayeFriday, 08:00e18:00) patientswere
taken directly to the cath-lab for PPCI if the CCU nurse identiﬁed
the ECG as suggestive of STEMI and the paramedic conﬁrmed
that itwould be possible to be at the cath-labwithin 60 min of the
diagnostic ECG.Atother times, patientswere takenbyEMS to the
ED to wait while the on-call cath-lab team were en-route to
hospital. For patients with a STEMI ECGwho could not arrive at
the cath-lab within 60 min of diagnosis, the CCU nurse advised
the paramedic to consider PHTand transport the patient to the
nearest hospital. Patients self-presenting to one of the non-cath-
lab hospitals were treated with IHTandwith subsequent transfer
to the cath-lab hospital for rescue PCI if necessary. Degree of ﬂow
down the infarct-related coronary artery was measured using the
thrombolysis in myocardial infarction trial (TIMI) scoring
system. The TIMI-ﬂow grading system classiﬁes successful
reperfusion as either grade II (partial) or grade III (complete)
ﬂow.18 Vessels with TIMI grade 0 or grade I ﬂow are considered
functionally occluded. TIMI grade II and grade III ﬂows have been
shown to result in superior clinical outcome followingmyocardial
infarction.19
Outcome measures
Outcome measures: were deﬁned prior to commencement of data
collection. Readmission to hospital was deﬁned as all-cause
readmission to any of the three acute receiving hospitals within
12 months of STEMI admission. Mortality was recorded during
index admission, within 30 days of admission and within
12 months of admission using records of deaths held by the
General Register Ofﬁce for Scotland. The time of EMS call was
taken from the electronic EMS record accompanying the patient.
EMS response time was calculated from the difference between
the time of EMS call and the time of EMS scene arrival. EMS
scene time was calculated by from the difference between the
time of EMS scene arrival and the time of EMS scene departure.
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Likewise, EMS drive time was calculated from the difference
between time of EMS scene departure and the time of EMS arrival
at hospital. Time of reperfusion treatment was recorded at the
pointwhere either intravenous injection of a thrombolytic drug or
intra-coronary inﬂation of an angioplasty balloon took place.
Reperfusion assessment was deﬁned as the time at which the
clinician/team made an effort to assess the effect of the reper-
fusion treatment administered; either a 12 lead ECG 60 min after
administration of PHT/IHT, or contrast dye injection immedi-
ately following ﬁrst inﬂation of the angioplasty balloon. PPCI-
related delay was calculated by subtracting the TIT for PHT
from the TIT for PPCI.
Data analysis
The study was designed as an observational analysis of
contemporary reperfusion of STEMI. It was not a trial designed
to assess the effect of an intervention. Time-to-treatment is
studied for the differing reperfusion therapies both as individual
components and as TIT. Results are presented as number (n) and
proportions of outcomes (%), ages as mean (SD) and times as
medians (ranges).
Due to the nature of the study (an observational analysis of
a change in service provision) formal ethics committee review
was not sought. Patient data was encrypted, password
protected, stored anonymously and complied with internal and
external data protection procedures.
RESULTS
A total of 854 people had a coded discharge diagnosis of STEMI
during the 24 months of data collection, giving a STEMI rate of
527 per-million-population-per-annum. Summary patient and
presentation characteristics are given by treatment received in
table 1. A total of 229 (27%) patients met exclusion criteria and
were excluded from analysis, leaving a study group of 625
patients. The reasons for non-administration of reperfusion
treatment included late or atypical clinical presentation,
borderline 12 lead ECG changes and misdiagnosis.
The proportion of patients not receiving reperfusion treat-
ment (18%) is in line with international reports of 29% of
STEMI patients leaving hospital having not received acute
reperfusion therapy.20
Median length of hospital stay was shorter in PPCI patients
(3.9 days) than in patients receiving either PHT (6.7 days) or
IHT (5.9 days) (table 2). During year 2 28% (n¼69) of patients
who received PPCI were admitted directly to the cath-lab, with
similar proportions of patients receiving both PPCI and IHT
being admitted to the ED (70% vs 76%). A total of 552 patients
(88%) presented via EMS, with 93% of PPCI patients (n¼231)
presenting in this way.
Of the 73 patients (12%) who self-presented to hospital, 17
(23%) received PPCI and 56 (77%) received IHT, the majority of
the IHT being administered in the non cath-lab hospitals. Of the
552 patients (88%) who presented to hospital by EMS, 231
(42%) received PPCI, 101 received PHT (18%) and 220 received
IHT (40%). Patients who ultimately received IHT appeared to
take longer to call for help (79 min) than those receiving PHT
(49 min) or PPCI (54 min). In all 552 EMS patients, 283 (51%)
called for help within 60 min of symptom onset. EMS scene
time appeared to be shorter in patients receiving PPCI (29 min)
when compared to those receiving PHT (41 min).
Call-to-reperfusion treatment times were shortest in patients
receiving PHT who received reperfusion treatment within
43 min of calling EMS, compared with 87 min for IHT and
112 min for PPCI. Median EMS ECG-to-reperfusion treatment
time was 84 min in patients receiving PPCI, with 60% (n¼139)
receiving PPCI within 90 min of the EMS ECG (table 3). Median
hospital door-to-PPCI balloon time was 54 min in PPCI patients,
compared with a hospital door-to-thrombolysis time of 31 min
in patients receiving IHT.
Prehospital cardiac arrest occurred in the ambulance among 9
of the 231 EMS PPCI patients (3.9%). All nine survived to
hospital discharge and 30-day follow-up, with eight surviving to
12-month follow-up. The on-call team were called for PPCI on
three occasions when the patient did not undergo PPCI. All three
of these patients had widespread coronary disease with no
occlusive thrombus. None had normal coronary arteries.
TIMI II/III ﬂow was present in 40% (n¼119) of all PPCI
patients during the ﬁrst injection of contrast medium in the
cath-lab. TIMI III ﬂow was present in 88% (n¼218) of patients
immediately post-PPCI. Four cases had TIMI 0eI ﬂow post-
procedure, three had persistent thrombus and one had an acute
dissection which could not be recanalised.
Figure 1 displays timelines generated from detailed mapping
of all data for patients presenting via EMS over the 24 months
studied (n¼552). Median PPCI-related delay was calculated as
7 min against PHT and 0 min against IHT. Both PHT (152 min)
Table 1 Total STEMI, total patients excluded/included in analysis, and reperfusion treatment Dec 05 to
Dec 07
Year 1 Year 2 Total
(Dec 05 to Nov 06) (Dec 06 to Nov 07) (Dec 05 to Nov 07)
Discharge diagnosis of STEMI 438 416 854
Excluded from analysis: 110 (25%) 119 (29%) 229 (27%)
‘Normal’ ECG on presentation 11 (2%) 20 (5%) 31 (4%)
Out-of-hospital-cardiac arrest 9 (2%) 13 (3%) 22 (3%)
No reperfusion treatment given 69 (16%) 86 (21%) 155 (18%)
Year 1 PPCI 21 (5%) NA 21 (2%)
Included in analysis 328 (75%) 297 (71%) 625 (73%)
Reperfusion treatment
Thrombolysis 328/328 (100%) 49/297 (16%) 377/625 (60%)
Prehospital thrombolysis 96/328 (29%) 5/297 (1%) 101/625 (16%)
In-hospital thrombolysis 232/328 (71%) 44/297 (15%) 276/625 (44%)
Primary PCI NA 248/297 (84%) 248/625 (40%)
STEMI, ST elevation myocardial infarction; PCI, percutaneous coronary intervention.
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and PPCI (166 min) had shorter time between symptom onset
and reperfusion assessment than IHT (226 min).
DISCUSSION
A signiﬁcant majority of STEMI patients in this population-
based study presented via EMS. This is higher than in previous
reports from our centre13 and from others in North America21
and Sweden.22 The ﬁnding that very few patients during year 2
of the programme received PHT (n¼5) reﬂects the fact that NHS
Lothian is largely an urban area with 74% of the population
living within a 30-min drive time of the cath-lab and the
remaining population being within easy reach of motorways or
dual-carriageway roads.
The median door-to-balloon time of 54 min reported in this
study remains favourable when compared with data from else-
where. Median door-to-balloon times of 88e94 min in 241
hospitals in the USA,8 70e93 min in 190 hospitals in continental
Europe,1 and 74 min in England11 have been reported.
Nevertheless with evidence of mortality rates increasing as
both door-to-balloon and symptom-onset-to-balloon times
increase,23 we have endeavoured to continually improve our
programme and its performance. Figure 2 shows temporal trends
in door and diagnostic ECG-to-balloon times, and proportions of
patients receiving reperfusion treatment and being admitted
directly to the cath-lab over the 3 years of the programme to
date, all of which have moved in a favourable direction.
Although purely observational the similarities in inpatient,
30 day and 12 month mortality between patients receiving PPCI
and PHT are largely in line with European registry data. In the
French USIC Registry (2000), the combination of PHT with
a large proportion of patients undergoing PCI on index admis-
sion yielded favourable results24: in-hospital mortality was 3.3%
with PHT, 6.7% with PPCI, 8.0% with IHT and 12.2% in
non-reperfused patients. The more recent French nationwide
registry (FAST-MI) reported comparable mortality results in
patients treated with either thrombolysis or PPCI.25
The Swedish RIKS-HIA Registry showed similar mortality
data for ambulance-administered PHT and PPCI,26 while
a further analysis conﬁrmed superior results of PHT in
comparison with IHT, but showed that patients who received
PPCI had the lowest rates of mortality and reinfarction and the
shortest in-hospital stay.27
We believe prehospital decision-making to be key in facilitating
(1) preparation of the cath-lab and alerting of the team while the
patient is en-route to hospital during ofﬁce-hours, (2) activation
and simultaneous transport of the patient/on-call cath-lab team
during out-of-hours, (3) bypassing of the ED (during ofﬁce hours)
which has been shown by other investigators to reduce treatment
delay and improve outcome.28 Theremay however be undesirable
Table 2 Baseline characteristics, length of hospital stay, hospital readmission, death, cardiac catheterisation and mode of presentation
Total (n[625) Primary PCI (n[248)
Thrombolysis (n[377)
PHT (n[101) IHT (n[276)
Male sex n (%) 452 (72%) 184 (74%) 70 (70%) 198 (72%)
Mean age (+SD) 61 (+13) 63 (+12) 61 (+13) 63 (+13)
<60 years n (%) 280 (45%) 118 (48%) 45 (45%) 117 (42%)
Anterior infarction 174 (28%) 64 (26%) 28 (28%) 82 (30%)
Time from symptom onset to hospital arrival:
< 2 h n (%) 276 (44%) 117 (47%) 38 (38%) 121 (44%)
< 6 h n (%) 539 (86%) 213 (86%) 91 (91%) 235 (85%)
Length of stay (days)
Median 4.9 3.9 6.7 5.9
Range 0e65 0e47 0e65 0e42
Episodes of all-cause readmission within
12 months of STEMI n (%)
286 (46%) 114 (46%) 40 (40%) 132 (48%)
Cumulative mortality n (%)
Inpatient 45 (7.2%) 9 (3.7%) 5 (5%) 31 (11.2%)
Within 30 days of admission 54 (8.6%) 14 (5.6%) 5 (5%) 35 (12.7%)
Within 12 months of admission 75 (12%) 19 (7.8%) 7 (7%) 49 (17.7%)
Cardiac catheterisation n (%):
Primary PCI 248 (40%) 248 (100%) NA NA
Rescue PCI 84 (13%) NA 27 (27%) 57 (21%)
During STEMI admission (excluding
rescue and primary PCI)
100 (16%) NA 32 (32%) 68 (25%)
Area of hospital admission:
Emergency department 391 (63%) 173 (70%) 9 (9%) 209 (76%)
Coronary care unit 165 (26%) 6 (2%) 92 (91%) 67 (24%)
Cardiac catheterisation laboratory 69 (11%) 69 (28%) 0 (0%) 0 (0%)
Proportion presenting during ‘office hours’
(0800 to 1800, MondayeFriday)
269 (43%) 119 (48%) 41 (41%) 109 (39%)
EMS presentation 552 (88%) 231 (93%) 101 (100%) 220 (80%)
EMS, Emergency Medical Services; PCI, percutaneous coronary intervention, IHT, in-hospital thrombolysis; PHT, prehospital thrombolysis; STEMI, ST elevation myocardial infarction
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consequences in reducing the numbers of people with STEMI
initially managed in the ED, with evidence from other specialities
that decreased ED exposure to acute conditions (eg trauma) can
result in a poorer standard of ED care.29
Planners of ambulance services can be reassured that the
median on-scene time for crews dealing with PPCI was 12 min
less than those dealing with PHT (41 vs 29 min). This will partly
compensate for the extra time that may be needed to avoid
a nearby non cath-lab hospital and drive to a more distant
hospital with a cath-lab for some patients. There may however
still be local ambulance services that need to be convinced of the
beneﬁts of delivering patients to a hospital where deﬁnitive
STEMI care can be provided, rather than the geographically
nearest hospital. We found that a disproportionate number of
patients who received IHT resided in the catchment area of
a non cath-lab hospital. It appears that these patients may have
been delivered to the local hospital and received IHT despite
being within the potential timeline for PPCI.
The ﬁnding that 40% of PPCI patients arrive at the cath-lab
table with TIMI II/III ﬂow is of interest, particularly in terms of
adjunctive treatment in the prehospital management of STEMI.
Ambulance services across the UK have recently introduced
prehospital administration of Clopidogrel. Prehospital glyco-
protein IIb/IIIa inhibitor treatment has been administered in
some European ambulance services for several years, with recent
evidence supporting the beneﬁts of their administration in the
prehospital setting.30 This may be a factor worth considering
when planning PPCI services for the future, particularly if
acceptable PPCI-related delay is extended and acceptable travel
times becomes longer. The time-based nature of this treatment
may support an argument for prehospital administration aimed
at inhibition of the ﬁnal pathway of platelet aggregation. This is
an area worthy of further research and plans are being developed
to test this concept in our centre.
The ﬁnding of a PPCI-related delay of 74 min (ﬁgure 1) is
important. Experienced Danish investigators have highlighted
the need for careful mapping of individual components of the
patient journey in order to calculate PPCI-related delay and
design the most appropriate programme of care based on
geographical location and resources.31 They cite studies advo-
cating maximum PPCI-related delays ranging from 60 to
171 min, reassuring us that a median delay of 74 min is within
accepted limits. Furthermore while TIT is 74 min shorter in PHT
patients than in PPCI patients (the PPCI-related-delay), the time
from symptom onset to reperfusion assessment was only 14 min
between the two groups. Patients receiving PHTspend a median
of 7 min (from PHT-to-EMS scene departure) + 29 min (travel
time to hospital) + 24 min (delay while waiting to perform
a 12-lead ECG 60 min post-thrombolysis) between reperfusion
and assessment of its efﬁcacy, with thrombolysis failing to
Table 3 Timelines in patients presenting to hospital by EMS only
Primary PCI (n[231) Thrombolysis (n[321)
Symptom onset-to-EMS call (mins) PHT (n¼101) IHT (n¼220)
Median 54 Median 49 Median 79
Range 4e610 Range 7e505 Range 10e610
<60 min 127 (55%) <60 min 57 (57%) <60 min 99 (45%)
EMS scene time (mins) PHT (n¼101) IHT (n¼220)
Median 29 Median 41 Median 25
Range 8e60 Range 7e67 Range 2e66
<30 min 132 (57%) <30 min 40 (40%) <30 min 145 (66%)
EMS drive time (mins) PHT (n¼101) IHT (n¼220)
Median 19 Median 29 Median 15
Range 4e64 Range 4e54 Range 2e43
<30 min 166 (72%) <30 min 53 (53%) <30 min 172 (78%)
EMS call-to-Rx (mins) PHT (n¼101) IHT (n¼220)
Median 112 Median 43 Median 87
Range 59e395 Range 12e71 Range 39e168
<120 min 176 (76%) <60 min 84 (84%) <60 min
EMS ECG-to-Rx (mins) PHT (n¼101) IHT (n¼220)
Median 84 Median 34 Median 67
Range 38e196 Range 7e59 Range 39e168
<90 min 139 (60%)* <90 min 101 (100%) <90 min 37 (17%)
Hospital door-to-Rx (mins) PHT (n¼101) IHT (n¼220)
Median 54 Median NA Median 31
Range 12e255 Range NA Range 7e69
<60 min 164 (71%) <60 min NA <60 min 205 (93%)
Symptom onset-to-Rx (mins) PHT (n¼101) IHT (n¼220)
Median 166 Median 92 Median 166
Range 64e886 Range 49e634 Range 50e796
<180 min 120 (52%) <180 min 83 (83%) <180 min 128 (58%)
*EMS-to-PPCI balloon inflation within 90-minutes achieved during office-hours (Monday-to-Friday 0800 to 1800), in 84% of cases and out-of-office-hours in 44% of cases.
EMS, Emergency Medical Services; PCI, percutaneous coronary intervention; IHT, in-hospital thrombolysis; PHT, prehospital thrombolysis; Rx, treatment.
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reperfuse the artery approximately 30% of the time. In PPCI
however, balloon inﬂation is followed by an almost immediate
contrast injection to assess TIMI ﬂow, and therefore immediate
assessment of treatment outcome.
Study limitations
This study reports a single-centre experience of an ORP. We
suggest that, although other regions of the UK may have
differing in-hospital logistics and EMS provision, the principles
of our programme could apply in any setting. The patients were
not randomised and this study reports real-life experience of an
ORP through application of contemporary STEMI guidelines.
This was not an attempt to replicate the multiple published
studies, enrolling many thousands of patients, which have
compared the differing treatment modalities of PHT, IHT and
PPCI. We also acknowledge that we acknowledge that our
pragmatic assessment of TIT and reperfusion assessment uses
proxy measures of points in time throughout the patient
journey, rather than scientiﬁc measurements of arterial
recanalisation.
Ongoing developments
Patient pathways have been redesigned since year 1 of the ORP
(year 2 of the study). Rather than be kept in the hospital nearest
to the scene of their STEMI, patients receiving PHTanywhere in
the region, or patients receiving IHT in one of the non cath-lab
hospitals are routinely transferred to the heart attack centre for
either rescue PCI (in the event of inadequate resolution of
ST-segment elevation), or inpatient PCI during their STEMI
admission. This is line with national12 and international
guidance.4
Furthermore we have continually improved our programme
and its performance in terms of door and diagnostic ECG-to-
Figure 1 Total ischaemic timelines for
patients presenting to hospital by EMS
(time from symptom onset to delivery
and assessment of reperfusion
therapy). (Abbreviations: EMS,
emergency medical services; PPCI,
primary percutaneous coronary
intervention; IHT, in-hospital
thrombolysis; PHT, prehospital
thrombolysis; Rep, reperfusion; Rx,
treatment; ORP, optimal reperfusion
programm; TIT, total-ischaemic-time).
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Figure 2 Temporal trends in direct admission to cath-lab, ECG-to-
balloon and door-to-balloon times from Dec 2006 to Nov 2009.
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balloon time, and proportions of patients receiving reperfusion
treatment and being admitted directly to the cath-lab. This
comes as a result of the small-scale process redesign suggested by
other centres over the 3 years of the programme to date,32e34
and the beneﬁts of these changes are made clear in ﬁgure 2.
CONCLUSION
Based on telemetric transmission of a prehospital 12-lead ECG
and telephone conversation between ambulance paramedic and
CCU nurse, it is possible to offer PPCI for the majority of
patients with STEMI although it is challenging to meet current
targets regarding time to treatment. This study, like others in
the literature, demonstrated that more than two-thirds of the
total-ischaemic-time in STEMI occurs before the patient reaches
hospital, with less than one-third being accounted for by door-
to-needle (IHT) or door-to-balloon (PPCI) time. We have also
demonstrated that the difference in the time between symptom
onset-and-assessment of reperfusion treatment efﬁcacy is much
shorter than total-ischaemic-time between PHT and PPCI
patients, and should be considered, particularly in patients
treated with thrombolysis in hospitals without cath-lab facili-
ties. As reperfusion programmes evolve and measures are put in
place to address system inefﬁciencies, it appears that door and
diagnostic ECG-to-balloon time, and proportions of patients
receiving reperfusion treatment and being admitted directly to
the cath-lab improve. Optimal reperfusion treatment including
PHT, IHTand PPCI, as recommended in international guidelines,
is feasible in the UK, and allows evidence-based reperfusion
treatment to be available for all patients with STEMI.
Acknowledgements The authors would like to express thanks to the paramedics,
nurses, doctors, technicians and radiographers who delivered reperfusion services
to the patients in this study. Thanks to Mrs. Fiona Bett for efforts in data collection,
Mr. Ian Archibald in the Scottish Ambulance Service, the Scottish Government
Health Department and Dr Paul MacIntyre.
Funding Funding for this study was provided by the Chief Scientist Office of the
Scottish government Health Department.
Competing interests None.
Provenance and peer review Not commissioned; externally peer reviewed.
REFERENCES
1. Mandelzweig L, Battler A, Boyko V, et al. The second Euro Heart Survey on acute
coronary syndromes: characteristics, treatment, and outcome of patients with ACS in
Europe and the Mediterranean Basin in 2004. Eur Heart J 2006;27:2285e93.
2. Eagle KA, Nallamothu BK, Mehta RH, et al. Trends in acute reperfusion therapy for
ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better
but we have got a long way to go. Eur Heart J 2008;29:609e17.
3. Blomkalns AL, Roe MT, Peterson ED, et al. Guideline implementation research:
exploring the gap between evidence and practice in the CRUSADE Quality
Improvement Initiative. Acad Emerg Med 2007;14:949e54.
4. Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in
patients presenting with persistent ST-segment elevation: The Task Force on the
management of ST-segment elevation acute myocardial infarction of the European
Society of Cardiology. Eur Heart J 2008;29:2909e45.
5. Silber S, Albertsson P, Aviles FF, et al. Guidelines for percutaneous coronary
interventions. The Task Force for Percutaneous Coronary Interventions of the
European Society of Cardiology. Eur Heart J 2005;26:804e47.
6. Fox KAA, Huber KA. European perspective on improving acute systems of care in
STEMI: we know what to do, but how can we do it? Nat Rev Cardiol
2008;5:708e14.
7. Kalla K, Christ G, Karnik R, et al. Implementation of guidelines improves the standard
of care: the Viennese registry on reperfusion strategies in ST-elevation myocardial
infarction (Vienna STEMI Registry). Circulation 2006;113:2398e405.
8. Nallamothu BK, Wang Y, Bradley EH, et al. Comparing hospital performance in
door-to-balloon time between the hospital quality alliance and the national
cardiovascular data registry. JACC 2007;50:1517e19.
9. AHA. (online 31st May 2007). Mission: lifelineda new plan to decrease deaths from
major heart blockages. http://www.americanheart.org/presenter.jhtml?
identifier¼3048 034 (accessed 17 Jan 2010).
10. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the
management of patients with ST-elevation myocardial infarction: executive summary:
a report of the ACC/AHA Task Force on Practice Guidelines (Committee to Revise the
1999 Guidelines on the Management of Patients With Acute Myocardial Infarction).
Circulation 2004;110:588e636.
11. Department of Health. National infarct angioplasty project: interim report. London:
The Stationary Office, 2008.
12. Scottish Intercollegiate Guidelines Network. Acute coronary
syndromesda national guideline. Edinburgh: SIGN, 2007.
13. McLean S, Egan G, Connor P, et al. Collaborative decision making between
paramedics and CCU nurses based on 12 lead ECG telemetry expedites the delivery
of thrombolysis in ST Elevation Myocardial Infarction. Emerg Med J 2008;25:370e4.
14. Bassand JP, Danchin N, Filippatos G, et al. Implementation of reperfusion therapy in
acute myocardi al infarction. A policy statement from the European Society of
Cardiology. Eur Heart J 2005;26:2733e41.
15. Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2)
Investigators. Single-bolus tenecteplase compared with front-loaded alteplase in
acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet
1999;354:716e22.
16. Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-3)
Investigators. 0Efficacy and safety of tenecteplase in combination with the low-
molecular weight heparin enoxaparin or unfractionated heparin in the prehospital
setting: the ASSENT-3-PLUS randomised trial in acute myocardial infarction.
Circulation 2003;108:135e42.
17. Joint Royal Colleges Ambulance Liaison Committee. http://www2.warwick.ac.
uk/fac/med/research/hsri/emergencycare/prehospitalcare/jrcalcstakeholderwebsite/
guidelines/thrombolytics_reteplase_tenecteplase.pdf (accessed 15 Jan 2010).
18. White HD. Applying the open artery theory: use of predictive survival markers.
Eur Heart J 1998;19:1132e9.
19. Lincoff AM, Topol EJ, Califf RM, et al. Significance of a coronary artery with
thrombolysis in myocardial infarction grade 2 ‘patency’ (outcome in the Thrombolysis
and Angioplasty in Myocardial Infarction trials). Thrombolysis and Angioplasty in
Myocardial Infarction Study Group. Am J Cardiol 1995;75:871e6.
20. Fox KAA, Steg PG, Eagle KA, et al. Decline in rates of death and heart failure in
acute coronary syndromes, 1999-2006. J Am Med Assoc 2007;297:1892e900.
21. Canto JG, Zalenski RJ, Ornato JP, et al. Use of emergency services in acute
myocardial infarction and subsequent quality of care: observations from the national
registry of myocardial infarction 2. Circulation 2002;106:3018e23.
22. Herlitz J, Karlson BW, Bang A, et al. Characteristics and outcome for patients with
acute chest pain in relation to whether or not they were transported by ambulance.
Eur J Emerg Med 2000;7:195e200.
23. Pinto DS, Kirtane AJ, Nallamothu BK, et al. Hospital delays in reperfusion for ST-
elevation myocardial infarction: implications when selecting a reperfusion strategy.
Circulation 2006;114:2019e25.
24. Danchin N, Blanchard D, Steg P, et al. Impact of prehospital thrombolysis for acute
myocardial infarction on 1-year outcome. Circulation 2004;110:1909e15.
25. Danchin N, Coste P, Ferrie`res J, et al. Comparison of thrombolysis followed by
broad use of percutaneous coronary intervention with primary percutaneous coronary
intervention for ST-segment elevation acute myocardial infarction: data from the
French Registry on Acute ST-Elevation Myocardial Infarction (FAST-MI). Circulation
2008;118:268e76.
26. Bjo¨rklund E, Lindahl B, Stenestrand U, et al. Outcome of ST-elevation myocardial
infarction treated with thrombolysis in the unselected population is vastly different
from samples of eligible patients in a large-scale clinical trial. Am Heart J
2004;148:566e73.
27. Stenestrand U, Lindba¨ck J, Wallentin L. Long-term outcome of primary
percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for
patients with ST-elevation myocardial infarction. J Am Med Assoc
2006;296:1749e56.
28. Carstensen S, Nelson GC, Hansen PS, et al. Field triage to primary angioplasty
combined with emergency department bypass reduces treatment delays and is
associated with improved outcome. Eur Heart J 2007;28:2313e19.
29. http://www.dhsspsni.gov.uk/majortraumaanalysis.pdf (accessed 14 Jan 2010).
30. van’t Hof AW, Ten Berg J, Heestermans T. Prehospital initiation of tirofiban in
patients with ST-elevation myocardial infarction undergoing primary angioplasty
(On-TIME2): a multicentre, double-blind, randomised controlled trial. Lancet
2008;372:537e46.
31. Terkelsen CJ, Lassen JF. Treatment delays in ST elevation myocardial infarction:
can be reduced by prehospital diagnosis and transfer to high volume catheterisation
laboratories. Br Med J 2008;336:401e2.
32. Bradley EH, Roumanis SA, Radford MJ, et al. Achieving door-to-balloon that meet
quality guidelines: how do successful hospitals do it? J Am Coll Cardiol
2005;46:1236e41.
33. Moscucci M, Eagle KA. Reducing the door-to-balloon time for myocardial infarction
with ST-segment elevation. N Engl J Med 2006;355:2364e5.
34. Bradley EH, Herrin J, Wang Y, et al. Strategies for reducing the door-to-balloon time
in acute myocardial infarction. N Engl J Med 2006;355:2308e20.
McLean S, Wild S, Connor P, et al. Emerg Med J (2010). doi:10.1136/emj.2009.086066 7 of 7
Original article
 group.bmj.com on July 12, 2010 - Published by emj.bmj.comDownloaded from 
British Journal of Cardiac Nursing    February 2010    Vol 5 No 2 91
Research and Development
Chest pain suspected to be cardiac in origin is responsible for 6% of all emergency department (ED) attendances in the United Kingdom (Goodacre 
et al, 2005). It is the most common reason for 999 calls to 
ambulance services (Laird et al, 2004) and results in more 
than 149 000 admissions to hospital in Britain a year 
(Stewart et al, 2003).
Differentiating patients with acute coronary syndrome 
(ACS) from patients with chest pain not due to plaque 
rupture within a coronary artery is a major diagnostic 
challenge (Carruthers et al, 2005). There is an important 
paradox in that while Deakin et al (2006) reported only 
0.6% of 999 calls to ambulance services resulting in an in-
hospital diagnosis of ACS, Collinson et al (2000) stated 
that an estimated 6% of ED patients assessed solely on 
clinical and electrocardiographic findings, and as such 
discharged from hospital, could have experienced signifi-
cant myocardial injury. 
The GRACE (Global Registry for Acute Coronary Events) 
risk prediction tool provides a method of calculating the 
risk of in-hospital death, 6-month death and myocardial 
infarction (MI) (Fox et al, 2006). The tool is designed to 
reflect a broad population of patients with ACS and has 
enrolled 102 341 patients in 247 hospitals over 30 countries 
(Center for Outcomes Research, 2009). Portuguese investi-
gators reported that the GRACE score was superior to both 
the TIMI (Thrombolysis In Myocardial Infarction) 
(Antman et al, 2000) and PURSUIT (Platelet glycoprotein 
IIb/IIIa in Unstable agina: Receptor Suppression Using 
Integrilin) (Boersma et al, 2000) scores in predicting the 
risk of death or MI at 1 year following hospital admission 
(de Araújo Gonçalves et al, 2005). Investigators in the 
authors’ own institution have reported that the GRACE 
score stratifies risk in patients presenting to the ED with 
undifferentiated chest pain accurately (Lyon et al, 2007). 
There are however no reports in the literature of nurses 
assessing risk of death/MI by prospectively applying these 
risk scores.
Investigators have highlighted that risk scores such as 
TIMI, PURSUIT and GRACE are available to help nurses 
as they triage patients with chest pain in designated chest 
pain units (Siebens et al, 2007). They cite evidence of 
patients with chest pain being safely triaged by nurses 
(Smith, 2000), while Quinn et al (2000) concluded that 
CCU nurses were more likely to identify suitability for 
transfer to a general ward, as compared with a physician-
devised algorithm, in patients with chest pain.
Aims
The aim of this article is to determine whether systematic 
application of the GRACE risk-score by cardiology nurse 
specialists predicts long-term outcome among unselected 
Abstract
Suspected cardiac chest pain is responsible for a significant number 
of emergency department attendances and 999 calls to ambulance 
services in the UK. Differentiating patients with acute coronary 
syndrome (ACS) is a major diagnostic challenge. The GRACE risk 
prediction tool provides a validated method of calculating the risk of 
in-hospital death, 6-month death and myocardial infarction. This 
study aimed to determine whether systematic application of the 
GRACE risk-score by cardiology nurse specialists predicts long-term 
outcome in unselected patients with chest pain. Seven-thousand 
patients had a GRACE score recorded between September 2005 and 
April 2008. A random sample of 504 patients was extracted and 
their outcomes analysed. Incidence of death by April 2009 was 
recorded, with a follow-up period ranging from 31 to 44 months. 
Median length of hospital stay, confirmation of ACS and cardiac 
catheterization on index admission were recorded. There were 
significant differences in confirmation of ACS, length of hospital stay, 
inpatient cardiac catheterization and death at follow-up, over low, 
moderate and high-risk GRACE scores, with patients in the high-risk 
group suffering the worst outcomes. This study demonstrates the 
feasibility and the potential additional utility of objective risk scoring 
in a busy and challenging clinical environment.
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Figure 1. The GRACE score calculator. HR = heart rate; SBP = systolic blood pressure; Creat = serum creatinine levels;  
CHF = congestive heart failure
patients with chest pain. The setting for the study was the 
ED of a major teaching hospital with attendance over 
100 000 patients per year. The chest pain service at this 
institution has been described previously (McLean, 2006).
Design
The GRACE risk score was systematically and prospectively 
applied to all patients with undifferentiated chest pain in the 
ED assessed by the chest pain nurses (CPNs) between 
September 2005 and April 2008. Clinical staff remained 
blinded to the risk score. A random sample of 504 of the 
first 7000 patients was analysed retrospectively to deter-
mine the relationship between risk score and outcomes. 
The local ethical committee was consulted and ethical 
approval for this study was waived as it was a retrospective 
audit of data obtained in routine clinical practice.
Methods
As a routine part of their clinical work, the four CPNs 
recorded GRACE scores on patients presenting to the ED 
with undifferentiated chest pain. Scores were calculated 
on a handheld PDA device and entered into the weekly 
spreadsheet collected by the CPNs. The variables that 
make up the GRACE score are displayed in Figure 1.
All the information required for the GRACE score was 
readily available for all patients. Assessment of Killip class 
is a routine part of the CPN role. In the ED setting, creati-
nine blood level results are available within one hour for 
almost all patients, and there was no delay to treatment. 
A total population of 7000 patients had a GRACE score 
recorded by the CPN in the 32 months between September 
2005 and April 2008. A random sample of 504 patients 
(7% of the overall population) was extracted using a ran-
dom number generator (http://www.random.org) and 
their outcomes analysed. 
Details of the 504 patients were cross-referenced with 
records of deaths held by the General Register Office for 
Scotland. Incidence of death from all causes by April 2009 
was recorded, resulting in a follow-up period ranging 
from 31 to 44 months. Median length of hospital stay and 
cardiac catheterization on index admission were recorded 
from electronic hospital records. From the 504 patients 
181 were classified by the GRACE score as low-risk (0–
15% likelihood of death), 166 as moderate-risk (16–30% 
likelihood of death), and 157 as high-risk (>30% likeli-
hood of death). 
Statistical analysis
Kaplan-Meier analysis of survival (Figure 2) and associa-
tion between death and confirmation of ACS (Figure 3) 
were performed, with significance calculated by use of the 
log-rank test. Chi-square tests were used to calculate sig-
nificance of associations between GRACE score and car-
diac catheterization, and GRACE score and ACS. The 
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Figure 2: Kaplan-Meier analysis of survival to follow-up
Figure 3: Kaplan-Meier analysis of association between death and confirmation of acute coronary syndrome (ACS)
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Low risk Moderate risk High risk Total P
Median length of 
hospital stay (days) 
(Inter-quartile range)
2.3 
(1.7–3.9)
3.4 
(2.1–5.4)
6.5 
(5–7.9)
4.2 <0.0001
Cardiac catheterization 
on index admission
4/181  
(2%)
35/166  
(21%)
93/157  
(59%)
132/504 
(26%)
<0.0001
ACS confirmed on 
index admission in 
patients dead at  
follow-up
5/23 
(22%)
14/42 
(33%)
30/55 
(54%)
49/120 
(41%)
<0.0001
ACS = Acute coronary syndrome
Table 1. 
Length of hospital stay, cardiac catheterization and confirmed ACS  
stratified by low/moderate/high risk GRACE score 
Kruskall-Wallis test was used for significance between 
GRACE score and length of hospital stay.
Results
For the 504 patients the median time between index 
admission and follow-up was 38 months. The duration of 
follow-up was determined by the time interval between 
presentation and the date of the study. 21% of patients 
(n=105) had a follow-up duration of 31–36 months and 
for 79% follow-up was 37–44 months. Survival status was 
checked against the national death registry. By April 2009 
the overall number of deaths was 120/504 (24%) with a 
median time from admission to death of 219 days. These 
were deaths from all causes—it was not possible to track 
different causes of death and therefore single out cardiac 
deaths alone through the registry. There was a cumulative 
death rate of 14% within 12 months of admission, 19% 
within 24 months, and 24% within 36 months and 
44 months of index admission. 
Kaplan-Meier analysis demonstrated a difference 
between the survival of patients over the three GRACE 
score strata (P<0.0001).
There was an incremental rise in the likelihood of death 
over low (n=23, 13%), moderate (n=42, 25%) and high 
(n=55, 35%) risk groups. ACS was confirmed on index 
admission in 22% (n=5) of low-risk patients who were 
dead at follow-up, 33% (n=14) of moderate-risk and 54% 
(n=30) of high-risk patients. Survival to follow-up was 
significantly less in patients with confirmed ACS 
(P<0.0001) (Table 1).
Median length of stay for all patients during the index 
hospitalization was 4.2 days. Again there was an incre-
mental rise in median length of stay over low (2.3 days), 
moderate (3.4 days) and high (6.5 days) risk groups 
(P<0.0001).
Cardiac catheterization was performed on index admis-
sion on 132/504 patients (26%). The procedure was per-
formed in 2% of low-risk (n=4), 21% of moderate-risk 
(n=35) and 59% of high-risk patients (n=93) (P<0.0001).
Discussion
The study first demonstrates the feasibility of systemati-
cally determining the GRACE risk score during the assess-
ment of patients presenting to the ED with undifferenti-
ated chest pain. The additional time required to determine 
the GRACE score using a handheld PDA device was 
approximately 30 seconds. 
From this random sample of 504 patients the results dem-
onstrate that the GRACE risk score calculated by the CPN 
in the ED powerfully predicts outcome in terms of deaths 
during follow-up and length of hospital stay and likelihood 
of cardiac catheterization during the index admission. 
Although the sample size of 504 represents only 7% of 
the total number of patients for whom a GRACE score was 
calculated to April 2008, it was determined to be sufficient 
for the statistical analysis undertaken. 
Siebens et al (2007) stated that nurses assessing patients 
with chest pain can play an important role in the diagnos-
tic process by making it more efficient and cost-effective. 
They also stated that nurses in these roles are in a unique 
position to apply evidence-based practice published in 
guidelines and practice standards. 
Treatment guidelines for nurse practitioners in the 
United States (Albert, 2007) suggest clinical assessment 
from the patient history (Braunwauld et al, 2002), risk-
scoring by using TIMI (Antman et al, 2000), or risk-scor-
ing by using PURSUIT (Boersma et al, 2000). This study 
demonstrates that nurse practitioners in one centre in the 
UK can effectively use the GRACE score (Center for 
Outcomes Research, 2009) to accurately predict outcome, 
and in turn practice to a standard recommended in 
national (Scottish Intercollegiate Guidelines Network, 
2007) and European guidelines (Bassand et al, 2007).
While other investigators have established that CPNs 
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may help address suboptimal care offered to patients 
presenting with chest pain (Mullan et al, 2007) this study 
demonstrates the utility of an objective tool in risk-
assessing patients with undifferentiated chest pain. This 
is important given the findings of Hay et al (2001) who 
observed that nurses tended to over-estimate disease 
severity in patients presenting with chest pain.
There can be little argument that the clinical assessment 
of patients presenting to hospital with chest pain has been 
aided by the addition of troponin testing (Scirica and 
Morrow, 2004). However, it must be remembered that a 
negative troponin test is not a complete predictor of risk, 
and has had its appropriateness questioned in very low-
risk subsets (Fox, 2005; Steg et al, 2009). The multifacto-
rial nature of the GRACE score may therefore lend itself to 
a more complete evaluation in patients with undifferenti-
ated chest pain.
One possible limitation of this study would be if there 
were variations in scoring between the various CPNs. This 
was not analysed in this study, but could be an area for 
future research.
Conclusions
Although this is a single-centre study, the catchment 
population in South East Scotland provides the full spec-
trum of patients with chest pain and the results of this 
study are likely to be applicable in other centres. This study 
has added to the paucity of work which exists reporting 
the application of cardiovascular risk scores by nurses in 
the acute setting. When the CPN risk stratified patients 
presenting to the ED with undifferentiated chest pain into 
low, moderate and high-risk strata, using the GRACE 
score, this predicted incrementally the likelihood of death 
during follow-up, length of hospital stay and inpatient 
cardiac catheterization. 
The study demonstrates the feasibility of objective risk 
scoring and the potential additional utility of this infor-
mation in a busy and challenging clinical environment.
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ABSTRACT
Objectives: To describe a prehospital thrombolysis (PHT)
and expedited inhospital thrombolysis (IHT) programme in
south-east Scotland using prehospital 12-lead ECG
recordings transmitted by telemetry and autonomous
paramedic-administered thrombolysis with decision sup-
port being provided by coronary care nurses.
Design: Retrospective observational study.
Setting: Three hospitals in south-east Scotland covering
a population of 778 468 served by 54 ambulance
vehicles.
Patients: 11 840 patients who telephoned the ambu-
lance service with ‘‘chest pain’’ over 20 months, during
which 812 patients were admitted with ST segment
elevation myocardial infarction (STEMI).
Main outcome measures: All calls and cardiac/
potential cardiac calls to the ambulance service, type/time
of patient presentation, symptoms/call/door-to-thrombo-
lysis times.
Results: Of the 11 840 calls to the ambulance service for
chest pain over 20 months of the initiative, 60% were
cardiac/potentially cardiac-related by Scottish Ambulance
Service triage. ST segment elevation was present in 8% of
the 5150 12-lead ECGs transmitted by paramedics to the
ECG receiving station in the CCU. Over the 20 months, 812
patients were admitted to the three hospitals with STEMI
and 71% received thrombolysis. Median symptom-to-
thrombolysis times were 91, 148 and 184 min, respectively,
in the PHT, telemetry-facilitated IHT and self-presenting IHT
groups. Median call-to-needle time for the PHT group was
40 min. In 2/146 cases the cardiologists judged that the
patient should not have been administered PHT.
Conclusions: Based on prehospital 12-lead ECG tele-
metry, it is possible for paramedics and CCU nurses to
conduct live reperfusion decision-making in patients with
STEMI, with resultant benefits in symptoms-to-thrombo-
lysis time.
Clinical trials in the treatment of acute ST elevation
myocardial infarction (STEMI) have consistently
demonstrated the benefits of thrombolysis on
mortality. These benefits are time-dependent and,
in meta-analyses1 as well as in clinical practice,2 are
consistently reported to result in significant reduc-
tions in left ventricular systolic impairment and
mortality through early administration. It has been
argued that very early thrombolysis, whether in the
first 60 min,3 70 min4 or 120 min1 following symp-
tom onset, offers the greatest benefit when com-
pared with thrombolysis given more than 2 h after
the onset of symptoms.
Various strategies have been designed to reduce
delays between diagnosis and administration of
treatment with thrombolysis.5 These range from
GP diagnosis and administration without 12-lead
ECG recording6 to autonomous paramedic admin-
istration following a 12-lead ECG recording in the
community.7 To reduce inhospital delay (‘‘door-to-
needle’’ time), early warning or pre-alert of the
emergency department (ED) of incoming patients
allows different models of thrombolysis to be
delivered.8 In our own hospital a ‘‘fast track’’
response system was developed to reduce door-to-
needle time in the ED.9
In 2002–3 the Scottish Ambulance Service (SAS)
began moves towards prehospital thrombolysis
(PHT). Paramedics were trained to a nationally
accepted standard before being allowed to admin-
ister thrombolysis. Legislation has been in place
since April 2004 approving both tenecteplase and
reteplase under medicines provisions for parame-
dics. At the same time, the SAS became equipped
with ECG machines capable of transmitting the
12-lead ECG by mobile telephone technology. We
report our experience of working with the SAS in
providing decision support from coronary care unit
(CCU) nurses, facilitating PHT as well as expedited
inhospital thrombolysis (IHT).
METHODS
Prehospital 12-lead ECG recordings are performed
on patients aged over 16 years presenting with
non-traumatic chest pain or other symptoms
which the paramedic suspects to be cardiac-related
and potentially ischaemic (for brevity, the term
‘‘paramedic’’ has been used interchangeably to
include either paramedics or ambulance techni-
cians who perform and transmit 12-lead ECGs but
are not licensed to administer thrombolysis). The
ECG is transmitted to a receiving station in the
CCU by mobile telephone technology.
A Lifenet RS 12-lead ECG receiving station
(Medtronic Physio-Control, Basingstoke, UK) was
installed in The Royal Infirmary of Edinburgh
which is the tertiary referral centre for south-east
Scotland, with a 10-bed CCU, 2 catheter labora-
tories, 24 hour/7 day ED and 24 hour/7 day CCU
junior grade doctor. The population of 778 468 is
served by 3 acute receiving hospitals, 7 ambulance
stations, 54 vehicles, 160 paramedics and 200
technicians. In addition to standard equipment,
the ambulance thrombolysis pack includes a
10 000 unit vial of tenecteplase and a 5000 unit
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vial of heparin sodium. Responsibility for dealing with the 12-
lead ECG arriving at the receiving station in the CCU is assigned
either to the nurse in charge or a junior grade doctor.
Paramedics are instructed that if they receive no telephone
call within 1 min of transmitting the 12-lead ECG, they can
assume that the receiving nurse/doctor does not believe the
ECG to show changes compatible with STEMI. The ECG
receiving station alerts staff via very loud audio and visual
alarms and is answered very promptly in every case. As an
autonomous practitioner, the paramedic can ultimately choose
to administer or not administer tenecteplase regardless of the
advice given by the CCU.
Where there is a technical failure to transmit the ECG from
the field, paramedics continue with their usual process of care
and destination hospital. In the event of ST segment elevation,
they are encouraged to telephone the CCU and describe the
ECG changes over the telephone, giving PHT where they
consider it appropriate. The paramedic is advised to admit the
patient directly to the nearest appropriate CCU (with or
without PHT) rather than to the ED.
Statistical methods
In order to compare the results between two normally
distributed groups, two-sample t tests were used. In cases
where the distribution did not appear normal (eg, symptom-to-
call time), the Mann-Whitney test was used. In cases where the
distribution did not appear normal and there were more than
two groups (eg, symptoms-to-thrombolysis time and symp-
toms-to-hospital time), Kruskal-Wallis tests were used.
RESULTS
The initiative was implemented in October 2004. In the
20 months to May 2006 the SAS attended 11 840 calls within
the catchment population where ‘‘chest pain’’ was the main
presenting complaint. A total of 7060 calls (60%) were thought
to be cardiac or potentially cardiac in nature by SAS triage. A 12-
lead ECG was transmitted to the ECG receiving station in 5150
cases, 73% of calls with cardiac/potentially cardiac chest pain.
Table 1 shows the distribution of ECG findings. ST segment
elevation of >0.1 mV in leads I–III, aVF, aVL, V4–V6 or
>0.2 mV in leads V1–V3 was present in 412 (8%) of the ECGs.
Horizontal or downsloping ST segment depression of >0.1 mV
in two contiguous leads was present in 1030 (20%). Of the 412
ECGs classified as arrhythmias, 358 (87%) showed atrial
fibrillation with ventricular responses between 48 and
178 beats/min.
A total of 6179 patients had a 12-lead ECG recorded, 87% of
cardiac/potentially cardiac-related chest pain calls. The 12-lead
ECG failed to transmit to the receiving station due to technical
problems in 144 cases (2%) and the paramedic did not attempt
to transmit it in 885 cases (14%).
During the 20-month study period 812 patients were
admitted to the three hospitals with STEMI. Thrombolysis
was administered to 575 (71%). Patients presented via the
ambulance service in 544 cases (67%), of whom 146 (27%)
received PHT, 247 (45%) received IHT and 151 (28%) did not
receive thrombolysis (table 2). Twenty patients (2%) with
STEMI arrived at hospital within 1 h of the onset of symptoms,
3 were self-presentations and 17 from the SAS. A total of 222
patients presented between 1 and 2 h, 32 (12%) of which were
self-presentations and 190 (35%) via the SAS. Fewer patients
presented at.6 h via SAS than self-presentations (38 (7%) vs 43
(16%)).
Of the patients transported by the SAS who received
thrombolysis either before arriving at hospital or through
telemetry-facilitated IHT (thrombolysis given in hospital
following a pre-alert by 12-lead ECG transmission and direct
admission to the CCU, n=393), there were no significant
differences in symptoms-to-call time (p=0.067), SAS response
time (p=0.492) or time from symptoms-to-hospital arrival
(p=0.893). Patients in the PHT group had significantly reduced
SAS call-to-thrombolysis times (40 vs 86 min, p,0.001),
symptoms-to-thrombolysis times (91 vs 148 min, p,0.001)
and proportion of patients given thrombolysis within 60 min of
calling the SAS (130 (89%) vs 4 (2%)). The SAS spent more time
on-scene (26 vs 22 min, p,0.001) and travelling to hospital (47
vs 42 min, p=0.002) when giving PHT than when transferring
for telemetry-facilitated IHT (table 3).
When comparing those receiving IHT, the median door-to-
thrombolysis time in patients receiving telemetry-facilitated
IHT was 18 min (range 4–48) compared with 30 min (range 6–
94) in patients receiving IHT who self-presented to hospital
(p,0.001). Median symptoms-to-thrombolysis times were
significantly different between the three groups: 91 min (range
28–527) in the PHT group, 148 min (range 62–442) in the group
given telemetry-facilitated IHT and 184 min (range 32–517) in
the self-presenting group given IHT (p,0.001).
Emergency percutaneous coronary intervention (PCI), either
for failure to achieve >50% ST segment resolution on the
90 min post-thrombolysis ECG or for acute reinfarction within
6 h following initially successful ECG evidence of reperfusion,
was performed in 172/812 patients (30%). There were no
significant differences between the three groups (32% for PHT,
30% for telemetry-facilitated IHT and 28% for self-presenting
IHT).
DISCUSSION
We can find no previous reports of autonomous paramedic-
administered thrombolysis with telemedicine decision support
provided predominantly by nurses in a CCU. ST segment
elevation was present on the ECGs of 3.5% of all calls for chest
pain, which corresponds to previous observations.10 A study of
advanced medical priority dispatch (AMPDS) codes used by
ambulance services has shown that 5% of all calls with ‘‘chest
pain’’ have a hospital diagnosis of acute coronary syndrome.11
The observed rate of failure to transmit a prehospital 12-lead
ECG due to technical problems of 2% was not unreasonable and
is similar to the findings of previous Scottish investigators.12
Table 1 Calls to the ambulance service: distribution of successfully
transmitted ECGs
Calls to the ambulance service with presenting complaint of
chest pain
11840
Calls thought to be cardiac or potentially cardiac 7060
Presenting ECG successfully transmitted to CCU 5150
‘‘Normal’’ 2678 (52%)
ST depression/T wave inversion 1030 (20%)
Bundle branch block/ventricular paced rhythm 412 (8%)
Arrhythmia 412 (8%)
ST segment elevation 412 (8%)
Other 206 (4%)
Cardiac/potentially cardiac patients with an ECG not
transmitted to CCU
1910
ECG not performed 881
ECG performed, transmission attempted but transmission failure 144
ECG performed but no transmission attempted by paramedic 885
CCU, coronary care unit.
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Patients in this study were much more likely to use
ambulance services than North American and Swedish
patients,10 13 14 and those using the SAS were more likely to
arrive at hospital within 0–2 h than self-presenting patients
with STEMI. This may be particularly relevant to discussions
surrounding optimal reperfusion strategies in patients present-
ing early after the onset of symptoms, with particular regard to
the benefits of primary PCI or thrombolysis within 3 h of the
onset of symptoms.15
Improved time to diagnosis,16 time to treatment17 and
outcomes18 have been previously demonstrated by a strategy
of prehospital diagnosis. This study shows a twofold increase in
median symptoms-to-thrombolysis time from prehospital
administration, through telemetry-facilitated inhospital admin-
istration to inhospital administration in self-presenting
patients. MINAP data reported a PHT rate of 10% in England
and Wales in 2005.19 In all cases of STEMI receiving
thrombolysis, a prehospital administration rate of 25% in our
study appears reasonable given that up to 20% of patients with
STEMI may have a contraindication to thrombolysis20 and 10%
presented .6 h after the onset of symptoms (and were thus
precluded from PHT under the Joint Royal Colleges Ambulance
Liaison Committee (JRCALC) guidelines21 in place at the time).
Two previous studies22 23 have emphasised the constraints
placed on PHT by the JRCALC guidance. Hanson and
Williamson23 recommended revision of the guidelines in order
that they become more inclusive. It is encouraging that the
JRCALC has made moves to extend the time window from 6 h
to 12 h from symptom onset.
SAS response times were excellent and on average were better
than the national performance indicator of 8 min. Although
there was a statistically significant difference, the numerical
difference of 4 min spent on-scene between PHT and non-PHT
groups may be an encouraging finding for networks planning
primary PCI as either part or all of a reperfusion service in
STEMI. The extra 4 min spent delivering the intravenous
Table 2 Baseline characteristics, site of thrombolysis and times to hospital arrival (20 months)
Total STEMIs
(n= 812)
Self-presentation
with STEMI
(n=268)
Ambulance presentation
with STEMI
(n=544)
Baseline characteristics
Male sex 511 (63%) 163 (61%) 348 (64%)
Anterior territory infarction 317 (39%) 110 (41%) 207 (38%)
Age .75 years 253 (31%) 86 (32%) 167 (31%)
Treatment and time to presentation
Prehospital thrombolysis 146 (18%) 0 (0) 146 (27%)
Inhospital thrombolysis 429 (53%) 182 (68%) 247 (45%)
No thrombolysis 237 (29%) 86 (32%) 151 (28%)
Times from onset of symptoms to arrival
at hospital
0–1 h 20 (2%) 3 (1%) 17 (3%)
.1–2 h 222 (27%) 32 (12%) 190 (35%)
.2–6 h 489 (60%) 190 (71%) 299 (55%)
.6 h 81 (10%) 43 (16%) 38 (7%)
STEMI, ST elevation myocardial infarction.
Table 3 Baseline characteristics, performance indicators (20 months) expressed as medians
PHT
(n=146)
Telemetry-facilitated IHT
(n=247)
Self-presenting IHT
(n=182) p Value* (95% CI)
Baseline characteristics
Male sex 88 (60%) 153 (62%) 115 (63%)
Anterior territory infarction 63 (43%) 99 (40%) 69 (38%)
Age .75 years 45 (31%) 79 (32%) 53 (29%)
Performance indicators
Symptoms-to-SAS call (min){ 45 (31–85) 42 (28–75) NA 0.067 (0.00 to 10.99)
SAS response (min)1 8 (3.2) 8 (2.2) NA 0.492 (20.39 to 0.80)
SAS on-scene (min)1 27 (8.6) 23 (6.4) NA ,0.001 (2.19 to 5.40)
SAS travel time to hospital (min)1 47 (16.5) 41 (16.0) NA 0.002 (2.01 to 8.70)
SAS call-to-thrombolysis (min){ 40 (29–51) 86 (72–126) NA ,0.001 (254.00 to 245.00)
Call-to-thrombolysis (60 min 130 (89%) 4 (2%) NA
Hospital door-to-thrombolysis (min){ NA 18 (9–25) 30 (21–45) ,0.001 (12.00 to 17.00)
Door-to-thrombolysis (30 min NA 217 (88%) 126 (69%)
Symptoms-to-thrombolysis (min)" 91 (66–131) 148 (108–234) 184 (102–349) ,0.001
Symptoms-to-hospital arrival (min)" 130 (96–232) 131 (96–215) 149 (79–432) 0.893
Emergency PCI within 6 h of thrombolysis 47 (32%) 74 (30%) 51 (28%)
Data are presented as mean (SD) or median (interquartile range).
IHT, inhospital thrombolysis; PCI, percutaneous coronary intervention; PHT, prehospital thrombolysis; SAS, Scottish Ambulance Service.
*Telemetry-facilitated IHT vs PHT.
{Self-presenting IHT vs telemetry-facilitated IHT.
{Mann-Whitney test.
1Two-sample t test.
"Kruskal-Wallis test.
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heparin and thrombolytic agent suggests that, even with PHT,
85% of the ambulance on-scene time is spent reaching the
patient, primary and secondary assessment, therapeutic inter-
vention, 12-lead ECG, communication with CCU and decision-
making regarding the most appropriate destination for the
patient. This may influence those who believe that primary PCI
will be a paradigm shift for ambulance services, given that the
assessment, diagnosis and treatment processes remain the same,
with only the 10 s bolus administration of tenecteplase being
omitted.
While the paramedic can ultimately choose to administer or
not administer tenecteplase regardless of the advice given by the
CCU, this did not happen during the 20-month feedback.
Feedback from both paramedics and CCU nurses was that the
telephone discussion was mutually beneficial. Paramedics felt
supported in the knowledge that they had a live link to experts
in the care of STEMI, particularly in the context of cases which
were outwith the rigid JRCALC guidance.
There are a number of potential areas for further study. The
one-third of patients who continue to receive no thrombolysis
regardless of how they present to healthcare services are
arguably the most pressing of these. The finding of 29% in this
study is similar to findings of the GRACE investigators. Their
registry of 16 814 patients with STEMI across 113 hospitals in
14 countries reports that 29% of patients did not receive
reperfusion therapy.24
The 25% of patients who either had an ECG performed but
not transmitted by the paramedic or who did not have an ECG
performed require further investigation. This may simply reflect
confidence among paramedics who feel secure in their inter-
pretation of the ECG. With increased pressures on unscheduled/
emergency medical services, the 20% of patients who had a
prehospital 12-lead ECG showing ST segment depression or T
wave inversion (60% of whom had a diagnostic rise in troponin
I at 12 h) could perhaps be admitted directly to a cardiology
unit for further assessment, thus reducing pressure on the
emergency/medical assessment departments.
Although not prospectively measured, the CCU nurse in
charge independently received and reported 85–95% of incom-
ing 12-lead ECGs, with 5–15% involving the CCU junior grade
doctor. In a study by Quinn et al,25 95% of CCU nurse
respondents were found to reach a standard of 12-lead ECG
interpretation in patients with ST segment elevation deemed as
‘‘gold standard’’ by a panel of cardiologists. There were six cases
during the 20-month study period where there was not a
subsequent rise in cardiac enzymes following thrombolysis
administration by a paramedic. Four of these were thought by
their cardiologist to have clinical myocardial infarction and ECG
evidence deserving of PHT and two were thought not to have
merited PHT.
The technique of prehospital 12-lead ECG transmission by
cellular telephone was first described in 1987.26 Before this, only
single-lead rhythm strips could be transmitted to the ED.
Previous investigators12 found that 2% of attempts at prehos-
pital 12-lead ECG telemetry were unsuccessful, identical to the
failure-to-transmit rate in our study.
We found that 67% of the patients with STEMI presented to
hospital via the SAS. In the 329 122 patients sub-studied in the
large US NRMI-2 registry over 4 years in 1674 hospitals, 53% of
patients were transported to hospital by ambulance.10 The non-
users of emergency medical services (self-presentation or self-
transport) were younger, had less previous history of cardio-
vascular disease, presented later after the onset of symptoms,
were less likely to have anterior wall infarction or sustained
ventricular tachycardia/fibrillation and had a lower killip class,
TIMI risk score and hospital mortality (5.5% vs 14.3%). The
odds of ambulance use were reported to increase by 21% over
each decade of life. Previous North American studies of patients
with suspected or confirmed STEMI have reported varying
ambulance use of between 33%13 and 59%.27 Similar findings
were reported in Sweden where the 34% of patients who used
emergency medical services were older, had a greater likelihood
of previous cardiovascular disease and were more likely to have
a final diagnosis of myocardial infarction (69% vs 38% of
patients not transported by ambulance).
Herlitz et al14 concluded that, after correcting for confounding
factors, patients admitted to Swedish EDs with chest pain who
were transported by ambulance had a much higher mortality
during the subsequent 5 years than those not transported by
ambulance.
Limitations of the study
Long term outcome data are not reported which may have been
useful in determining the benefits (or otherwise) of prehospital
12-lead ECGs, particularly where 92% of patients did not have
ST segment elevation. Although data are available to suggest
the number of patients receiving PHT who perhaps should not
have, there are no data reported on patients who could have
received PHT but did not. In governance as well as research
terms it is unfortunate that we made no prospective documen-
tation of the decision-making discussion between paramedic
and hospital nurse/doctor. This is something we will remedy as
a result of this study. The statistically significant differences in
SAS on-scene time and travel time may have been a type I error
caused by the relatively small sample size.
CONCLUSIONS
Using cellular telephone technology, it is possible for paramedics
and CCU nurses to conduct live decision-making based on a
transmitted prehospital 12-lead ECG in patients with STEMI.
This is an important finding and may create opportunities for
reconfiguration of STEMI services. Prehospital administration
of thrombolysis was associated with significantly reduced
symptoms-to-thrombolysis times. Patients received IHT follow-
ing direct CCU admission as a result of prehospital diagnosis
more expeditiously than patients who self-presented to
hospital.
A prehospital diagnosis of STEMI and decision-making
process involving paramedics and CCU nurses may aid
reductions, not only in symptoms-to-thrombolysis time, but
also in the development of primary PCI services by reducing
diagnosis to balloon time and creating a hybrid system for
optimal reperfusion in STEMI.
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An exploration of the information
needs of spouse/partner following
acute myocardial infarction using
focus group methodology
Scott McLean and Fiona Timmins
ABSTRACT
This study aimed to explore spouse/partners’ experience of the information received and required in the acute myocardial infarction
(AMI) in-hospital recovery period. A dearth of information exists that uncovers the information needs of spouse/partners following AMI.
Although information needs, emotional reactions, support and information provision are prevalent themes within the literature, there
are few studies that specifically address these issues in this population. While survey methods abound, with more recent qualitative
interviews apparent, focus group methodology is underused. The study employed a qualitative descriptive design. Using focus group
techniques, 15 partners were interviewed. Emerging themes included: reactions to the event, feeling like a burden on the health service,
the need for information and pulling apart – pulling together. Spouse/partners play a critical role in helping patients recover from acute
cardiac events thus information and support for the latter are crucial. While spouse/partners commonly seek information as a problem-
solving coping strategy, in an effort to regain personal control, spouses often lack information. This study identifies spouse/partner
isolation and suggests that additional supports need to be in place to adequately deal with the challenges that AMI brings to family life.
Suggested support mechanisms to enhance current provision are inclusion of spouse/partner in cardiac rehabilitation programs and
hospital-based care, self-help groups supported and attended by professionals and telephone support systems.
Key words: Cardiovascular • Acute care facility • Focus group • Nurses • Nursing • Qualitative
INTRODUCTION
Over the past 20 years there has been increasing
emphasis on the provision of information to clients
following acute myocardial infarction (AMI). Contem-
porary hospital- and community-based education
programmes aim to deliver a service based on clients’
perceived information needs. Despite an impetus
towards promoting spousal involvement in education
programmes, there has been a bias, with the exception
of one seminal study (Turton, 1998), in developing
information packages that concentrate on the needs of
the client (Gerard and Peterson, 1984; Karlik and
Yarcheski, 1987; Chan, 1990; Wingate, 1990; Wang, 1994;
Ashton, 1997; Czar and Engler, 1997; Hughes, 2000;
Scott and Thompson 2003; Timmins and Kaliszer, 2003).
Despite the small body of research, it is acknowl-
edged that spouses ofAMI victims experience, physical,
psychological and economic difficulties. This includes
the threatened of loss of a partner, the trauma of
separation, child and household care problems, finan-
cial strain, role change, self-esteem problems and an
uncertain and unpredictable future (Nyamathi, 1987;
Clarke et al., 1996; Arefjord et al., 1998). It may also
involve physical and emotional symptoms such as sleep
and appetite disturbances, headache, chest and stomach
pains, anxiety, fatigue, depression, irritability and poor
concentration (Bennet and Connell, 1998; Daly et al.,
1998). Additionally, the consequences of having an AMI
are recognized to be stressful for both clients and their
families (McGee et al., 1994; Stewart et al., 2001).
Differences in information provided to spouse and
client have been shown to have a negative impact on
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overall outcome (Borkman, 1990; LaGaipa, 1990;
Figueiras andWeinman, 2003). Data from other studies
that have examined different cardiac groups reveal
that spouse/partners often encounter difficulties in
obtaining detailed information about the clients’ con-
dition (Albarran et al., 2004) and were generally poorly
informed (Thompson and Cordle, 1988; Theobald,
1997). Furthermore, the quantitative approaches used
in studies that have examined both client and spouse
(Turton, 1998) or client needs alonewere later criticized
in favour of qualitative methodologies (Scott and
Thompson, 2003). Authors have suggested that due
to the over reliance on the positivistic paradigm, a body
of knowledge may have developed based on health
care workers perception of what is considered impor-
tant to learn, rather than the individuals themselves
identifying learning needs (Theobald, 1997; Egan, 1999;
Scott and Thompson, 2003).
There is a dearth of research evidence, therefore, that
examines the perceived information needs and infor-
mation received by spouse/partners. No qualitative
studies were found in relation to spouse/partner
experiences in this area. If emphasis on tailoring
informational support to client need (Department of
Health and Children 1999, Department of Health 2000,
2004), lay participation and moving from ‘expert’
provider to equal partner (Stewart et al., 2000) be to
be realised in practice it is imperative that these needs
are addressed in a holistic manner that includes
spouse/partner in the trajectory.
AIM
This study aimed to explore spouse/partner experi-
ences of information received and required following
AMI.
METHOD
In order to provide rich data, a qualitative descriptive
design was chosen using focus group methodology.
Focus groups are advantageous as a method of data
collection as they provide the researcher with an in-
depth understanding of the phenomenon, rich data
may be gleamed through participant interaction, and
they are useful for proving a user perspective of
experiences or services (Webb and Kevern, 2001;
McLafferty, 2004).
The study was conducted in one hospital in the
Republic of Ireland in 2004, serving a mixed urban/
rural community with a population of approximately
105 000. The hospital provides a variety of both in-
patient and outpatient cardiology services. There is
also a hospital-based cardiac rehabilitation service
comprised of an exercise/education programme that
all clients may attend following hospitalization for
AMI.
Sample
Purposive sampling was used. The population
included spouse/partners of patients who had at-
tended (with at least 50% completion) a cardiac
rehabilitation programme over a 5-month period at
the hospital. Using cardiac rehabilitation records for
this period, a list of patients were identified who
entered into cardiac rehabilitation programmes with
the diagnosis of AMI. The records of these patients
(and where necessary the hospital/medical records)
were then reviewed to assess eligibility for inclusion in
the study, as per the study criteria (Table 1).
An information packwas sent to the home address of
each eligible couple (n = 27) containing:
• A cover letter explaining the study, and formally
inviting the partner to take part in a focus group.
The partner was asked to provide dates/times
that would be suitable to attend a group.
• A consent form for the partner to complete.
• A copy of the topic guide.
• A stamped addressed envelope for return of
consent form.
Couples who failed to reply were sent another pack
14 days later. Fifteen couples responded positively, and
one partner from each couple attended (n = 15).
Table 1 Inclusion/exclusion criteria
Inclusion criteria
Ability to communicate by written/spoken English language
Patient must have presented through the A&E Department,
received thrombolytic therapy for their first ever ST elevation
myocardial infarction and have been transferred to the
coronary care unit
Patient recently (<6 months) completed formal cardiac
rehabilitation programme, or is currently more than
50% through a programme
Exclusion criteria
Patient had cardiac arrest during AMI admission
Patient suffered cardiogenic shock which prolonged hospitalization
Patient had cardiac surgery or percutaneous coronary
revascularization during AMI admission
Patient/partner has a current psychiatric illness receiving treatment
Chronic disabling condition of either patient or partner
Patient/partner is a health care professional
Couple currently attending marriage/family counselling
A&E, accident and emergency.
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Data collection
Two focus groups were conducted, containing seven
and eight individuals, respectively. Before the focus
groups participants were clearly informed as to the
exact purpose and nature of the group. Participants
were also provided with a written copy of the
interview schedule (Table 2), which functioned as
a topic guide for group discussion. A cardiac rehabil-
itation specialist was available to deal with any
unexpected distress that some participants might have
encountered. The researcher also acted as moderator,
encouraging equal participation and refocusing the
interview if necessary (Twinn, 1998).
The focus group interviews lasted between 45 and 58
min. The data were collected using tape recording.
Notes were taken during the course of the interview
which pertained to non-verbal communications, clari-
fied issues when more than one participant was
speaking, and miscellaneous notes on thoughts, feel-
ings and emotions of the researcher. These notes were
used to support the transcribing.
Data analysis
Immediately upon completion of the groups, the tapes
were replayed. This entailed merely listening through
the conversation and further notes were made on the
main researchers’ thoughts and feelings. Data were
later transcribed verbatim and analysed using the-
matic analysis. A technique described by Reiskin
(1992) and Morrison and Peoples (1999) was used to
identify emerging themes. This involved summarizing
and classifying data using a thematic framework (Lane
et al., 1999). Identification of 157 significant words and
statements initially reduced the data from the tran-
scripts and notes. Each significant statement was
printed and cut into identically sized pieces of paper.
These pieces of paper were placed in a receptacle and
pulled out one by one. Once drawn from the receptacle,
the pieces of paper were placed along a desk on
a horizontal axis until such times as a statement or
word was drawn which was similar to another already
present. When this was the case, the statement/word
was placed on the vertical axis directly below the
associate. This data-reduction process was repeated
three times until the data were reduced in four final
themes: reactions to the event, feeling like a burden on
the health service, the need for information and pulling
apart – pulling together. Three themes (reactions to the
event, the need for information and pulling apart –
pulling together) will be discussed in congruence with
the overall aim of this paper.
Rigour
Four suggested criteria of rigour described by Lincoln
and Guba (1985) were used as the basis for establishing
the trustworthiness of the qualitative data: credibility,
dependability, confirmability and transferability. Steps
were taken to improve and data credibility, which
refers to confidence in the truth of the data (LoBiondo-
Wood and Haber, 1998). Firstly, by conducting the
study in such a way that believability is enhanced and,
secondly, by overtly demonstrating credibility (Polit
et al., 2001). Researcher credibility was assured, asmain
researcher in this study was a Clinical Nurse Specialist
in Cardiology, certified in cardiac rehabilitation.
Furthermore, there was no direct involvement, influ-
ence or relationship with the cardiac rehabilitation
team involved with clients or any vested interest in
client outcomes.
The dependability of the data in this study was
closely married to factors pertaining to confirmability
(Polit et al., 2001). Confirmability, or auditability as it is
otherwise known, places a responsibility on the
researcher to report all decisions involved in the
transformation of data to the theoretical schema (Burns
and Grove, 2001). Decisions made while synthesizing
the datawere clearly detailed and described in an audit
trail.
This audit trail comprised six types of crucial records
(Polit et al., 2001):
• raw data (interview transcripts),
• data reduction and analysis products (theoretical
notes, notation sheets),
• process notes (methodological notes),
• materials relating to intentions and dispositions,
• instrument development and information,
• data reconstruction products (drafts).
In accordance with Lincoln and Guba (1985), the
analysis aimed to provide sufficiently descriptive or
‘thick’ data in the report, so as to permit the reader to
Table 2 Question schedule
What new information (if any) do you feel you have learned since your
partner’s heart attack?
Has any information you received been helpful to you since your
partner’s discharge from hospital?
Are there things you did not receive information on that you
think you should have?
What are the main things you believe partners of heart attack
patients should be told about?
Do you feel you have received less than, more than, or similar
amounts of information than your partner has?
How does this make you feel?
Do you feel that the hospital staff attempted to discover what
information you would like to know?
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evaluate the applicability or transferability of the data
to other contexts.
Ethical considerations
The local Health Board Regional Ethics Committee
granted ethical approval to conduct the study. Partici-
pants completed informed consent prior to the focus
group interview. The right to withdraw from the study
was stated, prior to the interviews. The nature of the
focus group approach is such that true anonymity
cannot be assured (Lane et al., 1999), particularly in
a reasonably small community such as the one from
which the participants came. However, confidentiality
was maintained by the ascription of codes assigned to
participant data, and names were only known to the
main researcher. On completion of the study the
audiotapes were destroyed.
Findings
The group comprised three men and 12 women. Four
emergent themes, only the following: reactions to the
event, the need for information and pulling apart –
pulling together, will be discussed in congruence with
the overall aim of this paper. These themes relate more
generally to participants’ perception of information
received,whereas the fourth theme, feeling like aburden
on the health service was context specific and not
necessarily related to information giving or receiving.
Reactions to the event
The participants reported emotional reactions to the
event.
Emotional reactions
Spouse/partners found the event stressful and dis-
cussed the resultant reactions in emotive terms:
‘Well I mean it’s kind of a shock like, ye know? I mean
one day your grand and then the next day your up at
here at the hospital like with monitors and drugs and
all that.’ (R15, female partner)
They also reported the fear associated with witness-
ing the AMI:
‘It’s a wonder that partners actually. don’t get heart
attacks, you know? Cause it is an awful lot of stress. I
mean ..[my husband]..was super-fit, he’s only forty-
four and he was in the military and went orienteering
and everything and he had it at home.. he had it with
me. It was an awful fright..’ (R8, female partner)
The need for information
Spouses identified the perceived benefits of informa-
tion received, the support that information provided
and their views on the fact that spouses were not
present at cardiac rehabilitation classes. There were
also some views on the sequencing of information and
criticisms of information received.
Perceived benefits of information received
The informants perceived benefits of having infor-
mation and in particular it clarified aspects of
information that their spouse/partners may have
been previously told but not relayed to them
effectively. Spouse/partners were also concerned
with their perception of imposed limitations of the
patients’ condition:
‘I think though . you sort of want loads of
information to start and . cause my [husband]
would just get on with things like nothing would
happen . I said that to the cardiac girl that he’d be
back fishing and at the GAA next again day. I waited
til he’d gone and I was asking the girl what he
shouldn’t be doing.’ (R10, female partner)
‘My husband still goes mad even now that I’m
wrapping him up in cotton wool. We’d have a fight
nearly every other day that he’s says I’m minding him
too much or I’m fussing.’ (R13, female partner)
A common theme throughout was the self-expressed
need for spouse/partners to be informed of the
expected capabilities versus limitations of patients.
‘So just how much they can do. What they’re supposed
to do.’ (R5, female partner)
‘I need that information cause I would...I think I
may not have babied him if I thought he was capable of
X Yand Z, and I’m doing X Yand Z for him ye know.’
(R7, female partner)
This often resulted in over protectiveness:
‘Cause you end up doing the wrong thing then. My
husband still goes mad even now that I’m wrapping
him up in cotton wool. We’d have a fight nearly every
other day that he’s says I’m minding him too much or
I’m fussing.’ (R5, female partner)
Information gave them confidence to act effectively
in certain situations:
‘I don’t know though. I mean if you know a lot of the
in’s and out’s of things then it makes it easier. I mean
say six months ago if my wife had been going on about
being tired and dizzy and that I would have probably
have been giving out to here and telling her to liven
up, d’ye know? Even last week though she was that
way and I knew it was probably cause of the tablets
being put up and..’ (R9, Male partner)
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Indeed further information sources such as a nurse
phone line were suggested to provide confidence and
support after discharge:
‘Definitely a contact number should anything . I
mean you’re very raw in the early stages, you’re very
naı¨ve, you don’t know what’s going on, and of course
everybody has different symptoms, and you really
don’t know what to expect, and say hey love, this is
happening, rather than have to ring the doctor . in
the middle of the night..’ (R8, female partner)
‘That’s what I often felt, that you were alone when you
got home . no contact number.’ (R6 female
partner)
Information as support
Many of the study participants also believed that the
information they received helped them to cope with
events:
‘First in the admission I just needed someone to tell
me ye know, not to panic, that he was in the right place
and everything ye know. I just needed somebody to
say to me ye know your OK, he’s OK. that was the
first stage anyway.’ (R8, female partner)
‘This information is to help you cope and know things
after the heart attack.’ (R10, female partner)
There were many other sources of support for
spouse/partners identified received helpful informa-
tion from sources other than health professionals:
‘I definitely think that it helps ye if ye know somebody,
like that lady was saying about her cousin.’ (R15,
female partner)
‘Yes, yes. he’s not a cousin now I’d see a lot of but
just. well he’s only forty-seven. but it’s just good
like that ye can phone him up and ask how he was at
a certain time and not be bothered.’ (R11, female
partner)
‘Well. a good pal of mine. He had an attack about
four years ago. He’d be great and he’d tell you what
kind of things to be looking for.’ (R8, female partner)
Feeling left out
Sometimes the spouse/partners reported feeling left
out of the information receiving process:
‘But when we arrived here, I felt very very left out, and
the worry of everything. and I was actually not told
it straight out, but I was literally told to shut up by
a doctor in A&E.’ (R9, Male partner)
‘But when they brought him up to CCU then. they
were great, the care he was getting. but still, I never
saw a doctor who explained absolutely to me..’ (R8,
female partner)
There were also explicit mentions of the issue of
spouses not being present at cardiac rehabilitation
classes and many felt excluded from the process:
‘Definitely think it would have been better if we’d got
to come.’ (R10, female partner)
‘Well, we waited while they did their exercises.
Dropped them off and picked them up, but while we
were outside . discussions that were going on we
were here for.’ (R8, female partner)
‘I think that maybe it would’ve been good if we
could’ve had maybe one session, ye know, with our
husbands, and then the rest maybe on our own. I sat
in the car. I would’ve loved to have joined him.’ (R6,
female partner)
Criticisms of information received
Many found the information received overwhelming:
‘I think that maybe ye in the hospital think that we
need things that we might not think we need ourselves
. the book, the biggest thick book that the girls give
you. well I mean that just scares ye, well it scared
me anyway.’ (R9, Male partner)
‘Yeah, and I was thinking at the end of the day, your
still a wife. I mean you can support them and mind
them without having to be a mini encyclopaedia and
be able to know all of the information that there is
about heart attacks.’ (R13, female partner)
Others commented on the lack of individualized
tailored information:
‘Well like me and you and you would all have different
things. Like if you’re a young man who lives in the
country like, so the driving would be . the biggest
thing ye’d want all the information on.’ (R9, male
partner)
‘I mean for me, there’s probably about a hundred pages
in. the book you were saying. I’d say there are about
ten or twelve that actually really did be of help to me
. well us. What I’d like. and I know they’re busy
. if it was to be the gold standard (makes quotation
signs with two fingers of both hands) then it’d be to
concentrate on the things that would be really useful
to each individual.’ (R13, female partner)
‘And the staff like, they even had a list of things. They
were up in the ward above and they’d tell you a bit.
Exploration of the information needs of spouse/partner
ª 2007 The Authors. Journal Compilationª 2007 British Association of Critical Care Nurses 145
like I don’t know, exercise so many times a week for so
long, then they’d tick it on their sheet.’ (R9, male
partner)
Participants stated clearly that only a small pro-
portion of the information given to them was helpful,
and furthermore that they only utilized the informa-
tion that they felt was useful. It is clear that these
participants believed that the informational process
involved staff working from a prescribed menu.
Sequencing of information
Much of the time in the group discussion focused the
sequencing of information. One participant called her
perceived ‘stages’ of the journey’:
‘First in the admission I just needed someone to tell
me ye know, not to panic, that he was in the right place
and everything ye know. I just needed somebody to
say to me ye know your OK, he’s OK. that was the
first stage anyway.’ (R9, female partner)
‘I think it good, especially at the start that they don’t
tell you everything. I remember the nurse in the CCU
part was a lovely fella, but he was going on about
thrombosises and breaking them down and arteries
and things. Well I mean your just not able.’ (R13,
female partner)
‘It is yeah but like you say all you want to hear, like
you said the nurse in the Casualty said, is small
chunks of information that you can say over and over
in your head.’ (R11, female partner)
‘You probably don’t think about it like that but ye
definitely want the urgent kind of major things at the
start and then the smaller things near the end.mind
they’re still important but maybe’s not so important
as the start where ye’d be wondering are they going to
die.’ (R9, female partner)
These overt statements of spouses perceived needs
changing over the course of time.
Pulling apart – pulling together
This theme outlined both the tension and in some cases
harmony that became apparent within the relationship
after the AMI.
Conflict
There were a significant number of mentions over both
groups, of conflict, arguments, deceit and polarization
between couples. One spouse/partner felt:
‘One day she’s alright, the next day she’s like Jekyll
and Hyde. no matter what you do. I don’t do it I’m
wrong. And I say will I do this and then she’d say all
you keep saying to me is I’ll do this, I’ll do this ye
know? I’m walking on eggshells. and it’s a complete
change of our life.’ (R2, male partner)
In some cases, the client appeared to wish to suffer
alone; but spouse/partners felt that it that it was their
illness too:
‘Though they feel it’s their heart attack and. you’re
suffering too.’ (R3, female partner)
The tension was evident from the group discussions.
This tension appeared to be compounded by the
spouse/partners’ lack of information and com-
pounded by the perception in some cases that the
affected partner may be withholding information:
‘. most of the time I find, my husband doesn’t want
me to come to the doctor with him, therefore I can
speak for myself, so I really don’t know what’s going
on.’ (R3, female partner)
‘. I mean I know my husband tells me stuff that
there’s no way they told him at the hospital, but then I
wasn’t there so I can’t really argue the point.’ (R14,
female partner)
‘I say to her, how are you this morning. Oh I’m
alright. That’s what they always say. I know you’re
alright. She doesn’t. She doesn’t tell me what’s wrong
half the time. And her tablets. She wont leave me go
into the doctor with her.’ (R2, female partner)
In some cases, the spouse/partner avoided sharing
day-to-day information to spare the client stress:
‘. you start keeping everything from them, you don’t
let them go out, you take most things on board
yourself. it is difficult.’ (R6, female partner)
‘Oh if you have a minor headache, you don’t open your
mouth.’ (R5, female partner)
Harmony
Although there were no extensive dialogues involving
a number of participants, there were brief mentions in
the groups of harmony and togetherness.
‘I’ve even started walking with mine and we’d never
have been the type to walking just along the strand.’
(R13, female partner)
‘No though but ye have to be . mature about some-
thing about this. I mean if he feels better doing those
things and talking and that then.’ (R2, male partner)
Limitations
Generalizing from the study findings is limited by the
use of qualitative methodology, however, the rich
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findings illuminate an area little explored in nursing.
Congruent with qualitative methods, the study find-
ings are contextualized within the specific location,
although transferability of the data is possible. A small
study sample further limits the application of findings.
There are also limitations and resultant criticisms of
the use of focus group methodology. Webb and
Kevern (2001) suggest that focus group method-
ology provides a superficial discussion. They further
criticise a tendency towards an unsophisticated appli-
cation of the method. A rigorous approach to data
collection and analysis was used in this study to
address these issues.
DISCUSSION
Preference for individualized tailored information
post-AMI echoes a predominant theme in the literature
over the past 20 years (Scott and Thompson, 2003;
Timmins, 2005). Furthermore, in keeping with the
literature on the topic, spouse/partners were able to
identify their readiness to receive information and
their changing needs over time. Increasingly, UK and
Irish cardiac rehabilitation processes are encouraged to
adopt approaches that incorporate principles of adult
learning such relevance (to patients’ needs), individu-
alization, feedback and facilitation (Department of
Health and Children, 1999; Department of Health,
2000; SIGN, 2002). However, this current study
indicates that an individualized approach to informa-
tion provision to patients is not always provided,
spouses very clearly perceived a ‘tick box’ approach.
This mirrors recent findings from an Irish study that
examined nurses’ use of conceptual model-based
documentation (Hyde et al., 2005), whereby the authors
noted that explicit conceptual use was not evident, but
rather a medical model of care existed where tasks and
routine were prioritized. Hyde et al. (2005) termed this
‘impression management’. It is important for nursing
staff to give a firm commitment to evidence-based
principles, and embrace an individualized approach to
cardiac patient education, rather than a token approach
reflected within documentation only.
This study found that spouse/partners often felt
isolated from the information process. They were left
feeling suspicious if their partner knewmore than they,
often perceiving that they were receiving half-truths.
This undermined their confidence and their relation-
ship with the partner, and evoked a tendency to
baby their partners if they were unsure of their
limitations. Spouse/partners clearly indicated that
information reduced this tendency assisted and with
their confidence. Spouse/partner inclusion in the
information-giving process is being increasingly rec-
ognized (Turton, 1998), however, there is a dearth of
information about specific information needs of this
group.
Spousal involvement in cardiac rehabilitation pro-
grammes is one way of addressing their information
needs in the area, and many participants in this study
voiced a desire to attend with their partner, and indeed
felt excluded from the process. As early as 1994 in
Ireland, McGee et al. recommended spousal involve-
ment in cardiac rehabilitation programmes. However,
in keeping with the situation in the UK (Department of
Health, 2000), the priority focus in recent years has
been increasing the number of and equitable access to
such programmes (Department of Health and Children,
1999). Of interest to note that the most recent report of
the Irish Cardiovascular StrategyGroup (Department of
Health and Children, 2003) recommended family
involvement in the cardiac rehabilitation process, thus
indicating a reoriented focus towards family centred
care now that provision of basic services has been
improved at national level. Although spousal or family
involvement in these programmes has been reported in
the USA (PS Friedman, Massachusetts School of Pro-
fessional Psychology, Boston, unpublished PhD thesis;
CC Winchester, Massachusetts School of Professional
Psychology, Boston, unpublished PhD thesis; TB Hong,
Wayne State University, Detroit, unpublished PhD
thesis) with positive effects, the reporting of such
innovations fromwithin Ireland has yet to impact upon
the published literature.
Spouse/partners in this study experienced emo-
tional reactions consistent with international findings
(Nyamathi, 1987; Clarke et al., 1996; Arefjord et al., 1998;
Bennet and Connell, 1998; Daly et al., 1998). Unlike
Daly et al. (1998), specific cultural issues did not em-
erge with respect to this group. Information received by
nurses evidently provided support to many of the res-
pondents. Similarly, in the study of Ivarasson et al.
(2005), family perceived positive support when they
received attention and information and felt involved t in
the care. The concept of family involvement in care has
recently been revisited by Rutledge et al. (2000a, 2000b)
and this is an area that requires greater attention in the
Irish context. While recent Irish national policy (Depart-
ment of Health and Children, 2003) recommends family
involvement in rehabilitation services, a cohesive frame-
work for the delivery of such a service needs to be
outlined. Furthermore, the concept of family centered
care also needs to be integrated at hospital level.
Extending cardiac rehabilitation services into the
home is another potential option that would ensure
greater family/spouse/partner involvement. In the UK,
Jolly et al. (2003) report positive findings following a
randomized controlled trial of home-based intervention.
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Similarly, J. Bell (University of London, London,
unpublished PhD thesis) reports positive findingswith
a home-based program in Scotland. This finds signifi-
cantly reduced hospital admissions compared with
patients receiving usual care. Likewise in Canada,
a home-based cardiac rehabilitation program reported
a significantly improved quality of life (Arthur et al.,
2002). Home-based services could be developed in
Ireland in conjunction with the growing impetus
towards nurse-led services. Fallon and Ingram (2006)
report on the benefits of evolving nurse-led services in
cardiac rehabilitation in Ireland.
An adjunct to these developing services, or to current
services is the proposed development of a telephone
support service for patients and their families. This re-
commendation emerged from within the focus groups,
whereby spouse/partners felt it would be useful to be
able to summon assistance at odd hours, to answer
simple questions and relieve anxiety about their
partner’s symptoms. The use of telephone services for
patients following cardiac rehabilitation has been used
in theUSA for over 30 years (Miller, 1996). The literature
reports a range of cardiac rehabilitation services being
provided in this way, including provision of knowledge
and support (Miller, 1996). From a number of US-based
studies in cardiac rehabilitation, Miller (1996) is confi-
dent of their use within this setting. Mack (1997) later
supported Miller’s (1996) claim, in letter to the editor,
suggesting that this ‘showedgreat insight into the future
of cardiac rehabilitation’. Telephone support systems
area that requires research and development in both the
UK and Ireland. In addition, to providing benefits to
patients and families, these systems also hold the
attraction of cost reduction, as the costs aremoremodest
than other forms of home support (Miller, 1996).
In concurrence with Dickerson (1998), the informa-
tion received from non-health professionals was
identified by spouse/partners as a source of support.
Similarly, Hentinen (1983) and Coyne and Smith (1991)
found that spouse/partners turned to friends/family
and neighbours for additional information and sup-
port. This support emanates from a natural interaction
with a network of family/friends/peers and profes-
sionals. This support network communicates informa-
tion, emotional alliance, practical aid and affirmation
(Stewart, 1993). In keeping with the spouse/partners
need for a supportive network, collaborative self-help
support groups (between professionals and ex pa-
tients) may also be useful to provide emotional and
social support for patients and spouse/partner during
recovery. In Canada, Stewart et al. (2001) report that
12-week combined peer and professional support
intervention to families provided emotional and in-
formation support as well as affirmation. A positive
effect on coping, confidence and spousal relationship
was also noted. In Sweden, self-help groups for this
patient group are well establised (Hildingh et al., 2000).
Given the potential benefits of such an intervention,
this establishment of self-help groups in cardiac
rehabilitation settings in both UK and Ireland should
be considered.
Both present and alternative support structures for
both spouse/partner and patient following AMI need
to consider relationship support as a part component
of delivery. This particular aspect of an individual’s
life is not traditionally considered within rehabilitation
programs, however, given the obvious strain experi-
enced by some couples within the study its inclusion
would be prudent. This marital disharmony revealed
was reported elsewhere within the literature (Nelson
et al., 1998; Thompson and Cordle, 1988). As this study
reports primarily upon the female spouse/partner
greater consideration also needs to be given within
future research to the needs of men.
CONCLUSION
There appears to be almost universal recognition that
there is a need for families in the post-AMI period to be
provided with cardiac education (Theobald, 1997).
Increased spouse/partner involvement in information/
education sessions, including cardiac rehabilitation,
as suggested by Johnston et al. (1999) and Svedlund
and Axelsson (2000) is imperative. Westmacott et al.
(1999) suggest that the amount learned by spouses is
unpredictable unless they are explicitly included in
formal information/education sessions. Johnston et al.
(1999) find that spouses benefited from the support,
information and enhanced feelings of control experi-
enced by being formally included in cardiac rehabil-
itation classes. Greater inclusion of spouse/partner in
both formalized programs and hospital care may seek
not only to address the latter’s informational needs but
provide a solid basis for relationship development and
moving forward in the recovery period. Many spouse/
partners live in fear of another fatal event and thus
cosset their partner. They may also experience role
change and increased household responsibility during
the recovery period. They come to terms with events
andwith their new roles largely unaided, possiblywith
resultant tension in the relationship. Providing support
through tailored in-hospital information and shared
cardiac rehabilitation classes might lessen spouse/
partner isolation and distress. Furthermore, additional
support for the relationship could be included within
the rehabilitation programs. Telephone support sys-
tems and self-help groups could further support these
programs.
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WHAT IS KNOWN ABOUT THIS TOPIC
• AMI is a stressful event for both patients and their families.
• Spouse/partners are presented with a number of challenges such as the threat of loss of a partner, separation from family and friends,
child and household care problems, financial strain, change of role, change of self-esteem and an uncertain and unpredictable future.
• AMI can produce either a positive or a negative effect on the relationship.
WHAT THIS PAPER ADDS
• The use of focus group methodology illuminates the spouse/partners’ perspective.
• Spouse/partners’ isolation is identified and support groups are suggested for use in a UK and Ireland setting.
• The need for information and support for spouse/partners and greater inclusion in information/education programmes is revealed.
• Telephone support systems are also highlighted as a potential adjunct to current service provision in cardiac rehabilitation.
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Drug (DTD) time and improve the Emergency Department (ED) management of ST
elevation MI (STEMI): appointment of a Cardiology Nurse Specialist, application of the
American College of Cardiology and the American Heart Association (ACC/AHA)
guidelines, changing the site of thrombolysis from the CCU to the ED, the introduction
of a single bolus thrombolytic agent.
Methods. The 12-month period before and after the introduction of the measures
were retrospectively reviewed. One hundred and sixty patients were discharged from
the CCU with the diagnosis of myocardial infarction confirmed by ECG and enzyme
criteria. Eighty patients had STEMI and fulfilled criteria for thrombolytic therapy at
the time of presentation to hospital. A full data set was available on 35/38 of patients
in the 12 months prior to the measures (Year 1), and 39/42 in the 12 months sub-
sequent (Year 2).
Results. Median DTD time fell from 80 to 22 min after institution of the measures.
Median Pain-to-Drug time also fell from 270 to 140 min. Thrombolytic agent given in
the ED rose from 3% in Year 1, to 72% in Year 2. IV b-blocker administered in the ED
rose from 12% to 79%, resulting in median time to receiving IV b-blocker falling from
63 to 19 min. Elevated ST segments resolved by P 70% in <2 h in 53% of Year 2 pa-
tients, compared with 23% of Year 1 patients. Combined major in-hospital adverse
clinical events were reduced from 49% to 15%.
Conclusion. This combination of measures reduces DTD time, improves speed to
delivery of important concomitant medications, and significantly improves the time
to ST segment resolution and outcome in STEMI.c 2003 Elsevier Ltd. All rights reserved.
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Since the first successful administration of throm-
bolytic therapy some 25 years ago, acute myocar-
dial infarction (AMI) has been subject to the largest
multicentre international trials ever performedved.
Improving Door-to-Drug time and ST segment resolution 3(GISSI, 1986; ISIS-2, 1988; GUSTO, 1993; GISSI-2,
1990). The data show that thrombolytic agents
have resulted in the greatest reduction in AMI
mortality since the introduction of modern resus-
citation in the 1960s; decreasing overall 30–35 day
mortality by 18–25%, with increasing benefit as the
time from onset of symptoms to thrombolysis is
reduced (FTT Collaborative Group, 1994).
For every hour that thrombolytic treatment is
delayed after the onset of symptoms, 1.6 lives are
lost per 1000 patients treated (FTT Collaborative
Group, 1994). In many institutions, the Door-to-
Drug (DTD) time exceeds 1 h (White, 2000).
Symptom-to-drug delay consists of three distinct
phases: time from onset of symptoms to calling for
help, pre-hospital care and transportation, and
hospital door-to-drug time. Of the three, hospital
door-to-drug time is the most amenable to change
(Bracken, 1997).
Reports indicate that thrombolysis administra-
tion in the Emergency Department (ED) is safe and
effective in reducing DTD time (Sharkey et al.,
1989; Birkhead, 1992; Gonzalez et al., 1992;
Lambrew et al., 1997; Kendall and McCabe, 1996;
Hourigan et al., 2000; Edhouse et al., 1999; Nee
et al., 1994). Only 35% of EDs administer throm-
bolytic therapy, even though 58% of EDs believe
that they should (Hood et al., 1998). Many EDs do
not have policies or protocols for the management
of AMI.
Previous studies detailing the most appropriate
site for the in-hospital administration of thrombo-
lytic therapy, have compared strategies between
hospitals, reviewed registry data of hospitals using
different pathways, or solely compared DTD time
when moving the site of administration of throm-
bolytic therapy from the Coronary Care Unit (CCU)
to the ED (Sharkey et al., 1989; Birkhead, 1992;
Gonzalez et al., 1992; Lambrew et al., 1997; Ken-
dall and McCabe, 1996; Hourigan et al., 2000; Ed-
house et al., 1999; Nee et al., 1994). See Table 1.
Bolus thrombolytic therapy, is an attractive
regimen which facilitates the rapid administration
of reperfusion therapy in patients with acute my-
ocardial infarction (ASSENT-2, 1999). Third gener-
ation single bolus thrombolytic agents with a longerTable 1 Summary of median (Kendall and McCabe, 1996)
Nee et al., 1994) DTD times (min) after changing site of dr
C
Kendall and McCabe (Median) 1
Hourigan et al. (Mean)
Edhouse et al. (Mean)
Nee et al. (Mean) 1half-life than previous bolus drugs, are particularly
suitable for use in the ED due to their ease of ad-
ministration.
Subsequent to the availability of the single bo-
lus thrombolytic agent Tenecteplase (TNK), the
divisions of Emergency Medicine and Cardiology
made a joint decision to move the location of the
administration of thrombolysis from the CCU, to
the ED. This decision was facilitated by the ap-
pointment of a Chest Pain Nurse Specialist (CPNS)
based in the ED, and the promulgation of the
American College of Cardiology and the American
Heart Association (ACC/AHA) practice guidelines
for the management of patients with acute coro-
nary syndromes.
The aim of the change in practice to treating AMI
immediately in the ED, as opposed to diagnosing in
the ED then transferring patients to the CCU for
thrombolysis, was to meet national (Horgan et al.,
2000) and international (Ryan et al., 1996) targets
of a DTD time of less than 30 min.
The time lines (adapted with permission from
Hourigan et al., 2000) for ED vs. CCU patients are
represented in Fig. 1.
This paper reports the introduction and appli-
cation of a combination of measures in the ED,
aimed at: reducing DTD time, raising awareness
and speed of delivery of concomitant medications,
reducing time to ST segment resolution, and im-
proved clinical outcome.Methods
Guidelines were adapted to promote standard early
empirical therapies (oxygen, aspirin, sublingual
nitroglycerine) for patients presenting with chest
pain possibly attributable to myocardial ischaemia
(Hazinski et al., 2000), as well as immediate es-
sential therapies for ST elevation myocardial in-
farction (STEMI), namely thrombolytic agents, IV
heparin, IV b-blocking agents and IV opiate anal-
gesia using a simple algorithm. Copies of the al-
gorithm, derived from and closely following ACC/
AHA guidelines, were displayed prominently in pa-
tient care areas.and mean (Hourigan et al., 2000; Edhouse et al., 1999;
ug delivery from the CCU to the ED.
CU ED p
10 38 0.0006
88 47 <0.0001
59 44 0.004
21 38 <0.0001
Figure 1 Emergency Department vs. Coronary Care Unit
time lines for patients receiving thrombolytic therapy
(adapted with permission from Hourigan et al., 2000).
4 S. McLean et al.Study design
The study was conducted in a Regional Hospital,
serving a mixed urban/rural community with
40,000 ED visits a year. A new combination of
measures designed to eliminate delay in the
administration of thrombolytic therapy to pa-
tients suffering AMI was introduced on April 1st,
2001.
The measures included:
• Appointment of a Chest Pain Nurse Specialist
(CPNS).
• Application of the ACC/AHA guidelines for acute
coronary syndromes.
• Changing the site of administration of thrombo-
lytic agents from the CCU to the ED.
• Introduction of a single bolus thrombolytic agent
(TNK).
The management of STEMI patients treated with
thrombolytic agents in the year before April 1st
2001 and the year following, were reviewed to
compare:
• Door-to-Drug times.
• Time to ST segment resolution.
• Use of intravenous b-blocking agents.
• In-hospital adverse clinical events.Sample selection
The 12-month period before and after the intro-
duction of the changes (April 2000–April 2002)
were retrospectively reviewed. During that time
3060 patients presented at the ED with chest pain,
of whom 1960 were admitted to hospital. One
hundred and sixty were discharged from the coro-
nary care unit with the diagnosis of myocardial
infarction, confirmed by ECG and enzyme criteria.
Eighty patients who had STEMI, fulfilled criteria for
thrombolytic therapy at the time of presentation to
hospital. Thirty-eight of these were between 1st
April 2000 and 31st March 2001 (Year 1), 42 be-
tween 1st April 2001 and 31st March 2002 (Year 2).
The data set was complete and available for
analysis on 35 patients in Year 1 (92%), and 39 in
Year 2 (95%).Data
The demographic, ECG, treatment and outcome
data for Years 1 and 2 were extracted from the
hospital records, tabulated, analysed and statisti-
cally evaluated.
ST segment elevation was recorded using con-
ventional methods previously described (Schroder
et al., 1999; Fu et al., 2001), measured manually
20 mS after the J-point using a hand calliper;
summing ST segment elevation in leads I, aVL and
V1 to V6 for anterior myocardial infarction; and
leads II, III, aVF, V5 and V6 for inferior myocardial
infarction.Statistical analysis
Statistical analysis was carried out using two-sam-
ple t-tests for differences between means from
independent samples, two-sample tests for differ-
ences between proportions and the Mann–Whitney
test for differences between medians, where ap-
propriate.Results
There were 35 patients in the Year 1 group with a
median age of 64 years, 74% were male. The 39
Year 2 patients had a median age of 64 years, 79%
were male. Baseline characteristics for both groups
are compared in Table 2.
A thrombolytic agent was given in the ED to
3% of patients in Year 1, and 72% in Year 2 (D 69%,
95% CI 53% to 84%, p6 0:0001); with a DTD time of
Table 3 Door and pain-to-drug time.
Year 1 (n ¼ 35) Year 2 (n ¼ 39) p 95% CI
Median Door-to-Drug timea (range) 80 (20–235) 22 (9–80) <0.0001 39–70
Median Pain-to-Drug timea (range) 270 (90–1155) 140 (54–1290) 0.0003 50–206
Door-to-Drug time 6 30 min 2 (6%) 25 (64%) <0.0001 41–75%
Thrombolysis administered in ED 1 (3%) 28 (72%) <0.0001 53–84%
aMinutes.
Table 2 Baseline characteristics (pP 0:05 for all).
Characteristic Year 1 (n ¼ 35) Year 2 (n ¼ 39)
Median age (range) 64 (42–90) 64 (48–81)
Age >75 yr 6 (17%) 6 (15%)
Male gender 26 (74%) 31 (79%)
Diabetes 4 (11%) 4 (10%)
Current smoker 13 (37%) 19 (49%)
Median blood pressure (mmHg)
Systolic (range) 147 (101–220) 150 (78–205)
Diastolic (range) 81 (52–126) 88 (50–114)
Location of infarction
Anterior 19 (54%) 15 (38%)
Inferior 16 (46%) 23 (59%)
Other 0 1 (3%)
Previous
Myocardial infarction 5 (14%) 2 (5%)
Coronary angiography 2 (6%) 1 (3%)
Percutaneous coronary intervention 3 (6%) 1 (3%)
Coronary artery bypass grafting 0 0
Improving Door-to-Drug time and ST segment resolution 56 30 min in 6% of Year 1, and 64% of Year 2 patients
(D 58%, 95% CI 41% to 75%, p6 0:0001).
In the period after the introduction of the rapid
thrombolysis package, median DTD time was re-
duced from 80 to 22 min (95% CI 39% to 70%,
p6 0:0001) (Table 3). Median Pain-to-Drug time
was reduced from 270 to 140 min (95% CI 50% to
206%, p ¼ 0:0003).
Twenty-four (69%) patients received an IV b-
blocking agent in Year 1, 28 in Year 2 (72%).
IV b-b was given to 12% of Year 1 patients in the
ED, compared with 79% in Year 2 (D 67%, 95% CI 46%
to 86%, p6 0:0001) (Table 4). There was a reduc-
tion in median time to receiving IV b-b from 63 to
19 min (95% CI 27% to 58%, p6 0:0001). No adverse
reactions resulted from the use of intravenous b-
blocker.
Twenty of the Year 2 patients (53%) achieved ST
segment resolution P 70% in <2 h, and seven of
the Year 1 (23%) (D 30%, 95% CI 8% to 52%, p ¼
0:007) (Table 5).
Individual and combined major in-hospital ad-
verse clinical events of death, re-infarction, re-
fractory ischaemia (requiring Rx) and new heartfailure (requiring Rx) fell from 17 (49%) in Year 1 to
6 (15%) in Year 2 (D 33%, 95% CI 13% to 53%,
p ¼ 0:001) (Table 6).
There were three deaths in Year 1, and two in
Year 2. Year 2 saw two cerebrovascular events,
compared to one in Year 1.Discussion
The relationship between moving the site of ad-
ministration of thrombolytic therapy from the CCU
to the ED and reduced DTD time is clear. With an
increase in the number of patients thrombolysed in
the ED from 3% to 72%, median DTD time fell from
80 to 22 min.
The reduction in median Pain-to-Drug time from
270 to 140 min is a valuable sequelae.
The degree of ST segment resolution after rep-
erfusion therapy, is an important prognostic indi-
cator for patients with acute myocardial infarction
and an accurate index of reperfusion (de Lemos
et al., 2000; Dissmann et al., 1994; Schroder et al.,
1994; Schroder et al., 1995). Many studies have
Table 4 Thrombolytic agents and concomitant medications.
Year 1 (n ¼ 35) Year 2 (n ¼ 39)
Aspirin 34 (97%) 39 (100%)
Sublingual nitroglycerine 24 (69%) 30 (77%)
Intravenous heparin 34 (97%) 39 (100%)
Intravenous opiate analgesia 21 (60%) 19 (49%)
Thrombolytic agent
Streptokinase 1 (3%) 1 (3%)
Reteplase 23 (66%) 7 (18%)
ASSENT-3 trial drug 11 (31%) 0
Tenecteplase 0 31 (79%)
Intravenous b-blocking agent 24 (69%) 28 (72%)
b-Blocking agent given in EDb 3 (12%) 22 (79%)
Median time to b-blocking agenta ;c 63 19
aMinutes.
bD 67%, 95% CI 46% to 86%, p6 0:0001.
c 95% CI 27% to 58%, p6 0:0001.
Table 5 ST segment resolution of >70% distributed over time intervals.
Year 1 (n ¼ 31) Year 2 (n ¼ 38)
<2 ha 7 (23%) 20 (53%)
2–4 h 11 (35%) 5 (13%)
4–24 h 5 (16%) 7 (18%)
>24 h 8 (26%) 6 (16%)
aD 30%, 95% CI 8% to 52%, p ¼ 0:007.
Table 6 In-hospital major adverse events, 30 day sequelae.
Year 1 (n ¼ 35) Year 2 (n ¼ 39)
Deathi 3 (9%) 1 (3%)
Re-infarctionii 5 (14%) 1 (3%)
Refractory ischaemiaiii 6 (17%) 3 (8%)
New heart failureiv 3 (9%) 1 (3%)
Combinedi–iva 17 (49%) 6 (15%)
Second thrombolytic agent for FTRb 1 (3%) 3 (8%)
Cerebrovascular event 1 (3%) 2 (5%)
Significant non-cerebral bleed 1 (3%) 0
Cardiac arrest 2 (6%) 2 (5%)
30 day
Death 0 1 (3%)
Re-admission 2 (6%) 2 (5%)
aD 33%, 95% CI 13% to 53%, p ¼ 0:001.
b Failure to reperfuse.
6 S. McLean et al.demonstrated that early complete resolution of the
ST segment (classed by Schroder et al., 1999 as
P70%) is associated with higher infarct-artery pa-
tency, smaller infarct size, better left ventricular
function, and lower mortality rates (Schroder et al.,
1994, 1995; Roberts et al., 1991; Owen, 1998).
Furthermore, P70% ST segment resolution
within 180 min of thrombolytic therapy conferslower risk than resolution outwith this window
(Schroder et al., 1995).
Measuring the extent of ST segment resolution in
the context of ED administration of bolus throm-
bolytic agents is unreported in the literature.
Year 2 of the study saw an increase in the
number of such patients from 23% to 53%. Five
patients (7%) were excluded from ST segment
Improving Door-to-Drug time and ST segment resolution 7analysis because of either a (L) Bundle Branch
Block; or because they received a thrombolytic
agent in the context of having an absence of ST
segment elevation, but a clinical history of typical
chest pain with raised cardiac markers. Four of
these patients were from the Year 1 group and one
from the Year 2.
Despite evidence that early administration of an
intravenous b-blocking agent reduces the incidence
of ventricular fibrillation, non-fatal reinfarction and
recurrent ischaemia in acute myocardial infarction
(Ryan et al., 1996; Roberts et al., 1991), their use
varies considerably between centres, with reports
between 5% and 45% (Owen, 1998). In this study the
frequency was 70% (69% Year 1 vs. 72% Year 2).
Intravenous metoprolol was administered 5 mg
at 5-min intervals, over 15 min to a maximum dose
of 15 mg. The reduction in median time from
arrival at the ED, to administration of IV b-b from
63 min in Year 1 to 19 min in Year 2, is attributable
to the increase in patients receiving IV b-blocker in
the ED from 12% to 79%. The drive to reduce DTD
time and the subsequent heightened awareness of
acute coronary syndromes, encouraged the ad-
ministration of concomitant medications indicated
for the treatment of AMI.
The significant reduction in DTD time which
followed the introduction of the combination of
measures described, may have been responsible for
the twofold increase in the number of patients
achieving optimal resolution of elevated segments.
The early administration of IV b-blocker may also
have been beneficial.
While acknowledging the relatively small sample
size, the reduction in combined major in-hospital
adverse clinical events (death, re-infarction, re-
fractory ischaemia, new heart failure) from 49% in
Year 1, to 15% in Year 2 is encouraging.
The higher incidence of a second dose of throm-
bolytic agent for failure to reperfuse in Year 2, is
probably due to combination of increased aware-
ness of the phenomenon in the CCU, a greater em-
phasis on timely sequential post-thrombolysis 12
lead electrocardiograms, a formal protocol for
treating this important subgroup of patients, and an
increased confidence in the safety and efficacy of
thrombolytic agents.
Of the five deaths over both years, four occurred
in-hospital; three in Year 1, one in Year 2. A further
Year 2 patient died of cardiogenic shock after re-
admission.
Three cerebrovascular events were split be-
tween two in Year 2, and one in Year 1. All three
were intracranial haemorrhages (ICH), confirmed
on CT Scan. The patients were all males aged >75
years. The Year 1 patient, and one of the Year 2patients received rPA, the remaining Year 2 patient
received TNK.
One significant non-cerebral bleed (gastrointes-
tinal) requiring blood transfusion occurred in the
Year 1 group.
Thirty-day sequelae of hospital re-admission was
evenly spread over both groups, with two re-ad-
missions from each Year.
An essential component of the success of this
programme is an emphasis on education, training
and confidence building. This enables a team ap-
proach to improving the ED management of AMI. All
medical and nursing staff in the ED attended at
least one session, covering the physiology, clinical
and electrocardiographic diagnosis and treatment
of AMI. CD-ROMS, teaching packs, visual aids,
sample ECGs and placebo demonstration single-
bolus thrombolysis kits were used. Staff were
generally very appreciative of this initiative. A
heightened awareness and a competitive spirit to
achieve a shorter DTD time than the previous re-
gime was clearly evident.Limitations
We recognise various potential limitations of this
study.
The study was observational, using a relatively
small sample size and retrospectively collected
data.
There were some differences in the spread of
baseline characteristics between Years 1 and 2,
however these were not statistically significant
(current smoker, p ¼ 0:311; location of infarction,
p ¼ 0:2; previous MI, p ¼ 0:184).
Although consistent throughout the two years
studied, analysing time to ST segment resolution
may be limited by the initial lack of standard tim-
ing in the performing of post-thrombolysis 12 lead
ECGs. This has been resolved and ECGs are now
routinely performed at 90 and 180 min post drug
administration.
Thirty-one percent of the patients in Year 1
were involved in a clinical trial, which may po-
tentially prolong DTD times due to the randomisa-
tion and enrolment process. In Year 1 however, the
31% of patients in the ASSENT-3 trial had a median
DTD time of 78 min; while the 69% of patients not
involved had a median DTD of 80 min.Conclusions
Door-to-Drug time is a cardinal component in the
successful treatment of STEMI which helps achieve
8 S. McLean et al.optimal outcome in mortality and morbidity, and is
also an indicator of system efficiency. Reducing
Door-to-Drug time has been a problem for many
centres (Hourigan et al., 2000). Although achieving
marked reductions, reported similar studies con-
tinued to have DTDs in excess of 30 min (Kendall
and McCabe, 1996; Hourigan et al., 2000; Edhouse
et al., 1999; Nee et al., 1994). A reduced DTD time
leads to a reduced Pain-to-Drug time (Hourigan
et al., 2000), a more accurate marker of the
duration of ischaemia.
This comparative study, shows worthwhile im-
provement in the management of acute myocardial
infarction, by the introduction of a package of
measures directed at reducing DTD time and ad-
herence to international guidelines.
Education and training, fostered by a dedicated
Chest Pain Nurse Specialist, based in the ED, is
essential in promoting the teamwork necessary to
significantly improve the ED management of AMI.
Promulgation of guidelines for the management of
acute coronary syndromes has a major impact,
particularly in a clinical area (the ED) previously
unfamiliar with the routine urgent administration
of thrombolytic agents and intravenous b-blocking
drugs.
Changing the site of thrombolysis from the CCU
to the ED was the primary contributor to the re-
duction in DTD time in this study.
The combination of measures used in this study,
facilitated by a user-friendly single bolus throm-
bolytic agent, improved DTD time for acute MI
patients, and significantly reduced the time to ST
segment resolution.References
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Nice guidance on the
investigation of chest pain
Keith A A Fox, Scott McLean
The NICE guidance on chest pain provides
a structured and evidence-based approach
to the diagnosis and triage of patients
with chest pain and provides a series of
improvements on the status quo.1
However, the challenge is the high preva-
lence of occult vascular disease in our
community, especially in older people and
at younger ages in men than in women.
There is also a high prevalence of chest
pain (20%-40% of the population)2e4 but
this is frequently non-cardiac in origin.
Among those presenting to their primary
care doctor with chest pain, the ﬁnal
diagnosis was not ischaemic heart disease
in 83%.3 Nevertheless, because of the high
prevalence of asymptomatic coronary
disease there may be an unintended conse-
quence: detection of incidental non-obstructive
coronary disease. This non-obstructive
coronary disease may not have been
responsible for the symptoms and may
“convert” an individual into a cardiac
patient. Further, do we have good evidence
that deﬁning the anatomy with CT and
angiography in those with non-obstructive
disease will change the secondary preven-
tion treatments that should be provided
based on the patient’s risk factors? From
a professional and economic viewpoint we
must also consider the implications for
changes in clinical practice and the
increased demands on ﬁnite human and
economic resources.
Strengths of the guidance include the
emphasis on establishing an early and
accurate diagnosis based on clinical, elec-
trocardiographic and biomarker assess-
ments among those presenting with
suspected cardiac chest pain (see page
974).5 Appropriately, there is emphasis on
very early identiﬁcation of ST elevation
infarction and on the remainder of acute
coronary syndromes (in one diagnostic
pathway) and on managing those with
stable angina (second diagnostic
pathway). The subsequent management
of these conditions is dealt with in sepa-
rate NICE guidance.6 7 The NICE guid-
ance on chest pain also emphasises the
importance of providing clear and accurate
information to the patients and explana-
tion of the diagnostic pathway.
WHAT IS THE PROBLEM WITH CURRENT
MANAGEMENT OF CHEST PAIN?
As approximately a quarter of all emer-
gency hospital admissions are for chest
pain,4 robust triage pathways and accurate
diagnostic tools are of major importance.
International publications show that the
diagnosis of acute myocardial infarction
(MI) is missed and a patient discharged in
approximately 2% of cases,8 9 and many
patients are left with diagnostic uncer-
tainty about whether the pain is of cardiac
origin, even when infarction is “ruled
out”. Although STelevation infarction can
be identiﬁed with high diagnostic accu-
racy based on the ECG and clinical ﬁnd-
ings, non-ST elevation MI has less speciﬁc
ECG changes and the threshold for
differentiation from unstable angina is
dependent on the sensitivity of the
biomarker (troponin) assay. Further,
troponin elevation does not equal infarc-
tion: several non-coronary causes of
myocyte necrosis may precipitate
troponin elevation (for example, arrhyth-
mias, heart failure, myocarditis, pulmo-
nary embolism).10 Hence, improved triage
and diagnosis pathways are needed.
Without a systematic and evidence-
based approach to differentiating chest
pain and establishing a diagnosis, the
patient and the patients’ carers may be
left in limbo. For example, a discharge
statement, “chest pain MI excluded”, is
unhelpful as it does not establish a posi-
tive diagnosis and does not exclude prog-
nostically important or other
symptomatic coronary heart disease.
Furthermore, inadvertent discharge of
patients with acute coronary syndrome
(ACS) or with MI is well documented.8 9
For example, in a study of patients
presenting to emergency departments in
10 US hospitals (10 689 patients), 2.1% of
those with acute infarction were mistak-
enly discharged home and 2.3% of those
with unstable angina were mistakenly
discharged.9 The advent of more accurate
and speciﬁc biomarkers of necrosis has
improved diagnostic accuracy but
currently requires a prolonged period of
about 12 h of observation. However, even
in the absence of biomarkers of necrosis
the patient may have obstructive coronary
disease with stress-induced ischaemia, and
a further proportion have incidental non-
obstructive coronary disease unrelated to
the presenting symptoms.
The guideline emphasises clinical
assessment and a resting 12-lead ECG in
the initial investigation of any patient
with suspected ACS.5 The ECG can be
performed in the pre-hospital setting,
facilitating early triage, provided that this
does not signiﬁcantly delay transfer to
hospital. It is critically important to detect
evolving ST elevation myocardial infarc-
tion and although the patient may not
have diagnostic ST elevation at initial
presentation, these signs can evolve over
minutes or hours. The retrospective
ﬁnding of evolved MI the following
morning is a serious error and a missed
opportunity to salvage myocardium.
DELAYS IN ESTABLISHING THE
DIAGNOSIS
Once a patient arrives in hospital the
NICE guidance recommends measuring
troponin immediately in all patients with
a recent episode of cardiac sounding chest
pain, but it recognises that repeat
sampling 10e12 h after the onset of
symptoms is required to exclude MI.
Newer very high-sensitivity troponin
assays can identify patients earlier (within
about 2 h)11 but need testing in large
unselected cohorts of patients with
suspected cardiac pain. Importantly, the
NICE guidance emphasises that troponin
should not be interpreted in isolation, but
in the context of the clinical history in
ECG changes.
DOES THE PATIENT NEED RISK
STRATIFICATION?
The NICE guidance on management of
non-ST elevation ACS7 emphasises the
spectrum of risk across the ACS
syndrome. In the 12.5% of patients in the
lowest eighth of risk the 6-month
mortality is <2% (GRACE score <70),
whereas in the half of patients with
higher risk scores (GRACE score >112) the
6-month mortality is more than ﬁvefold
higher (>9.5%). This information will aid
clinical decision making. In contrast,
patients are currently transferred for
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angiography largely on the basis of
troponin elevation and without priority
for the higher-risk patients. The short-
comings have been deﬁned of the “binary”
approach to chest pain based only on
elevated troponin.12
DEFINING OTHER CAUSES OF CHEST
PAIN
A strength of the NICE guideline is the
recommendation that simply excluding
acuteMI isnot sufﬁcient.Other causesof the
chest pain need to be considered and
managed and a pathway provided for inves-
tigation of patients with stable chest pain.
DIAGNOSIS OF ‘STABLE’ CHEST PAIN
The guideline has chosen a diagnostic
probability, based on clinical assessment,
of >90% likelihood of coronary artery
disease (CAD) for diagnostic “rule in” and
<10% likelihood of CAD for diagnostic
“rule out”. These thresholds are arbitrary,
but useful. The guideline has adopted the
1979 Diamond and Forrester criteria13 to
stratify patients with chest pain into
those with typical angina, atypical angina
and non-anginal pain. This stratiﬁcation
then combines the clinical features of the
symptoms with other factors including
age, gender, cigarette smoking, diabetes
mellitus, hyperlipidaemia and the pres-
ence of ECG changes.5 The guideline
should be commended for re-emphasising
the importance and positive predictive
value of the clinical history, and for
stating explicitly than the diagnosis of
angina pectoris can be made on the basis
of the clinical history alone.
TESTS FOR CARDIAC PAIN
Two forms of testing are advocated for
investigating patients with stable angina
thought to be due to CAD: anatomical
testing to diagnose coronary arterial
narrowing, and non-invasive functional
testing for myocardial ischaemia. The
guideline has examined the sensitivity and
speciﬁcity of tests against a ‘gold standard’
of angiographically demonstrated CAD, but
this poses a number of problems because of
the high prevalence of non-obstructive and
functionally unimportant CAD.
Following clinical assessment the guide-
line recommends invasive angiography as
the most cost-effective ﬁrst test if the like-
lihood of CAD is 61e90%, and non-inva-
sive functional testing with either
myocardial perfusion scintigraphy with
SPECT, stress echocardiography, ﬁrst-pass
contrast enhanced magnetic resonance
(MR) perfusion or MR imaging for stress-
induced wall motion abnormalities if the
likelihood of CAD is 30e60%.1 If the like-
lihood of CAD is 10e29% CT scanning is
recommended (with 64 slices or above).
The guidance suggests that patients with
a low likelihood of CAD will not need
further testing (<10% likelihood).
IMPLICATIONS OF THESE
INVESTIGATION STRATEGIES
There are major implications associated
with these recommendations. As can be
seen from table 1 of the full guideline
a man >65 years with atypical chest pain
and no risk factors or a man >45 years
with atypical chest pain and risk factors
would exceed the 60% probability
threshold for angiography. No women
with atypical or non-anginal type pain
would exceed this threshold. However, all
men and women >35 years with atypical
angina would exceed the 30% probability
threshold for stress imaging if they have
risk factors (table 1).1 The NICE table is
based on 1030 patients referred for non
invasive testing in an observational study
conducted from 1983 to 1985, and only
168 underwent angiography.14 Those
authors acknowledge that severe disease
and left main disease were less reliably
predicted than any coronary disease.14
The extent to which the ﬁndings are
applicable to CT detection of coronary
disease, or current higher-resolution
radiological imaging is uncertain. Robust
information is required as this formulaic
approach to stress imaging and angiog-
raphy has huge resource implications and
may not be in the best interests of
patients with atypical chest pain that is
likely to be non-cardiac in origin.
THE “OBSOLETE” EXERCISE ECG
Despite its limitations, exercise ECG stress
testing is currently widely used in chest
pain and general cardiology clinics and
although the sensitivity and the speciﬁcity
are less good than the imaging techniques
listed above, a positive test provides a rapid
and cost-effective method of demon-
strating myocardial ischaemia. Replacing
all exercise ECG facilities with sufﬁcient
CT and imaging resources (staff and
equipment) will be a signiﬁcant challenge.
THE ROLE OF COMPUTED TOMOGRAPHY
There are important implications for
radiation exposure, especially with the
older slower 16-slice scanners. For these
reasons the guidelines recommends
calcium scoring initially, with no further
testing if this is zero. The NICE guideline
suggests a high degree of diagnostic accu-
racy with a sensitivity of 99%.1 However,
if the calcium score is >400 the guideline
recommends proceeding directly to inva-
sive coronary angiography. Unfortunately,
the issues are not as straightforward as
suggested by the guideline. For example,
there is recent evidence from a multicentre
trial using 64-slice CT that a zero calcium
score was nevertheless associated with
a 50% or greater coronary stenosis in 19%
of the population and a 70% or greater
coronary stenosis in 15% of the popula-
tion.15 The probable explanation is that
disrupted plaque may not contain sufﬁ-
cient calcium to be detected in the 64-slice
CT. Unfortunately, there were not reliable
multivariable predictors, using baseline
characteristics, for the presence of coro-
nary lesions, other than presentation to an
emergency department (OR¼4.7, CI 1.13
to 19.75, p value 0.03).15 The authors of
this publication conclude that a zero
calcium score should not be the gatekeeper
for coronary angiography. Nevertheless,
recent information indicates that among
those with a zero calcium score there is
a low rate of progression to an elevated
calcium score within 4 years.16
Table 1 Percentage of people estimated to have coronary artery disease according to typicality of
symptoms, age, sex and risk factors2
For men older than 70 with atypical or typical symptoms, assume an estimate >90%. For women older than 70, assume an
estimate of 61e90% except women at high risk and with typical symptoms, where a risk of >90% should be assumed.
Values are the percentage of people at each mid-decade age with significant coronary artery disease (CAD). Hi ¼ High risk ¼
diabetes, smoking and hyperlipidaemia (total cholesterol >6.47 mmol/l). Lo ¼ Low risk ¼ none of these three. The shaded
area represents people with symptoms of non-anginal chest pain, who would not be investigated for stable angina routinely.
Note: these results are likely to overestimate CAD in primary care populations. If there are resting ESG ST-T changes or Q
waves, the likelihood of CAD is higher in each cell of the table.
Reproduced from NICE guideline: http://www.nice.org.uk/guidance/CG95. Adapted from Pryor DB, et al14
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WHAT WILL BE THE IMPACT OF THE
PROPOSED INVESTIGATIVE STRATEGIES?
The NICE guideline on chest pain,
presented personal communications from
two of the authors. These suggested that
around 29% of patients were in the <10%
likelihood of CAD category, 11e17% in the
10e29% likelihood of CAD category,
17e18% in the 30e60% likelihood of CAD
category, about 15% in the 60e90% cate-
gory and 6e9% in the >90% category.
However, these ﬁgures are not in accord
with a published cohort of 504 randomly
selected patients from a complete cohort of
7000 consecutive patients presenting to the
emergency department with undifferenti-
ated chest pain.17 Only 3% were in the
<10% likelihood of CAD category, 12% in
10e29% likelihood group, 31% in 30e60%
likelihood group, 34% in the 61e90% likeli-
hood group and 20% in the>90% likelihood
group. The implications based on this
published cohort are for a 28% increase in
invasive angiography and a 43% increase
in non-invasive imaging (ﬁgure 1). Likewise,
in a second group of 500 consecutive
patients attending the rapid access chest
pain clinic in our owncentre (McLean 2010,
manuscript under review) the implications
would be for a 20% increase in invasive
angiography and a 42% increase in non-
invasive imaging (ﬁgure 2, table 2).
CONCLUSIONS
The NICE guidance on chest pain provides
a series of important advances over the
current status of investigation and triage
of chest pain and should be welcomed by
the profession. The clearer triage path-
ways and use of more robust investigation
tools will lead to improvements in clinical
care. However, a serious concern needs to
be addressed: the unintended consequence
of investigating patients with stress
imaging and/or invasive imaging on the
basis of their pre-test probability of coro-
nary disease. A high proportion of such
disease may be incidental and non-
obstructive (even though of prognostic
importance) and evidence supports
secondary prevention measures on the
basis of vascular risk factors, alone. Thus,
we must consider the beneﬁts versus
potential harm of investigating most men
and many women with chest pain and
vascular risk factors. We propose that,
before widespread adoption, a prospective
study is required to test the risk versus
beneﬁt of applying this approach.
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Diastolic stress testing: a new
trick to evaluate the ageing heart
Zoran B Popovic, Brian Griffin
Exertional shortness of breath in the
absence of an obvious cardiac abnormality
is a perplexing and relatively common
clinical scenario especially in older patients.
These patients often undergo multiple
evaluations by different specialists and end
upwithout a deﬁnitive diagnosis and,more
importantly, without any speciﬁc thera-
peutic target to improve their symptoms.
In some of these patients, exercise intoler-
ance is attributed to respiratory disease, in
others to deconditioning or obesity and in
many diastolic abnormalities are claimed as
the underlying problem without substan-
tiating data. In their article in this edition
of Heart, Tan et al describe a study of
diastolic function on exercise in a group
of patients with treated hypertension
without signiﬁcant diastolic dysfunction
at rest whose functional capacity is signif-
icantly reduced (see page 948).1 Their
ﬁndings that these patients exhibit signiﬁ-
cant abnormalities of diastolic function on
limited exercise and that these induced
diastolic abnormalities relate to the degree
of functional limitation are an important
contribution to our understanding of the
pathophysiology of functional impairment
in older hypertensive patients. This paper
also highlights the potential utility of
diastolic stress testing as a diagnostic
modality in this patient population.
It is not surprising that exercise stress
will provoke diastolic abnormalities that
are not apparent at rest. Indeed, diastolic
abnormalities, as a rule, accompany
systolic abnormalities during stress, and
demand ischaemia leads ﬁrst to diastolic,
and then to systolic abnormalities. One
can roughly divide diastolic function
parameters into ‘traditional’ or ‘hard’, and
‘contemporary’ or ‘soft’ indices. Tradi-
tional diastolic function indices are
usually considered as measures of relaxa-
tion, diastolic stiffness and ﬁlling pressure
(which results from the interaction of
relaxation, stiffness and preload). Relaxa-
tion occurs ﬁrst with mitral valve closure,
followed by left ventricular (LV) ﬁlling
along the pressureevolume curve that is
deﬁned by LV stiffness, and ﬁnally, results
in LV end-diastolic pressure. By default,
measuring traditional indices means
measuring LV ﬁlling pressures invasively,
which is impractical in routine clinical
diagnostic assessment and is particularly
difﬁcult on exercise.
In clinical practice, we most often use
‘contemporary’ indices, almost exclusively
obtained by echocardiography. These
indices can be considered ‘soft’ as they
often reﬂect factors other than ‘tradi-
tional’ indices.2 However, ‘contemporary ’
indices give us a slightly different
description. Here, the diastolic process
starts with LVuntwisting. This represents
the early relaxation of epicardial ﬁbres,
which in turn releases the elastic elements
within the ventricle and leads to clockwise
motion of the apex. This process starts in
the second part of the systole, and reaches
its maximum at the time of aortic valve
opening, preceding the beginning of
isovolumic relaxation as deﬁned by
‘traditional’ indices. Next, the mitral valve
opens owing to development of LV
suction. Suction can be quantiﬁed by
early diastolic intraventricular pressure
gradient, or by its surrogate, colour-M
mode ﬂow propagation velocity. This is
followed by downward motion of the
mitral annulus and outward motion of the
LV wall, which results in the early ﬁlling
ﬂow through the mitral valve. Of note, all
of the previous phenomena occur in this
deﬁnite order both in sickness and disease,
and show some correlation with ‘tradi-
tional’ parameters of relaxation. In con-
trast, the shape of the second half of the
early mitral ﬁlling wave depends on LV
stiffness: the greater the stiffness, the
shorter the LV ﬁlling.
The biggest drawback of ‘contempo-
rary’ indices is that their values are
a result of mixed inﬂuences of relaxation,
stiffness and ﬁlling pressures or even some
other parameters, such as LV geometry.
A potential strength is that in contrast
to ‘traditional’ pressure-based parameters,
echocardiography can provide regional
estimates of both relaxation and stiffness
indices obtained by measurement of
regional deformation (strain and strain
rate) and velocity. However, the compre-
hensive non-invasive assessment of dia-
stolic dysfunction is complex and time
consuming at rest and becomes more
difﬁcult with the effect of increased heart
rate with exercise. Fusion of the early
diastolic ﬂow velocity and the atrial
contraction velocity occurs at higher heart
rates and makes their differentiation
impossible. Furthermore, obtaining a tech-
nically adequate assessment is difﬁcult in
a patient who is ﬁghting for breath while
exercising.
Despite these difﬁculties, Tan and
colleagues have shown that diastolic stress
testing by Doppler echocardiography is
both feasible and useful.1 They compared
patients with heart failure and normal
ejection fraction (HFNEF) due to hyper-
tension with healthy volunteers. Patients
had a much lower exercise tolerance than
healthy volunteers, despite being of
similar age, gender, blood pressure and
ejection fraction. Both groups underwent
a challenging exercise protocol of supine
symptom limited exercise testing, with
the target heart rate of 100 bpm during
which two-dimensional, pulsed and colour-
M mode Doppler data were collected. The
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Reperfusion of old or new: 
left bundle branch block?
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Prevention and treatment of coronary heart disease (CHD) remains a significant challenge for the NHS across the UK. Data from 2006 
suggests that CHD was the most common cause of 
premature death in the UK, with more than 31 000 
premature deaths being attributed directly to heart 
disease. CHD accounts for around 19% of premature 
deaths in UK men and 10% in women (British Heart 
Foundation, 2006). 
Although these figures are disturbing, in reality, 
many patients with CHD manage their condition 
well, with varying levels of support from relatives, 
friends and NHS services. However when these 
patients—or indeed patients with no history of 
CHD—have an acute episode of ischaemic 
chest discomfort, emergency care is generally 
sought. 
Because of the time-critical nature of the 
condition, much effort has been placed on ensuring 
that these patients receive prompt evidence-based 
care both before they get to hospital and in the 
hospital itself. 
Scotland historically has one of the highest 
incidences of CHD in Western Europe (Scottish 
Public Health Observatory, 2009). However, recent 
data has shown a 49% reduction in mortality rates for 
CHD between 1995 and 2007 (now at 61 per 100 000 
population) and a 3% reduction in mortality rates 
from acute myocardial infarction (AMI) between 
2006 and 2007 (now at 69 per 100 000) (Information 
Service Division Scotland, 2007).
Data from the Scottish Ambulance Service (SAS), 
one of the UK’s largest ambulance services, showed 
that they responded to more than 27 000 emergency 
calls for chest pain during 2007–2008. ‘Chest pain’ 
was cited as the most common reason for category A 
(999) calls in Scotland during this period (Scottish 
Ambulance Service, 2008). Not all these calls, 
however, were directly related to coronary heart 
disease. Studies have shown that fewer than 60% of 
calls with ‘chest pain’ were triaged by emergency 
medical despatch centres (EMDC) to be cardiac or 
potentially cardiac related, and that only 0.6% of  
999 calls to ambulance services result in an 
in-hospital diagnosis of acute coronary syndrome 
(Deakin et al, 2006).
Advances in pre-hospital emergency 
care of acute coronary syndrome
Pre-hospital emergency management of acute 
coronary syndrome (ACS) has developed 
significantly over recent years.
Such advances have occurred in paramedic 
practice via extended training/education packages 
and the development and introduction of national 
clinical guidelines by the Joint Royal College 
Ambulance Liaison Committee (JRCALC, 2006). 
Significant progress was made in Scotland during 
2003–2004 when the SAS introduced pre-hospital 
thrombolytic therapy (PHT), supported by a national 
training and education programme. The combination 
of extended training, a robust clinical guideline and 
12–lead electrocardiogram (ECG) telemetry allowing 
shared decision making with critical care unit (CCU) 
staff enabled paramedics to consider delivery of 
Abstract
Reperfusion options for patients suffering ST-elevation myocardial infarction 
(STEMI) have developed significantly over recent years and now include both 
thrombolytic therapy and primary percutaneous coronary intervention (PPCI). This 
system of care means that patients presenting with STEMI can be transferred 
directly to a heart-attack centre to receive immediate PPCI. National guidelines 
state that pre-hospital thrombolysis (PHT) is a crucial part of STEMI reperfusion 
where PPCI cannot be delivered within 90 minutes of diagnosis. There is 
evidence describing rates of in-hospital thrombolysis in both MI with ST elevation 
and MI with LBBB. There is a knowledge gap however describing treatment of 
MI with LBBB based upon a pre-hospital 12-lead ECG. This paper describes the 
challenges around PHT in the context of LBBB and offers potential solutions that 
may provide assistance in making the decision to undertake PHT or not.
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Paramedic reading ECG: 12-lead ECG telemetry, allowing shared 
decision making with critical care unit staff, enables paramedics 
to consider thrombolysis before cardiac patients reach hospital.
 
thrombolytic agents to patients with ST elevation 
myocardial infarction (STEMI) and to symptomatic 
patients with new left bundle branch block (LBBB). 
Both prior to and since its introduction, a strong 
evidence base has developed around PHT. Data has 
been published on paramedics’ ability to recognise 
the ECG changes of STEMI (Pitt, 2002; Whitbread 
et al, 2002), the resultant reductions in ‘door-to-
needle’ and ‘call-to-needle’ times (Weaver et al, 
1993; McLean et al, 2008) and the positive impact on 
patient outcome (author not known, 1993). Meta-
analysis has shown that patients given thrombolysis 
in a pre-hospital setting have a 17% lower mortality 
rate than those who receive it only when they get to 
hospital (Morrison et al, 2000).
As evidence and international guidelines have 
evolved, reperfusion options for patients suffering 
STEMI now include both thrombolytic therapy 
and primary percutaneous coronary intervention 
(PPCI) (Van de Werf et al, 2008). This system of 
care means that patients presenting with STEMI 
can be transferred directly to a heart-attack centre 
to receive either immediate PPCI or, in the event 
of failure to reperfuse adequately following PHT, 
‘rescue PCI’. This is defined as an em rgency PCI 
procedure performed following administration of 
thrombolytic therapy which has failed to reduce 
ST-segment elevation by >50%. National guidelines 
state that PHT is a crucial part of STEMI reperfusion 
where PPCI cannot be delivered within 90 minutes 
of diagnosis (Scottish Intercollegiate Guidelines 
Network, 2007). 
Although the important role of PHT has been 
stated, there are suggestions that pre-hospital 
guidelines produced by JRCALC actually restrict 
PHT rates for STEMI to around 14% (Castle at al, 
2006). However, in a recent study undertaken in 
south-east Scotland, which involved collaborative 
decision-making between paramedics and CCU 
nurses, an impressive 27% of patients presenting 
with STEMI had received PHT (McLean et al, 2009). 
It was expected, however, that these rates would 
fall once PPCI was made available 24/7. Recent SAS 
audit data has shown that, in 2008–2009, of the 
1 248 patients diagnosed with STEMI, only 7.2% 
(n=177) received PHT. 
There is a lack of published evidence describing 
whether or not patients with a pre-hospital 12-lead 
ECG showing LBBB are as likely to be considered 
for reperfusion treatment with either PHT or PPCI, 
as patients presenting with MI with ST elevation. 
Anecdotal evidence in parts of Scotland, however, 
suggests that direct transportation to the heart-attack 
centre and/or administration of PHT depends very 
much on geographical location, with some patients 
presenting with LBBB still being transported to local 
emergency departments or critical care units.
In Scotland, during 2008–2009, only 2.5% (n=61) 
of patients with ACS were diagnosed with LBBB, with 
just 0.6% of these (n=1) receiving PHT (Monteath, 
personal communication, 2009). The apparently small 
number of patients presenting with LBBB and receiving 
PHT is concerning, particularly when this sub-group 
of patients is the most likely to benefit from prompt 
reperfusion therapy (Reuben and Mann, 2005). 
Challenges of LBBB and STEMI 
reperfusion therapy
There are a number of challenges in delivering 
reperfusion therapy to patients with LBBB. 
The first relates to difficulties in identifying 
LBBB changes on the 12–lead ECG. This is 
well documented in the literature (Brady and 
Aufderheide, 1997; Edhouse et al, 1999). There 
is some evidence, however, that suggests that 
paramedics perform as well as their emergency 
department colleagues when interpreting 12–lead 
ECGs (Whitbread et al, 2002). Although this evidence 
does not specifically relate to LBBB, it could be 
argued that the concept is transferable. 
SAS paramedics have received training and 
education on the identification of both LBBB and 
STEMI, which aims to minimise uncertainty around 
diagnosis/recognition. However, as stated above, 
delivery of PHT by paramedics—and therefore 
use of these skills—has depended very much on 
geographical location, ranging from 40% of STEMI 
in some regions to <5% in others. This presents 
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significant challenges for both training departments 
and operational managers.
Recognition of LBBB
Under normal circumstances, the heart’s ventricles 
are depolarized rapidly through specialised 
conduction tissue. If one or other of the bundle 
branches fails to conduct, however, activation of the 
ventricle normally supplied by that bundle occurs by 
spread of depolarization from the other ventricle. 
It is the delayed activation of that ventricle that 
results in the broadening of the QRS complex 
beyond the upper limit of normal (Colquhoun, 
1998). In the normal heart, the time taken for 
the depolarization wave to spread from the 
interventricular septum to the furthest part of the 
ventricle is no more than 0.12 seconds, or three 
small squares on ECG paper (Hampton, 1996). 
Providing it is preceded by a P wave, a ‘wide’ QRS 
(>0.12 seconds) is indicative of a left bundle branch 
block (Hampton, 1996).
In LBBB, the initial small negative Q wave 
normally seen in the left ventricular leads  
(V5, V6, lead I and aVL), is replaced by a larger 
positive R wave (Bennett, 1993). The QRS 
complexes in these leads can show what has been 
described as a ‘M-shaped’ pattern (Colquhoun, 
1998) as demonstrated in lead aVL of Figure 1. The 
broad QS complex in lead V1 is also characteristic 
of LBBB (Figure 1).
Comparison of presenting ECG with 
previous ECGs
Assuming the paramedic/clinician is competent in 
identifying LBBB on the 12–lead ECG, the next stage 
requires the clinician to determine whether the 
presenting changes of LBBB are new or old. This 
is incredibly difficult, particularly in patients who 
have pre-existing coronary heart disease, heart valve 
disease, ardiomyopathy or hypertension.
This decision, however, may be simplified in 
hospital (where patient records are often available) 
by comparing the presenting 12-lead ECG with 
an older one (Evans et al 2008). Unfortunately, 
previous ECGs are generally not available in 
pre-hospital settings and, on occasions, even in 
the emergency department, obtaining records 
containing ECGs can prove to be problematic, 
potentially resulting in delays in time-dependent 
treatments/interventions.
Consequently, when previous records are not 
available, both ambulance and hospital clinicians can 
be left with a decision-making dilemma, i.e. whether 
or not to consider the LBBB as a new finding and 
deliver reperfusion therapy. 
Patient undergoing PPCI in the cath lab: direct transportation to such a centre can depend on location – many 
patients are taken to emergency departments or critical care units.
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This dilemma can be compounded by reduced 
confidence levels as a result of infrequent exposure 
to this group of patients (Rajabali et al, 2009). There 
are reports that the average UK paramedic sees 
fewer than one patient a year with STEMI who is 
suitable for PHT (Fairhurst, 2006).
It has previously been suggested that, when 
ambulance paramedics are faced with this dilemma, 
they often default towards the ‘do no further harm’ 
and ‘risk averse’ ethos of their training/education 
(Humphrey et al, 2005), which, in this case, results 
in patients with LBBB not receiving reperfusion 
treatment.
Anecdotal evidence from SAS ambulance 
paramedics suggests that symptomatic patients with 
LBBB are not receiving prompt reperfusion therapy 
because of difficulties in determining whether or not 
the ECG appearance is new or old (SAS, personal 
communication, 2009).
Available solutions
A potential solution to this information deficit has 
previously been described in recommendations 
made by the Scottish Intercollegiate Guidelines 
Network (2007). Acute Coronary Syndromes states 
that ‘patients with persisting bundle branch block 
or ST segment change should be given a copy of 
their electrocardiogram to assist their future clinical 
management should they present with a suspected 
acute coronary syndrome’.
Although these recommendations were published 
in February 2007, audit data from one of Scotland’s 
main STEMI-receiving hospitals suggests that CHD 
patients continue to be discharged without copies of 
their 12–lead ECG (Scott, personal communication, 
2009). The reasons for this may be multi-factorial 
and include shortening length of hospital stay, 
poor communication and lack of prioritization of 
this recommendation among the milieu of others. 
Furthermore, there is no published data reporting 
the retention and safekeeping of the ECG by patients 
discharged from cardiology units.
The second solution, which is freely available on 
the market, is digital ECG archiving. While there 
are a number of centres across the UK using this 
technology, there are few systems if any that have 
smooth communication links between pre-hospital 
ECG technology, in-hospital technology and digital 
archiving. The gold standard utilisation of this 
technology is described in Figure 2, shown overleaf, 
as observed on a visit to the STEMI reperfusion 
programme in southern Sweden (McLean, personal 
communication, 2009).
Conclusions
The pre-hospital environment has many challenges, 
particularly in relation to reperfusion of ST 
elevation myocardial infarction. With the increasing 
availability of PPCI, fewer patients presenting with 
STEMI appear to be receiving PHT. While this will 
inevitably result in reduced exposure to the bolus 
administration of thrombolysis for paramedics, 
it is vitally important to focus on the role of the 
paramedic in contemporary STEMI reperfusion. 
Figure 1. 12-lead ECG showing left bundle branch block.
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that patients with pre-existing LBBB are not exposed 
to either the haemorrhagic risks associated with 
PHT or unnecessary fear and worry that must surely 
be provoked by direct/emergency admission to the 
cardiac cath-lab at 2am for PPCI.
Future research
Given the difficulties involved in determining the 
electrocardiographic diagnosis of MI in patients with 
pre-existing or previously unknown LBBB, our group 
intends to explore this area further. We intend to 
investigate the predictive value of novel ECG scoring 
criteria designed for in-hospital use, and how this 
correlates with a hospital discharge diagnosis of 
myocardial infarction when applied to pre-hospital 
12-lead ECGs.
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Clinical history versus the 
exercise ECG in assessment of 
stable coronary artery disease
While it is disappointing to note that a trawl of the world-wide-web still yields results of peer-reviewed publications directly comparing the 
abilities and outcomes of nurses versus doctors (Munday 
et al, 2007), or more popular press such as ‘Do you prefer 
doctors or nurses?’(BBC News website, 2002), it is slightly 
more reassuring that the majority of these pieces were 
published in the earlier rather than the latter part of this 
decade.
There are a host of publications from within our own 
specialty that demonstrate the benefits, non-inferiority or 
superiority of services provided by cardiovascular nurses 
(Pottle, 2005; Mullan et al, 2007; O’Neill and Currie, 
2007). The majority of these reports highlight the key role 
of education and training in preparing nurses for these 
roles, hitherto the domain of medical colleagues.
Paradoxically, one may argue that the very difficult and 
important skill of clinical history-taking is not one cov-
ered in generic nursing courses. The teaching of this skill 
remains the domain of either undergraduate medical 
training or specialist postgraduate nursing training. 
Indeed while Ramani (2004) states that the patient history 
is a truly vital piece of the patient encounter and helps lead 
to the final diagnosis approximately 75% of the time, he 
also states that skilled history-taking is reported to be 
declining among medical trainees and that current educa-
tional methods do not emphasize these skills during 
medical school training. There are few reports in the nurs-
ing literature describing the training in, quality of, or 
assessment of clinical history-taking by nurses. Given the 
ever-increasing number of clinical services provided by 
nurses (Albarran and Tagney, 2007) some may find this 
worrying.
The emphasis on history-taking in 
coronary artery disease
It is therefore important to elicit relevant and spe-
cific information from the patient that will inform 
the differential diagnosis of their chest pain 
(Albarran and Tagney, 2007: 23).
While it is a definition the cardiovascular nurse may 
have heard many times, it is important that we remember 
that angina pectoris is in fact ‘the symptom of oppression, 
pain or tightness in the centre of the chest’ (Youngson, 
1992). Angina pectoris is the term applied to the symp-
toms of certain types of chest pain: it is not a diagnosis 
(Forfar and Firoozan, 1995). 
Coronary artery disease (CAD) on the other hand could 
be defined as ‘stenosis of the coronary arterial lumen 
caused by atheromatous plaque’ (Timmis and Nathan, 
1988). Significant confusion arises when the two terms 
(‘angina’ and ‘CAD’) are used interchangeably. The guide-
line development group responsible for the consultation 
version of the National Institute for Health and Clinical 
Excellence (NICE) guideline for chest pain of recent onset 
acknowledged this (National Clinical Guidelines Centre 
for Acute and Chronic Conditions (NCGC), 2009). They 
stated that the term angina is used to describe two differ-
ent concepts. The first is the use of the term ‘angina’ as a 
symptom, and the second is the use of ‘angina’ as a 
description for CAD. They state that the reason for this 
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may lie in the fact that angina is the most common conse-
quence of symptomatic CAD in Western society, meaning 
that health professionals may often ignore the other causes 
of angina, for example aortic stenosis and hypertrophic 
cardiomyopathy. 
Poor history-taking is largely responsible for the patient’s 
symptoms being falsely attributed to CAD. The translation 
of the patient’s symptoms to a diagnosis requires specific 
and detailed questioning to elicit the location, quality, 
duration, severity, frequency, radiation, relieving and pro-
voking factors of the chest discomfort (Diamond and 
Forrester, 1979). The work of Diamond and Forrester 
(1979) was seminal and was followed by the work of 
Patterson and Horowitz (1989) who published simple cri-
teria, which at the completion of history-taking would 
allow the clinician to classify the patient as having: 
(i) typical angina pectoris, 
(ii) atypical chest pain, or 
(iii) non-anginal chest pain (Table 1).
Investigators at Duke University in the United States 
(Pryor et al, 1989) then developed a nomogram (a graphi-
cal calculation aid) to determine pre-test probability of 
CAD based on classification of chest pain, previous myo-
cardial infarction, ECG findings, presence of diabetes mel-
litus, age, smoking and serum lipids. While 20 years later 
we may find this pencil-and-ruler nomogram technique 
cumbersome and out-of-date, the principles of this meth-
od are absolutely key to contemporary practice. 
The importance of determining pre-test probability of 
CAD has been re-emphasized in the draft NICE guidance 
(NCGC, 2009). This draft document suggests:
w 20-40% of patients will experience chest pain in their lives
w Up to 40% of emergency hospital admissions are due to 
chest pain
w The diagnosis of angina might be made from
w A typical history alone, or
w The history in combination with functional testing 
demonstrating myocardial ischaemia, or
w The history in combination with the finding of sig-
nificant obstructive CAD, or
w All three of the above
w Pre-test probability of CAD should be measured using 
the Diamond and Forrester (1979) algorithm
w Where pre-test probability is measured by clinical 
assessment alone as >90%, this may permit a diagnosis 
of angina caused by CAD
w Where pre-test probability is measured by clinical 
assessment alone as <10%, this may permit a diagnosis 
of non-anginal chest pain and alternative causes for 
chest pain should be explored. 
w Where pre-test probability is intermediate (between 10% 
and 90%) either functional or anatomical testing may 
help confirm or exclude a diagnosis of CAD. The guide-
line development group make clear however that demon-
strable myocardial ischaemia (functional testing) or 
demonstrable obstructive CAD (anatomical testing) is 
neither necessary nor sufficient for a diagnosis of angina.
These suggestions are echoed in published guidance 
elsewhere in the United Kingdom (Scottish Intercollegiate 
Guidelines Network (SIGN), 2007), which state that diag-
nosis of angina caused by CAD can often be made on the 
basis of the clinical history alone. They reinforce that 
although a number of scoring systems are available to 
assess patients with chest pain and stable angina, an accu-
rate clinical assessment is of key importance.
Where the guidelines do differ however (bearing in 
mind that the NICE document is a consultation version 
only) is in the area of diagnostic testing. SIGN (2007) rec-
ommends that:
Patients with suspected angina should usually be 
investigated by a baseline electrocardiogram and an 
exercise tolerance test 
The draft NICE guidance (NCGC, 2009) on the other 
hand recommends that clinicians:
Do not use the exercise ECG as the primary diag-
nostic test for myocardial ischaemia in people with-
out known CAD
This is a significant difference and requires further 
discussion.
Exercise ECG testing in the diagnosis of 
stable CAD
The exercise ECG has been widely used across the world 
as a screening procedure for the assessment of cardiac 
status since the 1960s (Curzen et al, 1996). 
Even very early into its widespread use however it has 
been the subject of controversy, with investigators ques-
tioning its utility in women (Sketch et al, 1975), the eld-
erly (Curzen et al, 1996), specific ethnic groups (Lear et al, 
1994), patients with co-existing valvular heart disease 
Chest pain is classified by the following criteria:
1. Precipitation by exercise
2. Brief duration
3. Prompt relief by rest or nitroglycerine
4. Substernal location
5. Radiation from chest to jaw, left arm or neck
6. Absence of other causes of pain
Typical angina pectoris  Criteria 1–3 positive
 Any four criteria positive
Atypical chest pain Criteria 4–6 positive
 Any two criteria positive
Non-anginal chest pain Only one criterion positive
Adapted from Patterson and Horowitz, 1989
Table 1. 
Categorization of chest pain
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(Aronow and Harris, 1975) and patients taking digoxin 
(Mooss et al, 1991).
The primary concern regarding exercise ECG testing 
lies in the sensitivity and specificity. 
Sensitivity is a measure of the proportion of true posi-
tives which are correctly identified by the test (Altman and 
Bland, 1994) i.e. 100% sensitivity of the exercise ECG 
would mean that 100% of patients with CAD would have 
a positive test. In this ideal world, every patient with a 
negative ETT could be confidently ‘ruled-out’ for CAD.
Specificity is a measure of the proportion of true nega-
tives which are correctly identified by the test i.e. 100% 
specificity of the exercise ECG would mean that 100% of 
patients without CAD would have a negative test.
Detrano et al (1989) performed a meta-analysis of 60 
studies containing 12 030 patients and found reported 
sensitivities of 41–100% (mean 81%) and specificities of 
17–100% (mean 66%) for the exercise ECG. As an exam-
ple, extrapolation of Detrano et al’s meta-analysis to the 
definitions above would result in 81/100 patients with 
CAD having a positive exercise ECG (19% ‘false-nega-
tive’), and 66/100 patients without CAD having a negative 
ETT (34% ‘false-positive’).
In Curzen et al’s study (1996) the exercise ECG was a 
misleading predictor of the presence or absence of CAD in 
36% of women, with a sensitivity of only 56% and and 
specificity of 33% in women aged over 52 years with three 
or more risk factors for CAD. This would mean that the 
majority of exercise ECG results in this cohort of patients 
are misleading. 
This is made all the more important by the findings of 
the more recent work of Sekhri et al in London (2007) 
who found that patients continue to be discharged from 
the RACPC with an incorrect diagnosis of ‘non-cardiac 
chest pain’ and that those diagnosed with non-cardiac 
chest pain account for up to a third of patients who subse-
quently die from cardiovascular disease or suffer an acute 
coronary syndrome over 5 years of follow-up.
What are the alternatives?
There have been large strides in the development of, evi-
dence-base for, and application of non-invasive imaging 
techniques for the functional and anatomical assessment of 
CAD. Pooled analysis of over 800 patients (Schroeder et al, 
2007) indicates a sensitivity of 89% and specificity of 96% 
for 64-multidetector computed tomography (CT) in com-
parison with the gold standard of invasive coronary angiog-
raphy. According to Achenbach (2006) the most promising 
application of this technology is in the evaluation of stable 
patients with possible coronary artery disease.
The NCGC (2009) consultation document describes a 
plethora of non-invasive investigations including CT cor-
onary calcium scoring, CT coronary angiography, myo-
cardial perfusion scintigraphy, stress echocardiography, 
contrast-enhanced magnetic resonance perfusion imag-
ing, and several more. While at first this list may seem 
overwhelming, the guidelines group provide an eloquent 
description of how these tests may be best used, based on 
evidence-base, patient preference, resting ECG abnor-
malities, co-morbidity and, perhaps most importantly, 
assessment of pre-test probability of CAD based on the 
presenting clinical history. 
There are many reports of cardiovascular nurses special-
ising in non-invasive cardiac imaging in the United 
Kingdom (Royal Brompton and Harefield NHS Foundation 
Trust, 2009) and further afield (Àvila et al, 2003). 
‘Nurse-led’ cardiac perfusion imaging is now wide-
spread across the UK, although there is little in the peer-
review literature describing these services.
Translation to contemporary practice
The journey to today’s position whereby there are many 
chest pain services (whether for acute or stable chest pain) 
led by cardiovascular nurses was not straightforward. The 
position of nursing in the multidisciplinary cardiovascular 
team, education and training, pay and conditions, credi-
bility and validity, and inter-collegial relationships have all 
been tested en-route. Although not by explicit intent the 
role of nurses assessing patients with stable chest pain, 
generally in the rapid access chest pain clinic (RACPC), 
has in the majority of centres involved interpretation and 
application of the results of an exercise ECG. However 
even in one of the first published papers describing ‘nurse-
led’ RACPCs, Pottle (2005) questioned the prognostic 
value of exercise ECG testing, and described a move to 
non-invasive anatomical testing. 
If for evidence-based and valid reasons, the type of 
investigations performed  on these patients is set to change 
significantly, it is crucial that nurses assessing these 
patients evolve accordingly. This will of course mean a 
critical appraisal and evaluation of the evidence and 
guidelines. It will also however mean maintaining a focus 
on the point made in this article—the diagnosis of angina 
caused by CAD can be made solely on the basis of the 
presenting history. This will be a test. However, if cardio-
vascular nurses wish to claim the role of ‘clinician,’ it is a 
test very much worth taking.
Key Points
w There is a dearth of literature describing the training in or quality of 
clinical history-taking among cardiovascular nurses
w Recent publications and forthcoming national guidance will re-
emphasize the importance of clinical history taking
w The diagnosis of angina pectoris can be made solely on the basis of 
the presenting patient history
w Evolving guidance will discourage clinicians from using the exercise 
ECG as the primary diagnostic test for myocardial ischaemia 
w If cardiovascular nurses are to claim the role of ‘clinician’, critical 
appraisal and preparation for the resultant shifts in practice will be 
crucial.
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The cardiology nurse consultant 
in Scotland
development of consultant nurse posts, 
each with defined leadership functions and 
responsibilities, marks a significant bench-
mark in progressing clinical leadership in 
Scotland.’ At the time of writing, Scotland 
has 38 consultant nurses in post, 3 consult-
ant midwives and 11 consultant allied 
health professionals (AHPs), with approxi-
mately 40 enrolled in a succession plan-
ning development pathway. This compares 
with a ministerial target of 54 posts by 2007 
(O’Dowd, 2004).
Booth et al (2006) conducted a postal 
survey of all 16 consultant nurses and con-
sultant midwives in Scotland at the time. 
Of the 13 responses, they found that the 
mean time from RN/RM qualification to 
consultant appointment was 19.6 years, 
with 5 of the 13 posts being joint clinical/
academic posts. The mean salary was 
£40 000 (2003/4) and two-thirds of 
respondents continued to deliver direct 
patient care. Key emerging themes centred 
around role confusion ‘manifesting as a 
lack of clarity and understanding of the 
role among colleagues within the organiza-
tion and the consultant nurse/midwives 
themselves.’ (Booth et al, 2006: 87). This 
view was reinforced by Graham’s recent 
paper (2007) which concluded that the bat-
tle for consultant nurses to find achieve-
ment and acceptance will be made easier if 
the role is better understood. 
Cardiology context
Scotland’s Coronary Heart Disease Strategy 
states that ‘The development of nurse and 
AHP consultant posts would support local 
initiatives and could be pivotal in develop-
ing the non-medical contribution to CHD 
service developments’ (SEHD, 2002: 20). 
The subsequent National Advisory 
Committee for CHD report on cardiology 
services expands on this and makes a rec-
ommendation that ‘The Scottish Executive 
Health Department should invest in the 
expansion of nurse consultants, ensuring 
that the role of the nurse consultant in 
cardiology is developed.’ (MacIntyre, 
March 2006, personal communication).
Scott McLean
The Royal Infirmary of Edinburgh is South-
East Scotland’s major tertiary cardiology 
centre, serving a potential tertiary popula-
tion of 2.1 million people, and local emer-
gency/acute receiving population of around 
350 000–400 000. The state-of-the-art 
centre has an emergency department, 58-
bed acute receiving unit, 10-bed coronary 
care unit (CCU), 49 inpatient cardiology 
beds, 33 day case cardiology beds, 3 cardiac 
catheterization laboratories, 10 cardiolo-
gists, 11 visiting regional cardiologists, 
around 100 cardiology nurses and 15 spe-
cialist nurses in chest pain, cardiac rehab-
ilitation, heart failure and research.
The post of Nurse Consultant in Acute 
Cardiology was filled in July 2007 and is an 
NHS post with part funding from the local 
managed clinical network for coronary 
heart disease. Given the views of Graham 
(2007) I have strived to make this post as 
transparent as possible. 
I have constructed a job plan based on 10 
sessions per week, distributed as 40% 
expert clinical practice/caseload in the 
rapid access chest pain clinic (RACPC), 
20% leadership and service development, 
20% research, 10% education and training 
and 10% administration. From this I have 
developed a 12-month workplan detailing 
specific (measurable) objectives to achieve. 
This workplan has been widely distributed 
and can be easily accessed by colleagues of 
all grades, from a band 5 staff nurse in the 
Scott McLean, Catherine Mondoa and Frances Divers describe their roles as nurse consultants 
working in cardiology in Scotland, against the background of the Scottish Executive’s targets for 
increasing the number of such posts
In September 1999, Scotland’s Health Minister announced 12 centrally-funded consultant posts for nurses and invited 
bids from individual boards (Anonymous, 
1999). Twelve months later, with only three 
appointees in post, the minister reiterated 
the announcement (Anonymous, 2000) 
and detailed the specialties to which the 
remaining nine posts would be allocated: 
paediatrics, emergency receiving, cancer 
care, older people, mental health, sexual 
health, public health and epidemiology.
By 2004 the Royal College of Nursing, 
concerned at the lack of impetus, suggested 
that each of Scotland’s 12 health boards 
should have at least one consultant nurse 
specialising in each of the areas of paediat-
rics, older people, primary care, mental 
health, cancer and ‘heart care’. This was 
rejected by the Health Minister, on the 
grounds that ‘statutory minimums is not 
the approach we are adopting…the next 
step is to evaluate the work the nurses are 
doing. There seems to be enough evidence 
that specialists are good for patients’ 
(Anonymous, 2004).
Controversy erupted later in 2004 when 
the retiring Chief Nursing Officer heavily 
criticized the Scottish Executive Health 
Department (SEHD) over the lack of con-
sultant nurses. At the time there were fewer 
than 30 posts across Scotland, compared 
with more than 800 posts in England and 
Wales. She told nurses at conference to ‘Go 
and rattle some cages. Get more of them’ 
(Trueland, 2004). The Scottish administra-
tion responded that creating more consult-
ant nurse posts would be a priority for the 
incoming Chief Nursing Officer (Trueland, 
2004).
Implementation 
The most recent version of Scotland’s nurs-
ing strategy—Delivering care, Enabling 
Health (SEHD, 2006a)—has a clear aim for 
consultant level nursing in Scotland: ‘The 
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the first few hours of the patient journey, 
and to develop transparency in critical 
appraisal of the role and its benefits.
 
Catherine Mondoa
Serving a population of just less than 
300 000, NHS Forth Valley is a single 
integrated system comprising acute 
hospital services and community-
based services delivered through three 
community health partnerships. Although 
the local healthcare strategy has proposed 
the development of a new acute hospital, 
at present acute in-patient services are 
delivered in Stirling Royal Infirmary. 
Emergency services incorporate an 
emergency department and clinical 
assessment unit. In addition, there is a 
36-bed acute medical receiving ward, 
6-bed coronary care unit and medical 
ward designated for cardiology patients. 
Patients requiring coronary intervention 
are transferred to tertiary centres in both 
the East and West of Scotland.
Although my main focus is on develop-
ing cardiac rehabilitation and secondary 
prevention services for people affected by 
heart disease, primarily with a diagnosis of 
acute coronary syndrome or heart failure, I 
am able to exert an influence on the entire 
cardiac patient journey. The post involves 
working closely with the acute services 
team and cardiac managed clinical net-
work. Collaboration across organizational 
boundaries is one of the key objectives in 
the SEHD consultation document Better 
Care, Better Health (SEHD, 2007). 
I have been in post for just over a year 
and during this time I have received inval-
uable support from colleagues and the 
organization as a whole. The importance of 
organizational support and commitment 
in maximising the benefits of the nurse 
consultant’s position has been highlighted 
by the work of Woodward et al (2006). 
My role, which incorporates expert 
clinical practice in the above specialties, 
also embraces a close working relationship 
with an enthusiastic multidisciplinary car-
diac rehabilitation team that includes 15 
specialist nurses. In a paper discussing the 
challenges facing consultant nurses Coady 
(2003) advocates that consultant nurses 
should work as part of multidisciplinary 
teams if real improvements in patient out-
comes are to be realized. Certainly working 
in a team provides an ideal opportunity to 
engage in the empowerment of others, 
another important goal which emerged 
from Woodward et al’s (2006) research, as 
well as elsewhere (Williams et al, 2001; 
Jarman, 2007). 
Involvement in education and training is 
an important aspect of empowering col-
leagues. I have been a visiting university 
lecturer and I am currently engaged in the 
local promotion of post-registration 
education and continuous professional 
development. In order to fulfil the local 
strategic plan for coronary heart disease 
and cardiac services I am working along-
side clinical colleagues from both acute 
and primary care, seeking to identify edu-
cation and training needs of staff. In both 
care settings, competencies based on 
national frameworks are being introduced. 
Besides the benefit to the individual, invest-
ing in knowledge and skills is also key to 
improving services for patients.
This post presents an opportunity to 
truly affect local service development and 
delivery. It also maintains the link with 
research and evaluation. Involvement in 
strategic planning at local, regional and 
national levels also permits me to make a 
contribution towards the future shape of 
health services. 
Frances Divers
St John’s Hospital in Livingston is a busy 
district general teaching hospital serving a 
population of approximately 170 000. 
Patients with chest pain are admitted to 
cardiology either through the emergency 
department or via GP referrals. There are 
36 admission beds incorporating 6 high 
dependency/coronary care beds. Patients 
CCU to the director of nursing at health 
board level. 
I see this post as primarily focusing on 
the period between a patient being referred 
by (or self-referring from) primary care to 
the first 12 hours of hospitalization. This 
covers both scheduled and unscheduled 
care, ranging from GP referrals to RACPC, 
to primary percutaneous coronary inter-
vention (PPCI) in ST-segment elevation 
myocardial infarction (STEMI). As the 
RACPC here is reasonably well-established, 
much of my time is spent developing reper-
fusion services for STEMI which have 
evolved from in-hospital thrombolysis, 
through pre-hospital thrombolysis to a 
hybrid strategy of time-based reperfusion 
decision-making, involving ambulance 
paramedics and coronary care nurses. This 
optimal reperfusion initiative centres 
around the Scottish Intercollegiate 
Guidelines Network recommendation that 
‘patients with ST elevation acute coronary 
syndrome should be treated as soon as pos-
sible with PPCI, however, where PPCI can 
not be provided within 90 minutes of diag-
nosis, patients should receive immediate 
thrombolytic therapy’ (SIGN, 2007: 13). 
The nurse consultant role has been to cre-
ate a service allowing ambulance paramed-
ics and CCU nurses to communicate in an 
effective manner, facilitating an optimal 
reperfusion service. 
This clinical arena has given rise to a 
number of research interests. I am involved 
in several studies currently in progress (or 
at the planning stage) looking at pre-hospi-
tal thrombolysis in STEMI, decision-mak-
ing by ambulance paramedics, analysis of 
pre-hospital 12-lead ECGs transmitted via 
telemedicine and pre-test/post-test proba-
bility scoring in the RACPC.
My educational activities include playing 
a key role in the division’s advanced 
nursing practice agenda. This involves 
being part of the core development group, 
writing the cardiology-specific part of the 
curriculum and delivering course content.
While this role is relatively new, it has a 
key part to play in the development of 
cardiology nursing and services in Scotland. 
I see it as vital to focus on patient care in 
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I see it as vital to  
focus on patient care 
in the first few hours 
of the patient journey
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This post presents an 
opportunity to truly 
affect local service 
development and  
delivery
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requiring invasive intervention are 
transferred to the tertiary centre at the 
Royal Infirmary of Edinburgh. 
The cardiology staff at St John’s consists of 
one consultant cardiologist with visiting 
consultant cardiologist cover at weekends, 
one visiting consultant cardiologist for 1 
session of clinic work per week, 1 cardiology 
nurse consultant, 3 chest pain/cardiac reha-
bilitation rotational nurses, 1 heart failure 
nurse and 2 part-time research nurses.
I have been in post since February 2005. 
My role is developing continuously but the 
primary aim remains constant: to provide 
expert care for patients with acute coro-
nary syndromes and to give professional 
leadership and a consultancy function for 
cardiac services across the region.
Over the past two years I have main-
tained my clinical practice by carrying my 
own caseload through the RACPC, accept-
ing referrals from GPs and areas within the 
hospital. This service allows GPs access to 
the RACPC for advice regarding potential 
patients with coronary heart disease. I have 
continued to develop the post-myocardial 
infarction clinic, expanding it to capture 
patients who have undergone PCI. Much 
of my clinical work is based in the acute 
admissions area where acute coronary syn-
drome patients are managed. Being based 
in the CCU gives me the opportunity to 
strengthen the nursing and medical contri-
bution to patient care in the assessment 
and management of this population. The 
nurse consultant role has enabled me to 
exercise leadership, set standards and work 
towards best practice. A major part of my 
role has been to develop, adapt and imple-
ment protocols and guidelines in relation 
to a recent redesign of cardiac services 
across the region.
Much of my educational work is local 
multidisciplinary teaching of nurses, medi-
cal students and junior doctors. I am 
involved with the institutes of higher edu-
cation, teaching on postgraduate and 
undergraduate cardiac courses and influ-
encing curriculum content and course 
design. My special interests are in cardiac 
rehabilitation and the care of patients with 
chronic cardiology problems. I have been 
responsible for leading and conducting a 
number of qualitative/quantative studies 
within the field of cardiac rehabilitation 
which have led to several service improve-
ments, gaining three Government Charter 
Mark awards for excellence. 
Liaison with clinical teams in primary 
and secondary care allows me to promote 
an integrated approach to care, and to 
explore joined-up ways of dealing with 
shared issues, e.g. addressing repeated 
readmissions in complex patients.
The introduction of nurse consultants 
has created much debate ranging from the 
title of the post to the roles and function. It 
is vital that we remain focused—arguably 
the important objective of this role is 
retaining experienced practitioners in 
clinical areas. With the growing number of 
nurse consultants across Scotland there is 
increased potential to influence the way 
healthcare is delivered. 
The future
The three posts described here have differ-
ing expert practice, research, education, 
and service improvement components. 
Although not by design, this is advanta-
geous. There should be no desire or man-
date to make these posts generic. It should 
be left to the individuals to shape them as 
they see fit depending on the particular 
strategic and operational environment in 
which they practice. 
What is key for patients, national 
colleagues and healthcare planners is to 
have a Nurse Consultant in Cardiology 
with a special interest in every component 
of patient journey, through specialist out-
patient work to pre-hospital cardiology, 
front-door assessment of chest pain, STEMI 
and reperfusion, inpatient risk stratifica-
tion and intervention, cardiac rehabilita-
tion, follow-up clinics and back to special-
ist outpatient work.
The future of cardiology is set on two 
parallel paths. The first is towards improv-
ing the care of people with long-term con-
ditions, with an increased focus on antici-
patory care. Promoting self-care and 
empowerment through education and sup-
port is an intrinsic part of this. The second 
is the ever-narrowing ‘super-specialization’ 
of acute specialist inpatient services and 
regional programmes. 
It is vital that cardiology nursing is repre-
sented at the discussion table when key 
strategic and service-delivery decisions are 
made. The cardiology nurse consultant, 
with an influential foot in all camps, is 
ideally placed to achieve this.
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An audit was conducted by Greater Manchester and Cheshire
Cardiac and Stroke Network in 29 GP practices, on ECG received
between November 2006 and November 2007, to document the
level of satisfaction and the number of avoided referrals to
secondary care with using this service.
Results: Out of the 24 541 12-lead ECG, 15 698 patients were
symptomatic. The recommended plans of action were GP assess-
ment: 87.5%, cardiology referral: 6.5%, and emergency department
referral: 6%. In the 8843 asymptomatic cases, GP assessment was
recommended in 96.3%. The one-lead ECG was performed in 805
cases, GP assessment was advised in 96% of symptomatic patients
and 99% of asymptomatic patients. In the satisfaction audit, 60% of
the forms were returned (20 practices). Of the 29 GP practices, 17
had their ECG previously reported by their local NHS Trust, which
resulted in significant delay in receiving the reports of 1–60 days.
With the adoption of the telemedicine service, all ECG were
reported within 2 h of their receipt. Satisfaction level question-
naires were filled by 20 GP practices. All were either ‘‘very satisfied’’
or ‘‘satisfied’’ with the service (including the accuracy and speed of
ECG interpretation). Secondary care referrals were prevented in up
to 65.8% of the total cases (95% CI 61.6% to 65.8%). The
extrapolated gross savings derived was in excess of £300 000.
Conclusions: Telemedicine and wireless ECG interpretation can
enhance the practice by extending the medical consultation from GP
practices to a specialist ECG centre. This can ultimately broaden the
overall standard of patient care and potentially save time and money.
056 DECISION MAKING BETWEEN NURSES AND PARAMEDICS IN
REPERFUSION OF ST ELEVATION MYOCARDIAL INFARCTION
SM Mclean, ADF Flapan. The Edinburgh Heart Centre, Edinburgh, UK
Introduction: To describe a reperfusion programme in ST
elevation myocardial infarction (STEMI) based around prehospital
decision-making between coronary care unit (CCU) nurses and
ambulance paramedics.
Methods: Experience began in 2004 with nurses and paramedics
discussing 12-lead electrocardiograms (ECG) transmitted from the
ambulance to the CCU. This programme involved CCU nurses
providing support to paramedics considering prehospital thrombo-
lysis (PHT). The programme evolved in 2006 to include primary
percutaneous coronary intervention (PCI). Based on a 90-minute
diagnosis-to-PCI balloon time, nurses and paramedics now make a
joint decision on whether patients with STEMI should recieve
either PHT or primary PCI, based on clinical history, ECG findings,
travel time from hospital and availability of PCI facilities.
Results: Between 1 December 2006 and 31 August 2008 primary
PCI was the treatment for 70% of patients (526/751), with PHT
administered to 1.5% (11/751) and inhospital thrombolysis to 5.9%
(44/751). The mean length of hospital stay was 3.5 days for primary
PCI patients and 5.9 days for all comers. Although non-randomised
data, inhospital and 30-day mortality are significantly reduced in
the primary PCI group at 3.2% and 4.7%, respectively. The 90-
minute diagnosis-to-PCI balloon inflation was achieved in 64% of
primary PCI cases (77% in in-hours cases and 45% out-of-hours).
The median door-to-PCI balloon time was 53 minutes. No
reperfusion therapy was administered to 14.2% of patients (107/
751) with a discharge diagnosis of STEMI over the 21 months of the
optimal reperfusion programme. This compares favourably with
141/487 (29%) in the first 12 months of the PHT programme, 89/
438 (20%) in the second 12 months of the PHT programme and
with the GRACE registry, which reported sustained rates of no-
reperfusion in up to 29% of patients with STEMI. The on-call team
were called for primary PCI on three occasions in which the patient
did not undergo primary PCI. All three of these patients had
widespread coronary disease with no occlusive thrombus. None had
normal coronary arteries.
Conclusions: Using prehospital 12-lead ECG transmission, CCU
nurses and ambulance paramedics can safely and effectively decide
on the most appropriate reperfusion therapy for patients with
STEMI. There are no other reported data of nurses and paramedics
operating in this way and despite the single-centre observational
nature of the data, this system of care appears to have a positive
predictive value worth further exploration.
057 6-MONTH HEALTH-RELATED QUALITY OF LIFE IN ST ELEVATION
MYOCARDIAL INFARCTION PATIENTS FOLLOWING
THROMBOLYSIS OR PRIMARY PERCUTANEOUS CORONARY
INTERVENTION
1CS Rogers, 2L McGowan, 1H Iles-Smith, 3C Dickens, 1F Fath-Ordoubadi. 1Manchester
Heart Centre, Central Manchester and Manchester Children’s University Hospitals NHS
Trust, Manchester, UK; 2School of Nursing, Midwifery and Social Work, University of
Manchester, Manchester, UK; 3School of Community-based Medicine, University of
Manchester, Manchester, UK
Introduction: Difficulty with psychological adjustment post ST
elevation myocardial infarction (STEMI) has been reported in as
many as 40% of patients. The process of rehabilitation, recovery
and the time taken to return to work can be adversely affected.
Treatment such as primary percutaneous coronary intervention
(PPCI) or thrombolysis (lysis), can also influence post-STEMI
rehabilitation and recovery. At present few published data are
available evaluating the health-related quality of life (HR-QoL) for
lysis and PPCI patients. The purpose of this cohort study is to
ascertain predictors of physical health status in STEMI patients
receiving lysis or PPCI for future service provision and adaptations.
Methods: A total of 430 STEMI patients will be recruited (200 lysis
and 230 PPCI) across the Manchester conurbation; the study is in
the recruitment phase at present. Four self-report questionnaires
including the ENRICHD social support instrument (ESSI), the
hospital anxiety and depression scale (HADS), the medical out-
comes study Short Form 36 (SF-36) and the brief illness perception
questionnaire will be collected at baseline, 6 and 12 months.
Further data including demographics, relevant medical history and
index treatment details are also recorded.
Results: Six-month interim data are available for 179 patients (94
lysis and 85 PPCI). Participant demographics are: lysis group 80%
male, mean age 61 years (38–90; SD 12.5) and PPCI group 72% male,
mean age 60 years (37–83; SD 11.2). Baseline data analysis showed no
differences on the ESSI, HADS and aspects of the SF-36 between the
two groups. Physical component scores of the SF-36, 6-month data
were analysed using regression analyses and showed baseline levels of
anxiety, depression, education level and several quality of life
indicators significantly predicted physical components of HR-QoL.
Conclusions/Implications: Analyses for interim data show no
significant difference between treatment groups on a range of
psychosocial variables at baseline. However, patients’ own self-
rating of their physical HR-QoL at 6 months was predicted by
quality of life and levels of psychological distress measured at
baseline. The findings show that a subgroup of patients post-
STEMI may benefit from targeted psychosocial interventions in
order to maintain their quality of life and aid recovery over time.
058 A QUALITATIVE STUDY OF THE EXPERIENCES OF MYOCARDIAL
INFARCTION PATIENTS WHO REPRESENT POST-PRIMARY
PERCUTANEOUS CORONARY INTERVENTION
1HM Iles-Smith, 2L McGowan, 1C Rogers, 1F Fath-Ordoubadi, 3C Dickens, 2C Deaton.
1Manchester Heart Centre, Central Manchester and Manchester Children’s University
Hospital, Manchester, UK; 2School of Nursing, Midwifery and Social Work, The
University of Manchester, Manchester, UK; 3School of Community Based Medicine, The
University of Manchester, Manchester, UK
Introduction: The current gold standard treatment for ST
elevation myocardial infarction (STEMI) is primary percutaneous
BCS abstracts
Heart 2009;95(Suppl I):A1–A87 A35
 on 20 July 2010 heart.bmj.comDownloaded from 
Abstracts of the 9th Annual Spring Meeting on Cardiovascular Nursing / European Journal of Cardiovascular Nursing 8 (2009) S1–S52 S23
(r=0,474, p=0,010) and the Payen scales (r=0,562, p=0.004). Signiﬁcant
differences were detected in SP levels in AMI patients compared to con-
trols (M=-199,97 pg/ml, p=0,04). In the coronary patients’ group, average
serum substance P levels while in pain were 195,27±181,1 pg/ml, and those
in controls were 113,52±76,32 pg/ml. Serum SP levels were signiﬁcantly
different among patients with different primary diagnoses (ANOVA, df=3,
F=4,615, p=0,013).
Conclusions: The observation of elevated SP serum levels in coronary
critical care patients and of associations with subjective pain perception and
pain scale scores may have important clinical implications. Further study
is needed to elucidate the merits and feasibility of SP measurements as a
biochemical “pain detector” in critical care
FP35
Use of behavioral pain scales in coronary and critical care patients.
A comparative validation study
E. Kletsiou1, M. Mpouzika2, E.D.E. Papathanassoglou3
1University Hospital Attikon, Athens, Greece; 2General Hospital
G. Gennimatas, Athens, Greece; 3University of Athens, Athens, Greece
Purpose: Pain management is a complex problem in critical care, due
to limitations in pain assessment. Behavioral pain scales are employed in
non-communicating critically ill patients, but their validity is difﬁcult to
be assessed, whereas they have not been applied in patients with coronary
pain. Concomitant pain ratings in communicating and non-communicating
critically ill patients may elucidate the metric properties of behavioral pain
scales.
This study explored and compared the applicability, reliability and valid-
ity of the Greek version of two behavioral pain scales (Payen 2001, Puntillo
1997) in coronary and trauma critical care patients.
Methods: The scales were translated, back-translated and validated by an
expert panel. A convenience sample of 24 coronary critical care patients and
of 36 intubated trauma patients was followed up for 3 days. Validity was
explored through associations with the numeric visual analogue scale (VAS),
administered to both groups of patients, when able to self-report pain, and
nurses. Test-retest reliability and inter-rater reliability were assessed (n=10
nurses).
Results: In both patients’ groups, a strong positive correlation was detected
between nurses’ ratings at the Puntillo (1997) scale and patients’ (r=0.6-
0.92, p<0.002), as well as nurses’ (r=0.57-0.66, p<0.003) VAS ratings. A
consistent association was observed with nurses’ ratings at the Payen (2001)
scale (r=0.57-0.85, p<0.004). In coronary care patients, there was a strong
positive association between the Payen score and patients’ VAS ratings
(r=0.67, p<0.0001), as well as nurses’ VAS ratings (r=0.67, p=0,000). In
intubated patients, a strong positive association was found only between
the Payen score and nurses’ VAS ratings (r=0.85, p<0.0001). Test-retest
reliability (r=0.93) and inter-rater reliability (r=0.81, McNemar test p>0.1)
were adequate.
Conclusion: Behavioral pain scales may be useful for pain assessment in
coronary patients, as well as in non-communicating critical care patients.
The Greek versions of these tools appear reliable and valid.
FP36
Decision making between nurses and paramedics in reperfusion of ST
elevation myocardial infarction
S. McLean
Bonnyrigg, United Kingdom
Purpose: To describe a reperfusion programme in ST Elevation Myocardial
Infarction (STEMI) based around pre-hospital decision-making between
Coronary Care Unit (CCU) Nurses and ambulance paramedics.
Methods: Experience began in 2004 with nurses and paramedics discussing
12-lead electrocardiogram’s (ECG’s) transmitted from the ambulance to
the CCU. This programme involved CCU nurses providing support to
paramedics considering pre-hospital thrombolysis (PHT). The programme
evolved in 2006 to include Primary Percutaneous Coronary Intervention
(PPCI). Based on a 90-minute diagnosis-to-PCI balloon time, nurses and
paramedics now make a joint decision on whether or not patients with
STEMI should recieve either PHT or PPCI, based on clinical history, ECG
ﬁndings, travel time from hospital and availability of PCI facilities.
Results: Between 1st December 2006 and 31st August 2008 PPCI was the
treatment for 70% of patients (526/751), with PHT administered to 1.5%
(11/751) and in-hospital thrombolysis to 5.9% (44/751). Mean length of
hospital stay was 3.5 days for PPCI patients and 5.9 days for all-comers.
Although non-randomised data, in-hospital and 30-day mortality are sig-
niﬁcantly reduced in the PPCI group at 3.2% and 4.7% respectively. The
90-minute diagnosis-to-PCI balloon inﬂation was achieved in 64% of PPCI
cases (77% in in-hours cases and 45% out-of-hours). Median door-to-PCI
balloon time was 53 minutes. No reperfusion therapy was administered to
14.2% of patients (107/751) with a discharge diagnosis of STEMI over
the twenty-one months of the optimal reperfusion programme. This com-
pares favourably to 141/487 (29%) in the ﬁrst twelve months of the PHT
programme, 89/438 (20%) in the second twelve months of the PHT pro-
gramme, and with the GRACE registry which reported sustained rates of
no-reperfusion in up to 29% of patients with STEMI. The on-call team were
called for PPCI on 3 occasions where the patient did not undergo PPCI.
All 3 of these patients had widespread coronary disease with no occlusive
thrombus. None had normal coronary arteries.
Conclusions: Using pre-hospital 12-lead ECG transmission CCU nurses
and ambulance paramedics can safely and effectively decide on the most
appropriate reperfusion therapy for patients suffering STEMI. There are no
other reported data of nurses and paramedics operating in this way and
despite the single-centre observational nature of the data, this system of care
appears to have a positive predictive value worth further exploration.
FP37
Gender differences in symptoms of myocardial ischaemia
M.H. Mackay, P.A. Ratner, C.E.H. Buller, J.L. Johnson
University of British Columbia, Vancouver, Canada
Background and Purpose: Better understanding of acute coronary syn-
drome (ACS) symptoms by all health professionals is needed to improve
diagnosis and timeliness of treatment. Nurses are often ﬁrst to assess symp-
toms of ischaemia, and are usually responsible for educating patients about
the nature of symptoms and appropriate actions to take, so this understanding
is particularly important for nursing. Prior research has suggested there are
gender differences in ACS symptoms, but has been plagued by methodolog-
ical ﬂaws. This study therefore sought to determine if gender differences
exist in reported symptoms of ACS, using PCI balloon inﬂation as a model
of myocardial ischaemia.
Methods: Consecutive patients having non-emergent PCI were prospec-
tively recruited. Exclusions were diabetes, haemodynamic instability, left
bundle branch block and total occlusion. Prior to PCI subjects answered
open-ended questions about symptoms that had led to PCI referral. Inﬂation
was maintained for 2 minutes or until a clinical reason to deﬂate occurred.
During inﬂation, subjects were questioned about current symptoms. ECG
data were collected prior to inﬂation and at deﬂation.
Findings: The ﬁnal sample was 305 (mean age 63.9 (±10.6); 39.7%
women). 83% had ECG-evident ischaemia during inﬂation. There were no
gender differences in rates of chest pain or typical ACS symptoms, regard-
less of ischaemic status, but women reported signiﬁcantly more symptoms
(though the statistical signiﬁcance of this difference did not persist in the
ischaemic subset).
Conclusions: This prospective study with ECG-afﬁrmation of ischaemia
suggests women and men have similar symptoms during ACS. However,
women, perhaps due to psychosocial factors, report more symptoms. Nurses
have a pivotal role to play in crafting educational messages for women (both
those with clinical disease and those at risk), so that they recognize that
